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Summary 
 
 Discovery of the function of oxidants as signaling molecules marks the 
beginning of the field of redox control of cell signaling. Understanding the 
mechanism of how free radicals regulate signaling is critical to distinguish between 
normal physiology and cellular toxicity both caused by reactive species. It is now 
known that free radicals influence various cellular processes by altering the function 
of critical proteins as a result of reversible oxidation of “reactive cysteine” within the 
proteins. Different types of oxidative modification such as S-nitrosylation, S-
glutathionylation, di-sulphide bond formation, sulphenic acid formation, have been 
proposed to mediate redox control of cell signaling. However, physiological relevance 
of these modifications is somehow missing. Furthermore, there has been a debate 
about relative importance of O2˙- versus H2O2 in mediating enhanced cell 
proliferation. Following up on our previous study that demonstrates that O2˙- activates 
survival kinase Akt through S-nitrosylation of the tumor suppressor PTEN, our 
current study deciphers the mechanistic aspect of how oxidative signal by O2˙- is 
transformed into nitrosative signal. We also provide evidence that physiologically 
relevant concentration of H2O2 predominately induces protein S-nitrosylation over 
non-SNO modifications. We demonstrate that protein S-nitrosylation induced by O2˙- 
and H2O2 is both mediated by common S-nitrosylating species, ONOO- although the 
pathways to formation of ONOO- are different in each case.  
 Moreover, we show that oxidation of proteins that occurs following incubation 
with PDGF, EGF and 10% FBS is by protein S-nitrosylation. Particularly in the case 
of PDGF, the growth factor does not generate a high level intracellular H2O2 
regardless of concentration of PDGF used and it consistently induces protein S-
	   viii	  
nitrosylation. Again, we find that the relevant S-nitrosylating species that mediates 
growth factors-induced protein S-nitrosylation is ONOO-. Removal of ONOO-
prevents protein S-nitrosylation as well as activation of Akt induced by O2˙-, H2O2 and 
PDGF demonstrating protein S-nitrosylation is of relevance to redox control of cell 
signaling.  
 We also highlight the consequences of disturbing O2˙-/NO˙ balance in cell 
signaling. On one hand, removal of NO˙ is effective in preventing S-nitrosylation but 
it increases the levels of intracellular O2˙- and H2O2 potentially causing oxidative 
stress with damaging consequences. On the other hand, we demonstrate the 
ineffectiveness of removing O2˙- alone to stop pro-survival signaling as the latter 
could continue by ONOO--independent but NO˙-dependent S-nitrosylation.  
 Lastly, we show that increased ROS and RNS production in breast cancer cell 
line (MCF7) correlate with sustained protein S-nitrosylation and Akt activation in the 
absence of serum. However, the prevalence of this finding still has to be tested in 
other types of cancers. We also find that protein S-nitrosylation and Akt activation in 
MCF7 is very stable requiring further studies on identifying the factors contributing to 
this stability.  
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CHAPTER 1: INTRODUCTION 
	  
1.1	   	  Biochemistry	  of	  Free	  Radicals	  
 
 The history of free radicals dates back to the time when oxygen was first 
recognized as a toxic gas in 1954 (Gershman R et al, 1954). Initially, it was suggested 
that toxic properties of oxygen could come from its direct inhibition of essential 
enzymes (Hauggard N, 1968), but subsequent findings revealed that these damaging 
effects are rather due to the action of oxygen-derived radicals (Glibert DL 1981). 
 A free radical can be defined as any species capable of independent existence 
that contains one or more unpaired electrons in atomic or molecular orbits (Halliwell 
B and Gutteridge JMC, 2007). It is this unpaired electron(s) that make(s) free radicals 
highly reactive, but the degree of reactivity varies widely among different radicals. 
Not all free radicals derive from molecular oxygen. There are many other types of 
non-oxygen derived free radicals made in living systems, namely; carbon-centre 
radicals such as CCl3˙, most transition metal ions with exception of zinc and some 
oxides of nitrogen such as NO˙ and NO2 (Halliwell B and Gutteridge JMC, 2007). 
 Current nomenclature of reactive species includes reactive oxygen species 
(ROS), reactive nitrogen species (RNS), reactive chlorine species (RCS), reactive 
bromine species (RBS) and reactive sulphur species (RSS).  Some reactive species 
belong to more than one category, for example, hydrobromous acid, HOBr is 
considered both as ROS and RBS, and peroxnitrite, ONOO- is referred to as both 
ROS and RNS.  Also note that “reactive species” is a collective term and they could 
either be radicals or non-radicals that are oxidizing agents easily convertible to 
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radicals (Halliwell B and Gutteridge JMC, 2007). Among reactive species, ROS and 
RNS have the widest range of biological functions and they are the main subjects of 
discussion throughout this thesis. Table 1 shows the list of ROS and RNS that are 
biologically important in living organisms.  
 
Table 1: Reactive Oxygen Species and Reactive Nitrogen Species 
 
 Reactive oxygen species    Reactive Nitrogen Species 
Radicals      Nonradicals   Radicals Nonradicals 
Superoxide (O2˙-),        Hydrogen peroxide (H2O2),    Nitric oxide (NO˙) Nitrous acid (HNO2),dinitrogen trioxide/tetroxide 
hydroxyl (OH˙), peroxyl,   hypochlorous acid (HOCl),    nitrogen dioxide (N2O3/N2O4), nitronium ion (NO2
+), peroxynitrite 
(RO2˙),alkoxyl (RO˙),        ozone (O3), singlet oxygen    (NO˙2)  (ONOO-), alkyl peroxynitrite (ROONO), 
hydroperoxyl (HO2˙)        (1ΔgO2), peroxynitrite     nitroxyl anion (NO-), nitrosyl cation (NO
+),  
                      (ONOO-)     nitryl chloride (NO2Cl) 
       (Adapted from Rigas B and Sun Y, 2008) 
	  
1.2	   	  Sources	  and	  Formation	  of	  Reactive	  Oxygen	  and	  
	   	  Nitrogen	  Species	  
 
 Reactive species are generated during irradiation by UV light, by X-rays and 
by gamma-rays or exist as pollutants in the atmosphere. In the biological systems, 
ROS are produced as by-products of mitochondria-catalyzed electron transport 
reactions or intentionally generated by neutrophils and macrophages during innate 
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1.2.1  Superoxide 
  
 The first byproduct of aerobic metabolism within mitochondria is superoxide 
(O2˙-). During the process of oxidative phosphorylation, a small number of electrons 
leak from the mitochondrial transport chain to oxygen prematurely, forming the 
oxygen free radical O2˙-. This leakage occurs mainly at complexes I and III (Cadenas 
E and Davies KJ, 2000). Another important source of O2˙- production is by stimulus-
induced activation of membrane-bound enzyme systems such as the NADPH oxidase 
complex (NOX). Superoxide generation by the NOX complex is deliberate and it was 
best characterized in phagocytic cells such as neutrophils that undergo a series of 
reactions called the respiratory burst in response to microorganisms or inflammatory 
mediators (Babio BM et al, 2002). The enzyme complex consists of six subunits- two 
membrane-bound components, p91phox, p22phox which together form cytochrome 
b558, the enzymatic centre of the complex, and four cytosolic proteins, p47phox, 
p67phox, p40phox and the small guanosine triphosphate (GTP)-binding protein Rac1 
and Rac2. This enzyme system was the first to disprove the rule that O2˙- was 
generated accidentally and served no particular cellular function. During the 1990s, 
the similar enzyme complex systems were found in various tissues other than 
phagocytes accounting for non-mitochondrial source of O2˙- production (Banfi B et al, 
2003; Cheng G et al, 2001; De Deken X et al, 2000; Edens WA et al, 2001; Geiszt M 
et al, 2000 & 2003; Lambeth JD et al, 2000). There are seven isoforms identified so 
far but the other six isoforms produce O2˙- at a fraction (1-10%) of the level produced 
in neutrophils by NOX2 (Lambeth JD, 2004 & 2007; Petry A et al, 2010). Tissue 
distribution of NADPH oxidase isoforms and their known regulators are summarized 
in the following table:  
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Table 2: Human NOX/DUOX enzymes 
 
       (Adapted from Lambeth JD, 2004) 
 
 NOX isoforms are homologues of gp91phox subunit that accounts for ROS 
generation. The regulation of gp91phox (NOX2) is well characterized (Groemping Y  
et al, 2003; Huang and Kleinberg, 1999; Vignais PV, 2002) but  little is known about 
the regulation of other isoforms. Generally, the catalytic component of NOXs 
responsible for generation O2˙- resides within the membrane structure whereas 
regulatory subunits scatter in the cytosol. Upon activation, cytosolic components are 
recruited to the membrane and form a mutually stabilizing complex with membrane 
catalytic subunits. The sequence of events leading to full activation of NOX is given 
for the prototypic isoform NOX2 in Figure 1.  
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        (Adapted from Lambeth, 2004) 
Figure 1: NOX2 (gp91phox) activation and generation of O2˙- in phagocytes 
At least three signaling cascades mediate the activation process. First, PI3K provides lipid 
docks for p40phox and p47phox to station in the membrane. Second, phosphorylation of 
p47phox by protein kinases such as PKC and Akt promotes its binding to p22phox by 
relieving autoinhibition in p47phox. Third, activation of guanine-nucleotide exchange results 
in active Rac-GTP, which then binds to p67phox for complete assembly of the holo enzyme 
for generation of O2˙-.  
 
 Other intracellular sources of O2˙- generation include xanthine oxidase 
(Fridovich I, 1970), NADPH cytochrome p450, lipoxygenase and cyclooxygenase 
(Goeptar AR et al, 1995) and the uncoupled nitric oxide synthase (Alderton WK et al, 
2001). However O2˙- generated from theses sources is associated with various 
diseased conditions such as hypertension and diabetes (Dixon LJ et al, 2003 & 2005; 
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1.2.2  Hydrogen Peroxide and Hydroxyl Radical 
 
 Hydrogen peroxide (H2O2) is produced directly in cells by several enzymes 
such as glucose oxidase (Bankar SB et al, 2009), xanthine oxidase (Kelley EE et al, 
2010) DUOX1, DUOX2 (Edens WA et al, 2001; Donkó A et al, 2005), and 
peroxisomes (Fritz R et al, 2007). And it is also derived from two molecules of O2˙- in 
a reaction called dismutation, which is accelerated by the enzyme, superoxide 
dismutase (SOD).  
O2˙- + O2˙- + 2H+ →  H2O2 + O2 
H2O2 interacts with O2˙- to generate highly reactive hydroxyl radical (OH˙) by the 
iron-catalyzed Haber-Weiss reaction as follows: 
  Fe3+ + O2˙- → Fe2+ + O2                (1) 
The second step is the Fenton reaction: 
Fe2+   + H2O2 → Fe3+ +	  OH− + OH˙             (2) 
Net reaction:  
  O2˙- + H2O2 → OH− + OH˙ + O2                        (3) 
In phagocytes, the enzyme myeloperoxidase produces HOCl from H2O2 (Anderson 
MM et al, 1999), which contributes to the inflammation of tissues during immune 
defense response.   
 
1.2.3  Nitric Oxide and its derivatives  
 
 Nitric oxide (NO˙) is a colorless gas that contains an unpaired electron on the 
anti-bonding 2π orbital, and thus is a radical. Since it is soluble in organic solvents, 
NO˙ can cross membranes and diffuse readily. NO˙ reacts slowly with most biological 
molecules. The removal of the unpaired electron results in nitrosonium cation, NO+ 
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whereas one-electron reduction gives nitroxyl anion, NO–. Both derivatives are more 
reactive than the parent NO˙ molecule (Stamler JS et al, 1992).  
 NO˙ is synthesized in biological tissues by the nitric oxide synthese (NOS) 
enzymes, which metabolize arginine to citrulline with the formation of NO˙ via five 
electrons oxidative reaction (Andrew PJ and Mayer B, 1999; Ortiz de Montellano PR 
et al, 1998). Synthesis of endogenous NO˙ is highly regulated by the activity of 
isoforms of nitric oxide synthase (NOS). There are three types of NOS. Neuronal 
NOS (nNOS or NOS1) and endothelial NOS (eNOS or NOS3) are constitutively 
expressed in nervous system tissues and endothelia cells respectively (Bredt DS et al, 
1990; Knowles RG et al, 1989; Palmer LA et al, 1988). Inducible NOS (iNOS or 
NOS2) was first identified in phagocytes in response to endotoxin or cytokines 
(Billiar et al, 1990; Marletta MA et al, 1988; McCall TB et al, 1989). While eNOS 
and nNOS require Ca2+ for their activation, iNOS enzymes are Ca2+ independent and 
upon induction, iNOS can generate highly localized concentration of NO˙ up to the 
micromolar range (Alderton W et al, 2001; Hauschildt S et al, 1990). NO˙ can also 
come directly from dietary nitrates and nitrite (Lundberg JO et al, 2009; McKnight 
GM et al, 1997 & 1998). Nitrite (NO2-) is the inert oxidative breakdown product of 
endogenous NO˙. It can be recycled back to bioactive NO˙ in blood and tissue and 
thus NO2˙- is thought to serve as part of NO˙ storage system in biological systems 
(Lundberg JO and Weitzberg E, 2005 & 2010). NO˙ storage system consists of free 
NO˙, NO2˙- and NO˙ adducts such as GSNO, protein-SNO and protein-bound 
dinitrosyl iron complexes. The most important NO˙ storage protein is S-nitroso-
haemoglobin (Hb-SNO) that travels throughout the body subserving NO˙ homeostasis 
(Angelo M et al, 2008; Martínez MC and Andriantsitohaina R, 2009; Muller B et al, 
2002).  
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 The most important NO˙ derived reactive nitrogen species is peroxynitrite 
(ONOO-) which is formed by the reaction of NO˙ with O2˙- at diffusion-controlled 
rates (∼ 1X1010 M-1. S-1) (Pacher P et al, 2007). The oxidant reactivity of ONOO- is 
highly pH-dependent and at physiological pH (pH 7.4), it has a very short half-life 
(∼10ms). ONOO- or its protonated form, peroxynitrous acid (ONOOH) reacts directly 
with various biomolecules or undergoes decomposition giving rise to peroxynitrite-
derived secondary radicals. The biochemistry of RNS is a complex process involving 
decomposition and recombination of individual RNS (Table 3) and occasionally 
involves bidirectional transition from one form to another. For example, dinitrogen 
trioxide N2O3 derived from reaction of NO˙ with molecular oxygen, O2 is a powerful 
S-nitrosylating agent resulting in formation of S-nitrosothiols (RSNOs) or S-
nitrosylated proteins (Grisham MB et al, 1999; Stamler JS and Hausladen A, 1998). 
Upon degradation, RSNOs in turn release NO˙ back to the NO˙ pool (Benhar M et al, 
2009). Similarly, once considered as a final metabolite of NO˙ together with NO3-, 
NO2- revert back to NO˙ particularly under hypoxic conditions by the action of 
xanthine oxidase (Martínez MC and Andriantsitohaina R, 2009). Decomposition of 
ONOO- gives rise to various RNS such as NO2-, NO2+, N2O3 and NO2˙ (Martínez MC 
and Andriantsitohaina R, 2009; Pacher P et al, 2007). (See chapter 4 for more details) 
Table 3: Major Reactive Nitrogen Species in Biological System 
 
 (Adapted from Martínez MC and Andriantsitohaina R, 2009) 
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1.3  EFFECTS OF REACTIVE OXYGEN AND NITROGEN SPECIES ON 
  CELLULAR STRACTURE AND SIGNALING 
1.3.1  Cellular Toxicity 
 
 Both ROS and RNS are known to cause damage to cell structures, nucleic 
acids, lipids and proteins. Their harmful effects are termed “oxidative stress” and 
“nitrosative stress” respectively. The primary ROS, O2˙- is not reactive itself. Only 
under stress conditions, an excess of O2˙- releases “free iron” from iron containing 
molecules, for example, (4Fe-4S) cluster-containing enzymes of dehydratase-lyase 
family. The released Fe2+ subsequently participates in Fenton reaction (Josef, 2007). 
In contrast, H2O2 reacts directly with transition metal centre of some heme-containing 
enzymes and thiolate of protein sulfhydryl (Forman HJ, 2004). OH˙ has a very high 
reactivity, with a very short half-life of approximately 10-9 s. It reacts indiscriminately 
with biomolecules close to its site of formation. (D'Autréaux B  and Toledano MB, 
2007; Riley, 1994). Toxicity associated with ROS in general and H2O2 in particular is 
mainly accounted for by excessive generation of OH˙ (Koppenol WH, 2001). OH˙ 
reacts with all components of the DNA molecule, damaging both purine and 
pyrimidine bases and the deoxyribose backbone (Halliwell B and Gutteridge JMC, 
2007). The formation of highly mutagenic oxidative product 8-OH-G by the hydroxyl 
radical represents the initial step in free radical induced carcinogenesis (Valko M et 
al, 2004; Wiseman H and Halliwell B, 1996). Alternatively, OH˙ can initiate a free 
radical chain reaction called “lipid peroxidation” by reacting with polyunsaturated 
fatty acid in the cell membrane with the final product being malondialdehyde (MDA) 
(Marnett LJ, 2002; Wang M et al, 1996). MDA reacts with nucleoside bases of DNA 
to form highly mutagenic adducts such as M1G, M1A and M1C (Wang M et al, 1996). 
Oxidation of proteins by ROS can be reversible or irreversible depending on the 
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target, concentration of the oxidants and the type of oxidative damage. Amino acids 
targets that are highly suspectible to oxidation include cysteine, methionine, lysine, 
arginine, threonine and histidine and proline. The hallmark of oxidative damage to the 
proteins is formation of protein carbonyls, and as a result, the protein carbonyls 
content (PCC) is used as a measure of protein oxidation caused by oxidative stress 
(Dean RT et al, 1997; Valko M et al, 2006).  Generally, cells can remove irreversibly 
oxidized proteins by proteolysis but when the amount of damaged protein exceed the 
cellular capacity to handle, pathologies such as diabetes, atherosclerosis and 
neurodegenerative diseases result (Davies KJ, 2001; Dean RT et al, 1997). The 
toxicity of peroxynitrite occurs through two mechanisms: oxidation and nitration 
resulting in altered protein function, apoptotic cell death and even tissue necrosis 
depending on the concentration and duration of exposure (Ahmad R et al, 2009; 
Szabó C 1996 & 2003). In the body, immune cells employ the toxicity of these 
ROS/RNS to launch a defense against invading microorganisms in innate immunity. 
Although the production of ROS/RNS in this context is highly regulated and 
localized, sustained ROS/RNS producing activities of these cells are associated with 
various chronic inflammatory conditions and cancer (Karin M et al, 2006; Kohchi C 
et al, 2009; Lambeth JD, 2007).  
 
1.3.2  Physiological Function: Redox Signaling  
 
 While free radicals are traditionally linked to cell damage and death, recent 
compelling data indicates that they also play a major role in several aspects of signal 
transduction ranging from cell proliferation, migration, contraction to secretory 
function (D'Autréaux B and Toledano MB, 2007; Giles GI, 2006; Hool LC, 2006;; 
Trachootham D et al, 2008). This aspect of signal transduction is often referred to as 
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“Redox Signaling”. It is established that cells are capable of generating low 
concentrations of ROS when stimulated by various ligands such as cytokines, growth 
factors and hormones (Petry A et al, 2010). Intentional generation of ROS was first 
observed in immune cells such as neutrophils and macrophages but certain cytokines 
such as TNF-α, IL-1 and interferon (IFN-γ) were later found to produce ROS in non-
phagocytic cells as well (Matsubara Tvand Ziff M, 1986; Meier B et al, 1989; Yang D 
et al, 2007). This was followed by reports of ROS generation upon growth factors 
binding to their receptors, and ROS thereby produced are required for their various 
functions (Bae YS et al, 1997; Marumo T et al, 1997; Shibanuma  M et al, 1991; 
Sundaresan M et al, 1995). Thannickal VJ and Fanburg BL have compiled a list of 
ligands known to generate ROSs (Table 4) to which more members are being added 
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     (Adapted from Thannickal VJ and Fanburg BL, 2000) 
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ROS, reactive oxygen species; TNF-a, tumor necrosis factor-a; MCP-1, monocyte 
chemoattractant protein-1; CSF-1, colony-stimulating factor-1; NF-kB, nuclear factor-kB; IL, 
interleukin; HSP27, 27-kDa heat shock protein; COX-2, cyclooxygenase-2; IFN-γ, interferon-
γ; PDGF, plateletderived growth factor; MAPK, mitogen-activated protein kinase; NOS, 
nitric oxide synthase; EGF, epidermal growth factor; JNK, c-Jun NH2-terminal kinase; PLA2, 
phospholipase A2; TGF, transforming growth factor; AOE, antioxidative enzyme; PLD, 
phospholipase D; 5-HT, 5-hydroxytryptamine (serotonin); ERK, extracellular signal-regulated 
kinase. 
 
 ROS generated during signal transduction are now regarded as second 
messengers beacause they are generated at the time of receptor activation, are short-
lived, and act specifically on effectors to transiently modify their activity (Sauer et al, 
2001). Previously, there was skepticism about specificity of ROS to fit as signaling 
molecules because of highly reactive nature of ROS that renders them indiscriminate 
in their reaction with biomolecules. Conventionally, the specificity in cell signaling is 
achieved by virtue of complementarity of participating macromolecules that bind to 
each other non-covalently (Alberts B et al, 2008). But in ROS signaling, the 
specificity relies on the presence of susceptible targets and vicinity of targets to the 
site of ROS/RNS production (D'Autréaux B and Toledano MB, 2007). Proteins vary 
widely in their oxidant sensitivity and only a small number of highly sensitive 
proteins are suitable for redox signaling. The redox sensivity of a particular protein is 
determined by the presence of oxidizable amino acids. The most important amino acid 
is cysteine that contains sulfhydryl or thiol (-SH). Its thiolate form (-S-) is far more 
nucleophilic than its protonated counterpart making it suitable for target of oxidation 
(Cross JV and Templeton DJ, 2006; Paulsen CE and Carroll KS, 2010). The typical 
pKa of cysteine residue is 8.5 implying that there would be < 10% in the thiolate form 
at a physiological pH of 7.2, but in the case of the susceptible proteins in which the 
pKa can be lowered to 4-5, the proportion of deprotonated cysteine rises up to >50%. 
In other words, the cysteine is rendered “reactive”(Winterbourn CC and Hampton 
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MB, 2008). The low pKa is achieved through electrostatic interactions of neighboring 
basic and acidic residues, which are either present in the primary structure or higher 
order configurations (Buchner J and Moroder L, 2009). Thus, in a single protein, only 
very few cysteines out of several present is targeted by oxidation. A case in point is 
the ryanodine receptor that contains approximately 50 free thiols in homotetrameric 
RyR monomer but only one single cysteine Cys3635 was identified as being redox-
active (Eu JP et al, 2000). Although methionine, tryptophan, and tyrosine residues are 
reported to be susceptible to oxidation, the physiological significance of these events 
is not fully understood.  
 
1.4  MECHANISMS OF REDOX-BASED REGULATION OF CELL 
  SIGNALING: FUNCTIONAL CONSEQUENCES OF OXIDATION OF 
  “REACTIVE CYSTEINE” 
 
 The notion of ROS/RNS acting as signaling molecules comes from evidence 
that reaction of these oxidants with signaling proteins results in alteration of protein 
functions (Janssen-Heininger YM et al, 2008). Majority of the targets proteins by 
oxidation includes phosphatases, kinases, ion channels, chaperone proteins and 
transcription factors. Function of these proteins is modified as a result of oxidation of 
reactive cysteine(s) within the proteins. The summary of possible functional 
consequences by cysteine oxidation is depicted in figure 2 and details are given in the 
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     (Taken from Janssen-Heininger YM et al, 2008) 
 
Figure 2: Consequences of oxidation of reactive cysteines within the target 
proteins.   
Consequences of protein oxidation are varied. Activities of some proteins are inhibited by 
cysteine oxidation whereas others are activated upon redox modification. Likewise, 
multimerization as a result of oxidation could lead to either inhibition or activation. 
Transcription factors can be activated by oxidizing their negative regulators or by direct 
oxidation of their redox active cysteine residues. ( -SH, reduced cysteine; -S-Ox, oxidized 
cysteine) 
 
1.4.1  Inhibition of Activity 
 
 Functional inactivation of proteins by oxidation is best characterized for 
protein tyrosine phosphatases (PTPs) and caspases (Denu TM and Tanner KG, 1998; 
Haendeler J et al, 1997; Li J et al, 1997). All PTPs contain a cysteine residue in their 
signature motif, CX5R. The unique environment surrounding this active site motif 
lowers the pKa of the cysteine to ∼5.4 (Lohse DJ et al, 1997). This thiolate anion 
participates in the formation of a thiol-phosphate intermediate that is essential for 
catalytic mechanims of PTPs (Zhang ZY, 2003). Oxidation of the active-site cysteine 
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residue results in inhibition of enzyme activity and an increase in tyrosine 
phosphorylation (Chiarugi P and Cirri P, 2003; Cho SH et al, 2004; Tanner JJ et al, 
2011). Similarly, proapoptotic proteins, caspases contain a cysteine in their active site. 
The reduced state of the cysteine is required for the enzymatic activities of caspases 
thus making them susceptible to oxidative inactivation (Mannick JB, 2007; Tenneti L 
et al, 1997). On one hand, s-nitrosylation (a form of oxidative modification, see 
below) of caspases under basal condition is associated with inhibition of their 
activities and prevention of apoptosis (Li J et al, 1997) but on the other hand, 
denitrosylation (reducing) of caspases following a variety of apoptotic stimuli triggers 
apoptosis (Kim TE and Tannenbaum SR, 2004; Mannick JB, 1999). Recently, it was 
suggested that antiapoptotic effect of the antioxidant protein, thioredoxin 1, Trx1 
might exert through transnitrosylation of caspase-3 (Mitchell DA and Marletta MA 
2005; Mitchell DA et al, 2007).   
 
1.4.2  Activation of Protein Functions 
 
 Some kinases and ion channels are activated as a result of oxidation of their 
reactive cysteines. Activation of many small GTPases within the Ras superfamily by 
S-nitrosylation is implicated in Angiotensin II signaling, the adaptive immune 
response and tumor maintenance (Heo J and Campbell SL, 2004; Raines KW et al, 
2007). N-Ras is S-nitrosylated at cysteine 118 in eNOS dependent manner in T-cells. 
Mutation of this redox sensitive cysteine residue leads to abrogation of Angiotensin II 
signaling and T-cells response mediated by N-Ras activation (Ibiza S et al, 2008). In 
skeletal muscles, high-conductance Ca2+ release channels or ryanodine receptors 
(RyR) are activated by various ROS/RNS signals (Anzai K et al, 2000). Out of 50 free 
cysteine residues in RyR, Cys 3635 was identified as the site of S-nitrosylation by 
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NO˙ that modulate channel activity. (Sun J et al, 2001).  In general, redox activation 
of enzymes and channels occurs in an allosteric  manner rather than direct impact on 
the active sites (Klomsiri C et al, 2011). 
 
1.4.3  Multimerization of Subunits 
 
 Another mechanism by which cysteine oxidation influences the signal 
transduction is through multimerization. For example, Hsp33 in its inactive state has 
four reactive cysteine residues in the thiolate anion form that bind Zn2+. Upon 
oxidation, each monomer releases the bound Zn2+ to form a homodimer, which 
enables the full activation of Hsp33’s function as a chaperone (Jakob U et al, 1999 & 
2000; Winter J et al, 2005). The other chaperone proteins that are subject to oxidative 
dimerization and activation include mammalian Hsp25, 60, 70 and 90 (Diaz-Latoud C 
et al, 2005; Hoppe G et al, 2004; Nardai G et al, 2000).  On the other hand, formation 
of Src protein tyrosine kinase homodimers through a disulphide bond between 
Cys277 of two monomers upon oxidation results in inactivation of the protein (Sun G 
and Kemble DJ, 2009).  
 
1.4.4  Release of Regulatory Proteins 
 
 Redox regulation of signaling is also achieved by oxidation of a regulatory 
protein, which then dissociates from its binding partner, thereby activating the 
function of the partner. The prime example of this is the redox regulation of ASK-1 
function by Trx1 (Saitoh M et al, 1998). In the reduced state, Trx1 binds ASK-1 
keeping the activity of ASK-1 in check. Formation of disulphide linkage between the 
reactive cysteines 32 and 35 of Trx1 as a result of oxidation releases Trx1 from ASK-
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1, which results in the activation of ASK-1. ASK-1 is a known activator of JNK that 
triggers cell death. This mechanism of redox dependent regulation of cell death by 
Trx1 has been demonstrated in macrophages that were stimulated to produce H2O2 
(Liu H et al, 2006). Another example is Nrf2-KEAP regulatory system in response to 
oxidants. Nrf2 is a transcription factor that activates antioxidant responsive element-
dependent gene expression to maintain redox homeostasis (Itoh K et al, 2004; Zhang 
DD, 2006). Under normal conditions, KEAP-1 binds to Nrf2 and Cul3-based ligase 
promoting rapid degradation of Nrf2 via ubiquitin proteasome system. Upon oxidative 
stress, oxidation of cysteines 273 and 288 in KEAP-1 causes its dissociation from 
Nrf2 allowing accumulation of Nrf2 in the nucleus and activation of target genes 
(Dinkova-Kostova AT et al, 2002; Kobayashi A et al, 2004; Tong KI et al, 2006; 
Wakabayashi N et al, 2004). 
 
1.4.5  Oxidation of Transcription Factors 
  
 The transcription factors themselves are the direct targets of oxidation 
modulating their activities. That was first demonstrated in the bacterial transcription 
factor OxyR which acts as a redox sensor, particularly to H2O2. Oxidation of Cys199 
causes conformational change in dimeric OxyR, which then triggers the activation of 
OxyR site-specific binding to DNA promoters (Choi H et al, 2001; Christman MF et 
al, 1985; Lee C at al, 2004). Similarly, oxidation of Cys-800 of HIF-1 alpha by S-
nitrosylation stimulates its transcriptional activity (Sumbayev BB et al, 2003; 
Yasinska I et al, 2003). On the other hand, the reduced form of Cys62 of the subunit 
p50 is essential for the DNA binding capacity of NF-KB, a transcription factor for 
genes involved in inflammatory response, growth and differentiation (Marshall HE 
and Stamler JS, 2001; Pineda-Molina E et al, 2001). Similarly, the transcription factor 
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AP-1, the critical cysteine residues present in the DNA binding domain such as Cys 
154 of c-Fos subunit and Cys 269 and 320 of c-Jun unit must remain reduced for 
DNA binding at tetradecanoylphorbol acetate (TPA) response element, TRE (Klatt P 
at al, 1999; Hsu TC et al, 2000).   
 
1.5  TYPES OF REVERSIBLE CYSTEINE OXIDATION  
 
 One feature rendering specificity to ROS/RNS mediated signal transduction is 
selective chemical reactivity of cysteine residues within the proteins. Another 
essential feature in redox signaling is reversibility of protein oxidations. Highly 
reactive species such as OH˙, hypochlorous acid, lipid peroxides and many 
decomposition products of ONOO- lack specificity, and most oxidation caused by 
these oxidants are not easily reduced and thus unlikely to participate in signal 
transduction. For example, 3-nitrotyrosine and protein carbonyls caused by 
peroxynitrite are not reducible and their presence is associated with aberration of 
signal transduction and various pathologies (Beal MF, 2002; Ischiropoulos H and al-
Mehdi AB, 1995). In contrast, Cys-based modifications have emerged as possible 
physiologically relevant redox-based post-translational protein modifications because 
some types of oxidations occurring to the cysteines are reversible by either 
intracellular reductants or enzymes. Five types of reversible modification of reactive 
cysteines (S-) have been recognized and they are depicted below together with 
enzyme systems controlling respective cysteine oxidations. 
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     (Adapted Modified from Janssen-Heininger YM et al, 2008) 
Figure 3: Schematic representation of various types of reversible cysteine 
oxidations.   
S- reactive cysteine, S-S disulphide, PSSG glutathionylation, SNO nitrosylation, SOH 
sulphenic acid, SO2H sulfinic acid.  
 
Table 5: Enzymes that reduce reversible cysteine oxidation 
     (Taken from Janssen-Heininger YM et al, 2008) 
 
 Reversible oxidation of the reactive cysteine was initially studied following 
H2O2 mediated oxidation. Oxidation by H2O2 produces a variety of reaction products 
(Stone JR and Yang S, 2006) such as sulphenic acid (SOH) which is highly unstable 
and go on to form sulfinic acid or disulphide bond (S-S) if there is a neighbouring 
reactive cysteine within the molecule (intramolecularly) or outside the molecule 
(intermolecularly) (Denu JM and Tanner JE, 1998; Salmeen A et al, 2003; Sarma BK 
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and Mugesh G, 2007). S-nitrosylation (SNO) is the covalent addition of NO group to 
a reactive cysteine mediated by various S-nitrosylating species derived from nitric 
oxide (Hess DT et al, 2005) while s-glutathionylation (PSSG) is the addition of 
gluthione (GSH), or other low-molecular-weight thiols to the cysteine sulfhydryl and 
it usually occurs under oxidative stress (Gallogly MM and Mieyal JJ, 2007).   
 
1.6  DIFFERENTIAL REDOX-MODIFICATION AND FUNCTIONAL 
 CONSEQUENCES 
 
  The functional consequences of protein oxidation do not always follow a 
simple “On-Off” switch mechanism. With more mechanistic insight into oxidative 
modification of proteins acquired, fine-tuning nature of redox regulation of protein 
functions become clear. Generally, there are three peculiar features of cysteine 
oxidation. Firstly, a single cysteine residue could be subject to alternative redox-based 
modifications resulting in differential functional outcomes. The archetypical example 
of this is a redox regulatory protein, OxyR. OxyR is a DNA binding protein and 
transcription factor that induces multiple genes in response to oxidative and 
nitrosative stress. Various groups have reported that the activity of OxyR is controlled 
by a variety of redox-modifications at Cys199 (Choi H et al, 2001; Hausladen A et al, 
1996; Zheng M et al, 1998;). Stimulants inducing oxidative, nitrosative or 
glutathionylation stress lead to formation of Cys199-SOH, Cys199-SNO, Cys199-
SSG respectively with differences in conformational change, co-operative properties, 
DNA binding abilities and promoter activities of OxyR. This is believed to underlie 
the differential and graded transcriptional responses observed with specific 
physiological stimulants  (Kim SO et al, 2002). Secondly, depending on redox 
modification, the same protein could perform different or sometimes totally opposite 
Chapter	  1:	  Introduction	   22	  
functions. Trx1 is cytosolic protein of Trx family. In the reduced state, it binds to and 
inhibits ASK1, an activator of the c-Jun N-terminal kinase (JNK) and p38 MAPK 
kinase pathway. Intramolecular disulphide bond formation between Cys 32 and Cys 
35 under oxidative stress results in dissociation of Trx1 from ASK-1 leading to 
activation of ASK-1 and ultimately cell death (Liu H et al, 2000 & 2006; Saitoh M et 
al, 1998). On the other hand, cysteine 69 of Trx1 is S-nitrosylated under basal 
condition. This is required for its oxidoreductase activity for scavenging of reactive 
oxygen species and protection from apopotosis (Haendeler A et al, 2002). 
Furthermore, S-nitrosylated Trx1 specifically transnitrosylates procaspase 3, thus 
inhibiting the activity of the latter and protecting cells from apoptosis (Mitchell DA 
and Marletta MA 2005; Mitchell DA et al, 2007). Lastly, the reactive cysteines of 
proteins could vary in their thresholds to oxidative modification with some displaying 
ready oxidation at lower threshold than others. Numajiri and co-workers recently 
reported that at low concentration of NO˙, only PTEN is S-nitrosylated and 
inactivated, and as a result, Akt is phosphorylated whereas at high NO˙ concentration, 
both PTEN and Akt are S-nitrosylated leading to inactivation of Akt (Numajiri N et 
al, 2011).  
 
1.7  REDOX-MODIFICATION: PHYSIOLOGICAL SIGNALING VERSUS 
 CELLULAR TOXICITY  
 
 Although ROS/RNS have been assigned a signaling role in regulating cellular 
function, highly reactive nature of these radicals could turn one from friend to foe 
readily. Whether a particular oxidative or nitrosative challenge results in 
physiological or pathological outcome was generally predicted from a balance of the 
strength of the oxidant versus anti-oxidant capacity of cellular system. But this 
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requires extensive ROS/RNS profiling and determination of various cellular anti-
oxidant parameters. Redox-based modification of proteins has overlapping targets 
with a single protein or a single cysteine residue subject to different oxidative 
modifications that lead to different functional outcomes. It has been suggested that 
some types of oxidative modifications could preferably occur under certain 
circumstances, for example, protein glutathionylation that is usually observed under 
oxidative stress (Townsend DM, 2007). In 2007, Forrester MT and Stamler JS 
proposed a classification scheme for redox-based modifications of proteins as 
homeostatic/physiological, stress/adaptive and maladaptive/injurious depending on 
the level of ROS/RNS exposure and functional consequence (Forrester MT and 
Stamler JS, 2007).  
 
      (Taken from Forrester MT and Stamler JS, 2007) 
Figure 4: A continuum of redox-based modifications.  
Left to right: -SNO, S-nitrosylation; -SOH, sulphenic acid; -SSG, disulphide including 
glutathione mixed disulphide (glutathionylation); -SO2H, sulphinic acid; -SO3H, sulphonic 
acid; nitrotryptophan; and nitrotyrosine. Reversible modifications such as -SNO,-SOH and -
SSG is frequently observed in physiological redox signaling whereas partially reversible or 
irreversible modifications such as SO2H, -SO3H, nitrotryptophan  and nitrotyrosine represent 
mainly oxidative stress and nitrosative stress.  
 
 A large body of recent evidence indicates that S-nitrosylation could serve as a 
ubiquitous redox-based physiological or homeostatic regulator of cellular functions 
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since its formation is agonist or stimulus coupled, compartmentalized, coordinately 
regulated at multiple steps of the transduction pathways, dynamic and reversible, and 
operates on physiological time scales, usually milliseconds to minutes (Huang Y et al, 
2005; Matsushita K et al, 2003; Morrell CN et al, 2005; Rizzo MA and Piston DW, 
2003; Wang G et al, 2006). 
 
1.8  PROTEIN S-NITROSYLATION 
 
 When it was first discovered, NO˙ was only known to exert its biological 
functions by binding to the heme-iron in soluble guanylate cyclase, which activates 
the enzyme resulting in accumulation of guanosine 3’, 5’-cyclic phosphate (cGMP). 
The activation of cGMP dependent pathways lead to tissue specific outcomes of NO˙ 
activity such as vasorelaxation in endothelial cells and neuronal signal transduction in 
central nervous system (Calabrese V et al, 2009; Denninger JW and Marletta MA, 
1999; Derbyshire ER and Marletta MA, 2009; Nandagopal K et al, 2001).  cGMP was 
thus thought to be the only mediator carrying out the diverse biological functions of 
nitric oxide (Lane P and Gross SS, 1999). However, it was later discovered that most 
NO-based bioactivity cannot be explained by generation of cGMP alone. 
Subsequently the search for cGMP independent pathway of NO signaling reveals that 
S-nitrosylation of cysteine residues within the target proteins plays a key role in 
mediating various physiological functions of NO˙ (Hess DT et al, 2005).  
 S-nitrosylation is the covalent coupling of an NO moiety to a reactive cysteine 
thiol and it is now regarded as a major mechanism of action by NO˙. Over the past 
decade, the number of reported substrates for protein S-nitrosylation has grown to 
over a hundred covering various proteins in almost all physiological functions such as 
a number of metabolic enzymes, oxidoreductases, proteases, protein kinases and 
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phosphatases, respiratory proteins, receptor/ion channels and transporters, cytoskeletal 
and structural components, transcription factors and regulatory elements such as G 
proteins (Foster MW et al, 2009).  
 
1.8.1   Factors influencing protein S-nitrosylation 
 
 Despite mounting evidence that S-nitrosylation plays an important role in 
mediating the diverse biological functions of NO˙, the exact mechanism of how S-
nitrosylation occurs in specific cellular contexts is still not fully understood. In 
general, there are four key factors influencing the formation of protein S-nitrosylation:  
1) formation of the biologically relevant S-nitrosylating species  
2) proximity of protein thiol targets to nitrosylating species 
3) structural determinants such as inherent susceptibility of protein thiol targets, to 
nitrosylation, hydrophobic compartmentalization and alloteric regulation 
4) rate of protein de-nitrosylation. 
 The current understanding is that S-nitrosylation does not result from direct 
reaction of NO˙ with the thiolates (S-), but rather through the formation of 
intermediate NO˙ species called S-nitrosylating species or agents (Derakhshan B et al, 
2007; Hess DT et al, 2005; Lane P et al, 2001). There are four types of S-nitrosylating 
agents that are recognized as relevant in biological systems: 
1) Higher oxides of nitrogen, (NOx), e.g. N2O3 (Grisham MB et al, 1999; Stamler JS 
and Hausladen A, 1998;), 
2) Metal-NO adducts, e.g. dinitrosyl iron complexes with the general formula 
(NO)2(RS)2Fe (Stamler JS, 1994), 
3) Peroxynitrite (OONO-) (Viner RI et al, 1999) and  
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4) Low molecular weight S-nitrosothiols such as S-nitrosoglutathione (GSNO) or 
protein-SNO in a process called transnitrosylation (Stamler JS et al, 1992; Grisham 
MB et al, 1999).  
 Which S-nitrosylating intermediate is involved in any particular situation is 
not fully understood but there are conditions that could favour formation of particular 
S-nitrosylating species. Examples are - high concentration of NO˙ level is associated 
with formation of N2O3 (Stamler JS and Hausladen A, 1998); availability and 
oxidative state of transition metals influence the level of metal-NO adducts (Stamler 
JS, 1994); favourable conditions for reaction of NO˙ with O2˙- to form OONO- 
(Pacher P et al, 2007); and level of GSNO which is under the control of GSNO 
reductase enzyme (Benhar M et al, 2009).  
 Compartmentalization of NO˙ sources and its targets is another key feature 
that renders S-nitrosylation specific and physiologically relevant among various 
redox-based modifications. The best-characterized example is S-nitrosylation of the 
N-methyl-D-aspartate receptor (NMDAR), which forms a complex with nNOS 
(NOS1) through scaffolding protein (PSD95) (Brenman JE et al, 1996; Kornau HC et 
al, 1995). NO˙ produced by nNOS upon stimulation promotes S-nitrosylation of 
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(Adapted from Hess DT et al, 2005) 
Figure 5: Compartmentalization of cellular NO source and its targets 
NO˙ that is generated by NOS upon NMDAR stimulation activates guanylate cyclase, and S-
nitrosylate and activates neighbouring G proteins (Fang M et al, 2000) . S-nitrosylation of 
NMDAR and NOS is inhibitory acting as a feedback mechanism (Choi YB et al, 2000). 
 
 Similarly, co-localization of eNOS proteins in cell membrane patches called 
caveolae with other proteins involved in cell signaling such as receptors, 
heterotrimeric GTP-binding proteins and effectors enables NO˙ to function as a 
master controller that orchestrates cell signaling (Patel HH and Insel PA, 2009). 
Although compartmentalization facilitates the process of S-nitrosylation, it is also 
possible that the leaked NO˙ from the site of production could directly react with the 
susceptible cysteines of the protein substrates that it reaches.  
 The most important structural determinant for S-nitrosylation is the presence 
of susceptible cysteine or cysteine in thiolate state at the physiological pH as 
discussed previously. In fact, the nature of the reactive cysteine is best characterized 
in S-nitrosylation and for this regard, it is named “SNO motif”(Stamler JS et al, 
1997). The proposal for this predictive motif stems from the detailed analysis of NO 
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transfer in hemoglobin (Hb). Beta-Cys 93 in Hb is flanked by a basic residue on its 
NH2-terminus (His) and an acidic residue on its COOH-terminus (Glu). This structural 
arrangement allows the sulphur of beta-Cys 99 to move toward the acidic residue 
when hemoglobin is in R state favouring thiolate state thus promoting  S-nitrosylation 
whereas transition to T state results in the opposition of the sulphur to the basic 
residue promoting de-nitrosylation. This mode of acid base catalysis is observed in 
many other proteins, and thus a motif was proposed as XYCZ where X= G,S,T,C,Y, 
or N; Y=K,R,H,D, or E; AND Z=D or E (Hess DT et al, 2001; Stamler JS et al, 1997). 
This motif is observed either in the primary structure or in the higher order structure 
as in the case of methionine adenosyl transferase in which consensus acid-base motif 
is only observed in three-dimensional structure (Pérez-Mato I et al, 1999). The 
hydrophobic pockets within the proteins may allow the concentrations of the 
precursors such as NO˙, O2 and O2˙- to become enriched and to react with each other 
to form the potent S-nitrosylating agents. On the other hand, this hydrophobic 
compartment may limit the access of hydrophilic reductants that promote de-
nitrosylation (Foster MW et al, 2005; Lane P et al, 2001). Lastly, S-nitrosylation/de-
nitrosylation is also subject to allosteric regulation by ions (Ca++, Mg++, H+) and 
oxygen (hemoglobin), which cause changes in protein structure (Eu JP et al, 2000; Lai 
TS et al, 2001; Singel D et al, 2004).  
 The process of protein de-nitrosylation is not fully understood yet. Due to 
lability of SNO compounds, de-nitrosylation was previously viewed as spontaneous 
and unregulated decomposing non-enzymatically on exposure to heat, light and 
reducing agents or nucleophilic compounds (Barone E et al, 2009; Stamler JS and 
Toone EJ, 2002). Decomposition of SNO might be catalyzed by transition metals such 
as iron and copper (Espey M et al, 2001; Eu JP et al, 2000; Forrester MT et al, 2007; 
Foster MW et al, 2004; Stamler JS and Toone EJ 2002). One key factor in 
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determining the rate of protein de-nitrosylation is the concentration of intracellular 
glutathione (GSH) which is not only the most abundant cellular anti-oxidant but also a 
highly nucleophilic compound that participate in transnitrosylation reactions. 
Conditions that favor glutathione oxidation in cells would enhance steady-state levels 
of protein S-nitrosylation (Stamler JS and Toone EJ 2002). Reaction of GSH with 
proteins SNO results in the formation of GSNO that is rapidly and irreversibly 
metabolized by GSNOR enzymes (Liu H et al, 2001; Staab C et al, 2008). There is 
equilibrium between the level of GSNO and protein SNO and it is under the control of 
GSNOR. The knockout of GSNOR in both yeast and mammalian cells results in the 
increased level of cellular GSNO and protein SNO (Foster MW et al, 2009). GSNOR 
is one of the two cellular denitrosylases identified so far (Benhar M et al, 2009). The 
other cellular denitrosylase is the Trx system comprising Trx proteins, TrxR proteins 
and NADPH. The proposed mechanism of the process of de-nitrosylation mediated by 
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(Taken from Benhar M et al, 2009) 
 
 
Figure 6: Mechanism of enzyme-mediated protein de-nitrosylation 
a) S-nitrosylated protein is de-nitrosylated first by GSH forming reduced protein and GSNO 
that is rapidly reduced by GSNOR. GSNOR thus indirectly de-nitrosylates proteins by driving 
the equilibrium from protein SNO to GSNO. b) Trx denitrosylates S-nitrosylated proteins 
through its dithiol moiety, forming a reduced protein thiol (-SH) and oxidized Trx; oxidized 
Trx is reduced by the seleno-flavoprotein Trx reductase (TrxR) using NADPH as a reducing 
substrate. Of the two systems, GSNOR system is specific to S-nitrosylated proteins whereas 
Trx system is involved in reducing di-sulphide bonds as well (Berndt M et al, 2007). 
 
 Protein S-nitrosylation and de-nitrosylation is a complex yet versatile system 
involving interaction of NO˙ with transition metals and ROS thus allowing integration 
of various redox signals into an effective second messenger system. It is likened to 
phosphorylation/dephosphrylation process mediated by kinases and phosphatases 
since the process of S-nitrosylation and de-nitrosylation is subject to regulation by NO 
generating enzymes (NOSs) and denitrosylases (GSNOR & Trx) acting similar roles 
as kinases and phosphatases (Benhar M et al, 2009; Lane P et al, 2001). It also 
displays the classical features of second messenger function as demonstrated in 
various S-nitrosylation-mediated signaling processes (Benhar M et al, 2009; Huang Y 
et al, 2005; Matsushita K et al, 2003; Rizzo MA and Piston DW, 2003). Therefore, 
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among various oxidative modifications, S-nitrosylation is often put forward as being 
physiologically relevant for redox signaling (Benhar M et al, 2009; Janssen-Heininger 
YM et al, 2008; Lane P et al, 2001;). 
 
1.9  ABERRATION OF REDOX SIGNALING AND CARCINOGENESIS 
 
 Many types of cancers, regardless of their initiating events, are associated with 
increased intracellular ROS production (Benhar M et al, 2001; Hileman EA et al, 
2001; Hileman EO et al, 2004; Toyokuni S et al, 1995;). Sources of ROS production 
in cancer cells are varied. In addition to oncogene-mediated ROS overproduction, 
another important source involves mitochondrial respiratory chain. Cancer cells are 
metabolically highly active putting a constant demand for ATP supply on the 
respiratory chain leading to increased leakage of electrons (respiratory injury) and 
increased ROS production (Warburg O, 1956). Furthermore, since the mitochondrial 
DNA codes for 13 components of the respiratory complexes, overwhelming level of 
ROS produced locally could damage the function of its encoded proteins resulting in 
malfunctioning of mitochondrial respiratory chain and subsequently, increased ROS 
production thus perpetuating the vicious circle (Augenlicht LH et al, 2001; Carew JS 
et al, 2003; Fliss MS et al, 2002; Kang D and Hamasaki N, 2003; Kumimoto H et al, 
2004). 
 Overproduction of ROS/RNS is a double-edged sword for tumours giving 
proliferative and survival advantage on one hand but inducing death on the other 
hand. But cancer cells adapt to this accumulating oxidative stress by various 
countermeasures such as over-expression of antioxidant enzymes and increased 
mobilization of redox buffering systems such as nicotinamide adenine dinucleotide 
phosphate (NADPH/NADP+), thioredoxin (TRXred/TRXox) and glutathione 
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(GSH/GSSG) (Holmgren A, 2000; Pelicano H et al, 2004; Schafer FQ and Buettner 
GR, 2001). MnSOD protein expression is significantly higher in adenocarcinomas of 
the stomach and squamous cell carcinomas of the esophagus compared to adjacent 
normal mucosa cells (Janssen AM et al, 2000). Similarly, overexpression of SOD 
enzymes was observed in other tumors such as colorectal adenomas and carcinomas, 
ovarian carcinomas, malignant brain tumors and breast cancer tissues (Janssen AM et 
al, 1999). In addition to protein overexpression, increased activities of antioxidant 
enzymes also contribute to the defense mechanism of tumor cells against oxidative 
stress. The work of Kanbagli et al revealed that the activities of MnSOD, glutathione 
peroxidase, and glutathione-S-transferase were significantly increased in the 
mitochondria of colorectal cancer tissues (Kanbagli O et al, 2000).  But on the other 
hand, there were some studies reporting decreased anti-oxidant enzymes expression 
and activities in cancer cells compared to normal cells (Marklund SL et al, 1982; Van 
Driel BE et al, 1997). These diverse findings seem to be related to different stages of 
tumorigenesis according a recent work by Dhar SK et al. In their multistage skin 
carcinogenesis model, they found out that MnSOD expression is suppressed at early 
stage of skin cancer but increased at late stages (Dhar SK et al, 2011).   
 Tumorigenicity of ROS/RNS is traditionally attributed to the initial damage 
caused to DNA backbone of cells and subsequent tumor promoting mutations. 
ROS/RNS induced DNA damage can lead to various cellular consequences such as 
arrest or induction of transcription, induction or inhibition of signal transduction 
pathways, replication errors, and genomic instability, all of which are associated with 
carcinogenesis (Marnett LJ, 2000; Valko M et al, 2006). There are now more than 100 
oxidized DNA products identified to date and many of these products are very 
frequently observed in various types of cancer (Valko M et al, 2007). For example, at 
the site chronic inflammation, there is ongoing ROS/RNS production by activated 
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macrophages and neutrophils in the process called respiratory burst. This persistent 
overproduction of ROS/RNS cause DNA lesions such as single strand break, double 
strand break and oxidized bases (eg. 8-oxo-dg) that ultimately leads to tumor 
transformation (Valko M et al, 2001, 2004 & 2006). Various chronic inflammatory 
conditions such as chronic gastritis, oesophagitis, hepatitis, inflammatory bowel 
diseases, and prolonged smoking or exposure to asbestos are well-recognized risk 
factors for their respective cancers (Franks AL and Slansky JE, 2012; Rook GA and 
Dalgleish A, 2011).  
 In addition to DNA damaging and mutagenic properties of ROS/RNS, 
sustained endogenous ROS/RNS overproduction itself is associated with cellular 
transformation with little genotoxic effects. For example, over-expression of MOX1, 
a catalytic subunit of NADPH oxidase, which was later renamed as NOX1, stimulates 
the generation of O2˙- and induces malignant transformation without associated DNA 
damage (Arnold RS et al, 2001; Suh YA et al, 1999). More interestingly, several lines 
of evidence suggest that oncogenic signals collaborate the ROS generation in the 
transformation process (Behrend L et al, 2003). In Ras-transformed oncogenic 
fibroblasts, Ras onco-protein activates Rac, which is an essential regulatory 
component the membrane-associated NADPH oxidase, resulting in increased 
generation of O2-, which in turn maintains the transformed state (Alexandrova AY et 
al, 2006; Irani K et al, 1997). Increased ROS production by oncogene c-Myc not only 
facilitates oncogenic signaling but also induces DNA damage, and mitigates p53 
function. It is proposed as a mechanism for oncogene-induced genetic instability 
further enhancing tumor evolution (Vafa O et al, 2002).  
 The explanation for non-mutagenic carcinogenic property of ROS/RNS is 
found in aberration in redox signaling as a result of increased and sustained ROS/RNS 
production in cancers. Major redox-controlled targets responsible for enhanced cell 
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proliferation in cancer cells include kinase-signaling cascades such as PI3K/Akt 
survival pathway and MAPK pathways, transcription factors such as HIF1-α and 
NrF2, and proteins of apoptotic pathways such as caspase 3 and Bcl-2. Redox 
regulation of Akt\PI3K pathway is well documented. Redox-activation of PI3K/Akt 
pathway is mainly through inactivation of its negative regulator PTEN (Chiarugi P, 
2005; Leslie NR et al, 2003) and is implicated in various cancers (Pelicano H et al, 
2006; Silva A et al, 2011; Yalcin S et al, 2010). The MAPK pathways can be broadly 
grouped into two distinct function domains, ERK1/2 signaling kinase domain and 
stress-activated protein kinases (SAPKs) domain comprising of Jun N-terminal kinase 
(JNK), p38 kinase pathways (Kyriakis JM and Avruch J, 2001, Matsuzawa A and 
Ichijo H, 2005). Activation of ERK1/2 under mild oxidative stress promotes cell 
growth and proliferation (Chen W et al, 1998; McCubrey JA et al, 2006; Torres M, 
2003; Verma A et al, 2004) whereas SAPKs pathway activation results in cell death. 
(Shen HM et al, 2006; Shrivastava P et al, 2004). Life and death decision in MAPK 
pathways activation depends on apoptosis-regulating signal kinase 1 (ASK1), the 
initiator for SAPK signaling cascade (Matsuzawa A and Ichijo H, 2008). Under non-
stressed condition, Trx1 binds to and inhibits the activity of ASK1 (Saitoh M et al, 
1998). Oxidative stress that induces disulphide bond formation between Cys32 and 
Cys 35 of Trx1 results in dissociation of Trx1 from Ask1 that is now released to 
initiate apoptosis (Liu H et al, 2000). Furthermore, intermolecular disulphide 
formation in Ask1 maintains a sustained activation of its downstream target, JNK and 
thus ensures induction of apoptosis (Nadeau PJ et al, 2007).  In cancer cells, 
proliferation predominates over cell death. This seems to be achieved by selective 
oxidation of proliferative MAPK kinase such as ERK1/2 over death MAPK kinase 
such as JNK (Galli S et al, 2008). 
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 ROS mediated cell survival also occurs at the transcription level. Hypoxia-
inducible factor (HIF) is an important transcription factor that mediates cellular 
metabolism and cell survival under hypoxia. In tumor cells, HIF stablization and 
activation plays a major role in the metabolic switch from mitochondrial respiration to 
cytosolic glycoloysis (Lu H et al, 2002). The key negative regulator of HIF 
stablization is the dioxygenase PHD (prolyl hydroxylase domain) that under 
normoxia, hydroxylates HIF1α on two proline residues thus tagging HIF1α for 
proteosomal degradation (Fulda S and Debatin KM, 2007). Increased generation of 
ROS has been correlated with inactivation of PHD activity (BelAiba RS et al, 2004; 
Metzen E et al, 2003) and S-nitrosylation of HIF1α was shown to cause stablilization 
of HIF1α and increase its transcriptional activity (Li F et al, 2007; Palmer LA et al, 
2007). Another important transcription factor for cell survival is NrF2 that plays a 
critical role in protecting cancer cells against oxidative damage by inducing the 
expression of various anti-oxidant enzymes such as SODs, catalase, glutathione 
peroxidase, and thioredoxin (Chan K et al, 2001; Liu XM et al, 2007; Tan KP et al, 
2007). Keap1 acts as a key negative regulator in NrF2 activation pathway by forming 
a complex and keeping NrF2 activity in check. Sulfhydryl modifications of multiple 
Cys residues in Keap1 dissociate Keap1 from Nrf2, allowing the translocation of Nrf2 
to the nucleus where it transactivates target-gene expression (Dinkova-Kostova AT et 
al, 2002; Kobayashi M et al, 2006). In the face of increased and sustained ROS 
production in cancer cells, NrF2 activation is crucial for the redox balance that cancer 
cells need to maintain. 
 Cell death effectors such as caspases, XIAP and Bcl-2 are redox sensitive and 
their death execution function is significantly affected by ROS/RNS (Benhar M and 
Stamler JS, 2005; Mannick JB, 2007; Nakamura T et al, 2010; Tsang AH et al, 2009). 
Since caspases are cysteine-dependent proteases, their active site Cys is subject to 
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oxidative inactivation, particularly by S-nitrosylation (Jiang ZL et al, 2010; Mannick 
JB et al, 2001). Bcl-2 is the prototype of anti-apoptotic Bcl2 family members and S-
nitrosylation of Bcl-2 was demonstrated to inhibit its ubiquitin proteosome 
degradation thus protecting the cells from death signals (Azad N et al, 2006). Redox 
regulation of these apoptotic proteins are believed to be involved in carcinogenesis 
and drug resistance of tumors (Benhar M et al, 2009; Chanvorachote P et al, 2006;  
Iyer AK et al, 2008).  
  
1.10 RATIONALE OF THESIS 
 
 Since the seminal work of Sundaresan et al that demonstrated the requirement 
of generation of H2O2 for platelet-derived growth factor signal transduction, the field 
of redox-regulated signaling has grown rapidly with many reports supporting the 
function of oxidants as signaling molecules in control of cell and tissue homeostasis, 
cell division, migration and other various cellular processes (Sundaresan M et al, 
1995; Trachootham D et al, 2008). However, there were only a few studies that focus 
on the mechanistic aspects of how these free radicals modify proteins to alter their 
functions. In most cases, these studies employed a very high concentration of 
exogenous oxidants in an attempt to identify the specific type of oxidative 
modification in a particular protein caused by these oxidants and thus physiological 
relevance of their findings is in doubt. For example, one group reported that reversible 
oxidation and inactivation of tumor suppressor PTEN by H2O2 was through formation 
of disulphide bond between the active site Cys 124 and Cys 71 but in their study, a 
high concentration of H2O2 (up to 2mM H2O2) was used to induce oxidation in PTEN 
(Lee SR et al, 2002). That amount of exogenous H2O2 is unlikely to represent 
physiological concentration of H2O2 produced during growth factors signaling. In 
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another study, it was reported that mild oxidative stress induced by a low 
concentration H2O2 (up to 100uM H2O2) caused S-nitrosylation in protein tyrosine 
phosphatases (PTPs) raising the possibility that H2O2 could induce different types of 
oxidative modification depending on concentration (Barrett BM et al, 2005).  
 In the literature, there has been a debate on relative importance of O2˙- versus 
H2O2 in mediating enhanced cell proliferation. Over the years our group has been 
reporting on survival benefit of increased intracellular O2˙- production from enhanced 
cellular proliferation to drug resistance in tumor cells (Clement MV and Stamenkovi 
I, 1996; Pervaiz S et al, 1999 & 2001). Recently, we demonstrated that 
phosphorylation and activation of the survival kinase Akt by O2˙- is dependent on S-
nitrosylation of the tumor suppressor PTEN (Lim S and Clement MV, 2007). 
However, it was not clear how the oxidative signal caused by O2˙- is transformed into 
the nitrosative signal inducing S-nitrosylation in PTEN. Taken together, since low 
concentration of exogenous H2O2 and increased production of intracellular O2˙- 
caused S-nitrosylation of PTPs and PTEN respectively, we propose to investigate if 
there is any common pathway whereby initial oxidative signal produced by O2˙- and 
H2O2 is converted to nitrosative signal leading to S-nitrosylation. Furthermore, we 
would like to assess whether cellular toxicity associated with high level of ROS/RNS 
has any correlation with the nature of oxidative modification with particular regard to 
H2O2. 
 Previously, determination of oxidative modification of proteins caused by 
various ligands was made based on extrapolation from the studies that employ 
exogenous ROS such as H2O2 on the same protein targeted by the ligands (Kwol J et 
al, 2004). Therefore, the knowledge on specific nature of physiologically relevant 
ligand-mediated oxidative modification is somehow missing. In the current study, we 
decided to observe direct oxidation caused by growth factors and specify its nature of 
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redox-modification. Finally, we are also interested in exploring the nature of oxidative 
modification of proteins in tumors in the hope that the finding could shed some light 
on developing strategies to eliminate aberration of redox-based signaling that give 
tumor cells proliferative and survival advantage. 
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2.1.1 Chemicals  
 
 The chemicals used in the study were purchased from the following sources 
and all are of analytical grade. 
 
AG scientific (San Diego,CA, USA) 
2-4-Carboxyphenyl-4,4,5,5-Tetramethylimidazoline-1-oxyl-3-oxide Potassium salt  
(c-PTIO) 
NG – monomethyl – L – Arginine. monoacetate (L – NMMA. monoacetate) 
 
Alexis Biochemicals ( Enzo Life Sciences, UK ) 
1-2-2-Aminiethyl-N-2-Ammonioethyl-Amino-Diazen-1-ium-1,2-diolate  
( DETA NONOate) 
 
Chemical Diversity Research Institute, Joint Stock Company (Moscow, Russia) 
Compound C3, GSNOR inhibitor 
 
Calbiochem (Calbiochem, San Diego, CA) 
5,10,15,20-Tetrakis (4-sulfonatophenyl)prophyrinato iron (III), chloride (FeTPPS) 	  
Invitrogen (Singapore) 
LipofectamineTM RNAiMAX 
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Merck (Germany) 
Hydrogen peroxide (H2O2) 
 
Molecular Probes (Molecular Probes Inc., Eugene, OR, USA) 
CM – H2DCFDA (5-(and-6) - chloromethyl-2’,7’ – dichlorodihydrofluorescein 
diacetate acetyl ester) 
DAF-FM diacetate (4-amino-5-methylamino-2',7'-difluorofluorescein diacetate)  
Calcium GreenTM -1, AM 
 
Pierce (Pierce Biotechnology, Rockford, IL, USA) 
Coomassie Plus TM Protein assay reagent 
Restore TM Western Blot stripping buffer 
Supersignal ® west Pico chemiluminescent substrate 
Supersignal ® west Femto chemiluminescent substrate 
 
Peptrotech (New Jersey, USA) 
Recombinant Human EGF 
Recombinant Human PDGF-BB 
 
Sigma Chemical C0. (St Louis, USA) 
L - Ascorbate 
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Diphenyleneiodonium chloride (DPI) 
HEPES 4-(-2-hydroxyethyl)-1- piperazineethanesulfonic acid 
Bis-N-methylacridinium (Lucigenin) 
N - ethylmaleimide (NEM) 
NaNO2, Sodium Nitrite 
Somatic ATP releasing reagent 




Thermo Fisher Scientific (Singapore) 
N-6-Biotinamido-hexyl-3ʹ′-2ʹ′-Pyridyldithio-Propionamide (Biotin-HPDP) 




 Cell	  Signaling	  Technology	  (Beverly,	  MA,	  USA)	  Rabbit	  polyclonal	  Anti	  –	  phospho	  Akt	  ser473	  Rabbit	  polyclonal	  Anti	  –	  Akt	  Rabbit	  polyclonal	  Anti	  PTEN	  	  Dakocytomation	  (Biomedia,	  SPD	  scientific,	  Singapore)	  Goat	  Anti	  Rabbit	  Immunoglobulin	  conjugated	  with	  Horse	  radish	  peroxidase	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Millipore (Singapore)	  
Mouse Monoclonal Anti-Nitrotyrosine 
 Sigma	  Chemical	  C0.	  (St	  Louis,	  USA) Mouse	  monoclonal	  Anti	  -­‐β-­‐	  actin	  Mouse	  monoclonal	  Anti-­‐biotin	  	  
Thermo Fisher Scientific (Singapore) ImmunoPure	   Goat	   Anti-­‐Mouse	   Immunoglobulin	   conjugated	   with	   Horse	   radish	  peroxidase	  ImmunoPure	   Goat	   Anti-­‐Rabbit	   Immunoglobulin	   conjugated	   with	   Horse	   radish	  peroxidase	  	  Upstate	  biotechnology	  (Lake	  placid,	  NY)	  Rabbit	  polyclonal	  Anti	  –	  CuZnSOD 
 
2.1.3 Cell Lines and Cell Culture 
 
 Mouse embryonic fibroblasts wild type (MEF WT) and PTEN knockout (MEF 
PTEN -/-) were obtained from Dr Tak W. Mak, University Health network, 610 
University Avenue, Toronto, Ontario Canada and maintained (37°C, 5% CO2) in 
Dulbecco’s medium modified Eagle’s medium (DMEM) (Hyclone , USA) containing 
10% FBS (Hyclone , USA), 2mM L-glutamine (Hyclone , USA), and 50 µg 
gentamycin (Gibco –BRL, Gaithersburg, MD, USA). 	   MCF7	  cell	   line	  was	  purchased	   from	  ATCC	  and	  maintained	   in	  RPMI-­‐1640	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medium	   (Hyclone,	   USA),	   supplemented	   with	   10%	   FBS,	   2mM	   L-­‐glutamine	   and	  50ug	  gentamycin	  and	  incubated	  at	  37°C	  in	  5%	  CO2	  atmosphere.	  	  
2.2	  	   METHODS	  
2.2.1 Whole Cell Lysate Preparation 
 
 Cells were washed once in cold 1 x PBS and were scraped on ice. After 
centrifuging at 2,500g for 5 mins, the supernatant was removed and the cells pellet 
was lysed with 1 x radioimmunoprecipitation assay (RIPA) buffer containing 50 mM 
Tris, pH 7.4, 150 mM NaCl, 5 mM Na2EDTA, 0.03% NaN3 and 1% NP-40 
supplemented with 1 mM phenylmethylsulfonyl fluoride (PMSF), 1µg/ml each of 
leupeptin, aprotinin andpepstatin A, 1 mM sodium orthovanadate before use. Cell 
lysates were stored at -80° C until use. Prior to determination of protein concentration, 
cell lysates were centrifuged at 20,000g for 5 mins and cellular debris was cleared. 
Equal amount of protein was aliquoted and loaded into SDS-PAGE gels.  
 
2.2.2 Sodium Dodecyl sulphate polyacrylamide gel electrophoresis  
 (SDS-PAGE) and Western Immunoblotting 
 
 The Bio-Rad Mini-Protean III system (Hercules, CA, USA) was used for 
protein gel electrophoresis. The resolving gel was prepared with 1.5 M Tris HCl, pH 
8.8, 10% SDS, 30% bis – acrylamide, ammonium persulphate (APS) and N, N, N’, 
N’- tetramethyl – ethylenediamine (TEMED) whereas the stacking gel was prepared 
with 1.0 M Tris – HCl, pH 6.8, 10% SDS, 30% bis - acrylamide and APS and 
TEMED. For routine protein gel electrophoresis, protein samples were denatured by 
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boiling with 5 x SDS buffer (2 M Tris HCl, pH 6.8, 10% SDS, 0.05% bromophenol 
blue, 10% glycerol and 0.5 M DTT) for 5 mins before loading into the gels. For non-
reducing gel electrophoresis, protein samples were mixed with 5 X SDS buffer 
without DTT and heated at 37ºC for 5 min. Typically, 80ug to 100ug of proteins were 
loaded and 8% gel was used throughout the study. Kaleidoscope pre-stained standards 
(Bio-Rad Laboratories, Hercules, CA, USA) were used as protein standard markers. 
After the electrophoresis was conducted at constant voltage at room temperature, the 
resolved proteins were transferred onto nitrocellulose membrane (Pall Corporation, 
Ann Arbor, MI, USA). Using the Bio-Rad Trans-Blot system, electroblotting was 
conducted at 350 mA for 1 hr at 4ºC. Thereafter, proteins were blocked with 5% (w/v) 
non-fat milk (prepared in Tris-buffered saling with 0.1% (w/v) Tween-20 (TBST)) for 
1 hour at room temperature. The membranes were washed three times in TBST and 
incubated overnight, at 4º C with optimal concentration of primary antibody in 5% 
bovine serum albumin (BSA) (prepared in TBST). Following three washes with 
TBST to remove unbound antibodies, the membranes were incubated with the 
respective horse-radish peroxidase conjugated secondary antibodies in 5% milk with 
gentle shaking for 1 hr at room temperature. The membranes were washed three times 
with TBST to remove excess antibodies and the immuno-complexes were detected by 
using the Supersignal West Pico Chemiluminescence Subtrate. To detect different 
protein in the same membrane, blots were incubated with Restore Western Blot 
Stripping Buffer for 10 mins at 37º C followed by 20 mins incubation at room 
temperatue to removed bounded antibodies. Following three washes with TBST, 
stripped membranes were re-probed with respective primary antibody and secondary 
antibody.  
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2.2.3 Transient Transfection 
 
 Transient transfection for MEF cells was done using Lipofectamine 
RNAiMAX (Invitrogen, Singapore) and Forward Transfection Protocol. MEF cells 
were plated in full growth medium (DMEM) for 24 hours before transfection. On the 
day of the study, 1 hour prior to the transfection, cultured cells were replaced with 
fresh DMEM containing 10% FBS but without antibiotics. Meanwhile, two 
transfection reagents were prepared in two separate tubes - one containing siRNA 
diluted in Opti-MEM® I medium and another containing Lipofectamine™ 
RNAiMAX diluted in Opti-MEM® I medium. The two reagents were then combined 
and mixed gently. After incubation at room temperature for 20 minutes, the 
transfection mixture was added to the respective culture and incubated 37°C	   in	  5%	  CO2	   incubator for further 6 hours. At the end of 6 hours, the culture was replaced 
with fresh DMEM containing 10% FBS. For serum deprivation, MEF cells were 
replaced again with 0.5% FBS 24 hour’s post- transfection and were cultured for 24 
hours before further treatment.  
 
2.2.4 siRNA Transfection 
 
 siRNA transfection was achieved using customized oligonucleotide 
synthesized by Ambion, Austin, TX USA. 5’GGUGGAAAUGAAGAAAGUAtt 
sequence was used to silence Cu-Zn SOD enzyme. A control siRNA (5’ 
GGUCCUCACUUUAAUCCUCtt) was used as a negative control. The transfection 
was done using Lipofectamine RNAiMAX with the final concentration of 10nM 
siRNA Cu-Zn SOD enzyme.  
Chapter	  2:	  Materials	  and	  Methods	   46	  
 
2.2.5 Detection of S-nitrosylated and Oxidized PTEN by Oxidation/Reduction 
 Assay 
 
 Cells seeded at a density of 0.4 x 106 per well in a 100mm tissue culture dish 
were serum deprived (0.5% FBS) for 24 hours. Cells subjected to various 
concentrations of H2O2 were washed once in cold 1 x PBS supplemented with 1mM 
EDTA and 0.1mM neocuproine and then scraped on ice in cold 1 x PBS. After 
pelleting at 2,500g at 4° C for 5 mins, cells were harvested in extraction buffer (100 
mM Tris-HCl, pH 7.8, 150 mM NaCl, 1 mM EDTA and protease inhibitors cocktail). 
Lysates were transferred to new 1.5 ml eppendorf tubes each containing one-tenth 
lysate volume of 10% triton and 50mM NEM. The samples were then incubated in the 
dark at room temperature for 15 mins before being stored at -80° C. Gel 
electrophoresis was performed under a non-reducing condition (using non-reducing 
laemmli loading buffer) to resolve the proteins and both oxidized and reduced PTEN 
were detected by immunoblotting with polyclonal PTEN antibody. To distinguish 
between S-nitrosylated and oxidized PTEN, a set of samples treated with various 
concentration of H2O2 were harvested with extraction buffer supplemented either with 
20mM ascorbate (for S-nitrosylated PTEN) or 200mM DTT (for oxidized PTEN). 
The samples were transferred to the eppendorf tubes containing 10% triton and 50mM 
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2.2.6 Biotin Switch Technique (BST) 
2.2.6.1 Detection of Total Protein and PTEN S-nitrosylation 
 
 Cells seeded at a density of 0.8 x 106 per well in a 150mm tissue culture dish 
were serum deprived (0.5% FBS) for 24 hours before drug treatment. Cells subjected 
to various treatments were washed once in cold 1 x PBS supplemented with 1mM 
EDTA and 0.1mM neocuproine and then harvested on ice in cold 1 x PBS.  After 
centrifuging at 2,500g at 4° C for 5 mins, cells were lysed in 150ul of HENT buffer 
(250mM Hepes (pH 7.8), 1mM EDTA, 0.1mM neocuproine and 1% triton) containing 
protease inhibitors cocktail. Cells debris was removed after pelleting in a 1.5ml 
eppendorf tube at 20,000g at 4° C for 5 mins. Protein concentration was determined 
using Coomassie Plus TM Protein assay reagent. Samples were adjusted with HENT 
buffer to achieve 150ul of total protein in equal concentration. 150ul of blocking 
buffer containing HENS 5% (250mM Hepes (pH 7.8), 1mM EDTA, 0.1mM 
neocuproine, 5% SDS) and 100mM NEM was added to each sample to achieve final 
concentrations of 2.5% SDS and 50mM NEM. Samples were then incubated in the 
dark at 50° C for 20 mins with frequent vortexing (blocking). Three volumes of 
chilled acetone (900ul) were added to each sample at the end of the incubation. 
Proteins were precipitated at -20° C for 20 mins and collected by centrifuging at 
5000g at 4° C for 5 mins. Protein pellets were gently washed twice in 1ml of 70% 
chilled acetone. After removing clear supernatant and resuspension in 200ul of HENS 
1% (250mM Hepes (pH 7.8), 1mM EDTA, 0.1mM neocuproine and 1% SDS), 25ul 
each of 200mM ascorbate and 10mM biotin-HPDP were added to each sample (25ul 
of HENS 1% buffer was added in place of 25ul ascorbate to -ve control sample). This 
labeling step was performed in the dark. Samples were then incubated at room 
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temperature for 1 hour protected from light. Proteins were precipitated again with 
three volumes of chilled acetone (750ul) at -20° C for 20 mins followed by 
centrifuging at 5000g at 4° C for 5 mins and gentle washing in 70% chilled acetone 
for twice. Clear supernatants ware aspirated and protein pellets were resuspended in 
300ul of 1/10 HENS 1% (25mM Hepes (pH 7.8), 0.1mM EDTA, 0.01 neocuproine, 
1% SDS). 30ul of each sample was set aside and used to determine total protein S-
nitrosylation by western blotting on the same day with anti-biotin antibody. 750ul of 
neutralization buffer (25mM Hepes (pH 7.8), 100mM NaCl, 1mM EDTA and 0.5% 
triton) was added to the remaining volume of each sample and transferred to a new 
1.5ml eppendorf tube containing 50ul of streptavidin beads resin. The samples were 
gently rotated at 4° C overnight. The beads were centrifuged at 200g for 10s and 
washed twice in 1ml of wash buffer (25mM Hepes (pH 7.8), 600mM NaCl, 1mM 
EDTA, 0.5% triton) and twice in 1ml of neutralization buffer. After aspirating the 
supernatant, the beads were eluted in 50ul of 1/10 HEN buffer containing 1% beta 
mercaptoethanol) and incubated at room temperature for 20 mins. 10ul of non-
reducing Laemmli loading buffer was added and PTEN-SNO was detected by western 
blotting with anti-PTEN antibody. 
 
2.2.6.2 Detection of Total Protein and PTEN Oxidation 
 
 Biotin switch technique was modified to detect total protein and PTEN 
oxidation. Initial steps were the same as in biotin switch technique to detect total 
protein and S-nitrosylated PTEN. Modification was made in the reducing step in 
which 50mM Dithiothreitol, DTT was used in the place of 50mM ascorbate and 
additional step of protein precipitation with chilled acetone at -20° C for 20 mins was 
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performed before the samples were labeled with biotin-HPDP. The remainder of the 
procedure was the same. 
 
2.2.7 Lucigenin Chemiluminiscence Assay for Detection of Intracellular 
 Superoxide 
 
 Cells were seeded at a density of 0.2 x 106 per well in a 60 mm tissue culture 
plate and were serum deprived (0.5% FBS) for 24 hours before exposure to drug 
treatment. Cells were washed once in 1 x PBS, trypsinized, and then collected in a 
1.5ml microcentrifuge tube after centrifuging at 5,000g for 1 min at room 
temperature. The supernatant was aspirated and cells were then permeabilized with 
450ul of 1 x somatic cell ATP-releasing reagent. Four hundred of 450ul 
permeabilized cell suspension was transferred into a glass tube, which was then 
quickly placed in the tube holder of the Sirius luminometer (Berthold detection 
system, Germany).  After one hundred of 10mM lucigenin solution was injected 
automatically, the reading of chemiluminscence was monitored for 30 secs. The peak 
value of lumininscence was taken and normalized against the protein concentration, 
determined using Coomassie Plus reagent. Intracellular level of O2˙- is reported as a 
change in % of lucigenin luminescence relative to the control.  
 The specificity of lucigenin in detecting O2˙- has been questioned based on the 
observation that the probe itself has the potential to generate O2˙- (Vasquez-Vivar et 
al, 1997). Luminescence occurs when O2˙- reacts with the free radical (LC˙+) obtained 
upon reduction of lucigenin. LC˙+ is prone to auto oxidation giving rise to generation 
of O2˙- as in the following reaction. 
LC˙+ + O2  LC2+ + O2˙- 
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However several studies have defended that this auto oxidation of lucigenin is dose 
dependent and could be avoided by using a low concentration of the probe (Li Y et al, 
1998 & 1999, Munzel T, et al, 2002). Therefore in every set of our experiment, a low 
concentration of lucigenin was used and a blank consisting of the somatic cell ATP 
releasing agent and lucigenin was included and was used to subtract off the 
luminescence contributed by O2˙- generated from any possible auto oxidation of 
lucigenin.  
 
2.2.8 Fluorescence Flow Cytometry Assay for Detection of Intracellular 
 Hydrogen Peroxide, Nitric Oxide and Calcium 
 
 Cells seeded at a density of 0.1 x 106 per well in a 6 well tissue culture plate 
were serum derived (0.5% FBS) for 24 hours prior to various drug treatments. Cells 
were washed once in 1 x PBS and 500ul of 1 x PBS containing 5uM of CM-
H2DCFDA or 5uM of DAF-FM or 5uM of Calcium GreenTM -1 (measuring 
intracellular Ca2+) was loaded to each well. After incubation at 37° C for 30 mins 
protected from light, cells were trypsinized and collected in a 1.5ml microcentrifuge 
tube. The supernatant was removed after pelleting the cells at 5,000g at 4° C for 1 
min. The cell pellet was washed twice in cold 1 x PBS, and then resuspended in 400ul 
of cold 1 x PBS. The cell suspension was filtered through a filter (pore size ~ 41 µm) 
before being loaded into BD FACSCanto II Flow Cytometer. DCFDA, DAF and 
Calcium Green fluorescence were measured using the laser channel for FITC. 
Intracellular levels of H2O2, NO˙ and Ca2+ were reported as a change in % of mean 
fluorescence relative to the control. 
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 Although H2DCFDA is widely used as an intracellular probe for detecting 
H2O2, it does not itself react with H2O2. However H2O2 facilitates oxidation of 
H2DCFDA via intermediate catalysts such as cytochrome c, heme, Fe3+ or Cu2+ 
(Cathart R et al, 1983, LeBel CP et al, 1992, Wardman P 2007), which are usually 
present either in the medium or within the cells. The strong oxidants, which can cause 
direct oxidation of H2DCFDA include decomposition products of ONOO-, OH˙ and 
HOCl (Crow JP, 1997; Kooy NW et al, 1997; Tarpey MM et al, 2004). H2DCFDA 
has a very low reactivity towards O2˙-, which could be of value to distinguish the 
identity of these two radicals when used in conjunction with lucigenin probe for O2˙-. 
DAF-FM is a fluorinated fluorescein derivative used in many studies to measure 
intracellular NO˙. Its reaction with NO˙ results in DAF-triazole that is intensely 
fluorescent (Nagano T, 2009). However it has been suggested that fluorescent triazole 
formation from the probe comes from nitrosation reaction with higher NOx such as 
N2O3 (Williams DHL, 2004; Wardman P 2007). 
 
2.2.9 Statistical Analysis 
 
 Results were calculated as means ±SE. Statistical analysis was done using the 
paired Student's t-test from Microsoft Excel software (Redmond, WA, USA) with 
p<0.05 considered significant. 	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CHAPTER 3: RESULTS 
___________________________________________________ 
 
3.1 INCREASE IN INTRACELLULAR O2˙- INDUCES GENERALIZED 
 PROTEIN S-NITROSYLATION  
 
 O2˙- has been shown to have mitogenic activities (Suh YA et al, 1999; Zhang 
Y et al, 2002) and participate in signal transduction (Bloomfield G and Pears C, 2003; 
Huang WC et al, 2002). However, due to low reactivity, there is little evidence that 
O2˙- causes direct oxidation to the proteins to alter their functions. Over the years, our 
group has demonstrated the survival benefit of an increase in the level of intracellular 
O2˙- ranging from inhibition of apoptotic cell death to drug resistance by tumor cells 
(Clement MV and Stamenkovi I, 1996; Pervaiz S et al, 1999; Pervaiz S et al, 2001). 
The first insight into mechanistic explanation for pro-survival effect of O2˙- came 
from our recent report that an increase in the level of intracellular O2˙- activates 
survival kinase Akt via S-nitrosylation and inactivation of tumor suppressor, PTEN, 
which is the negative regulator of PI3K/Akt pathway (Lim S and Clement MV, 2007). 
Considering the requirement of NO˙ for S-nitrosylation, we hypothesize that there 
exists a pathway by which initial oxidative signal by O2˙- leads to formation of one of 
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3.1.1  Serum withdrawal causes a reduction in basal production of 
 intracellular O2˙- 
  
 Growth factors are known to generate ROS including O2˙- (Bae YS et al, 1997; 
Griendling KK et al, 1994; Krieger-Brauer HH et al, 1992; Ohba M et al, 1994; 
Sundaresan M et al, 1995). Serum is a mixture of various components including 
growth factors. One aim of the current study is to find out if O2˙- produced by growth 
factors oxidizes proteins by S-nitrosylation. Thus to eliminate the effect of growth 
factors contributing to O2˙- production, we set out to remove serum from cell culture 
and establish the baseline. Throughout the project, we would use mouse embryonic 
fibroblast (MEF) because it is an immortalized cell line widely used as a non-
tumorigenic model to study various cellular processes and the current project is the 
continuation of our previous work that use MEF as a model (Lim S and Clement MV, 
2007). 
 
Figure 7: Serum withdrawal results in a decrease in base level O2˙- production.  
MEF cells were cultured in normal growth medium containing 10% fetal bovine serum 
(FBS). A set of MEF cultures were serum deprived (0.5% FBS) whereas fresh 10% FBS were 
replaced for another set and both sets were grown for further 24 hours. Intracellular O2˙- level 
was assessed by lucigenin luminescence assay as described in Materials and Methods. The 
result represents mean ± SD of three independent triplicate experiments.  *p < 0.05 compared 
to the control.  
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 The figure 7 showed that MEFs grown in 0.5% FBS had a lower level of 
intracellular O2˙- than cells grown in the presence of 10% FBS. This is contrary to the 
previously studies reporting that serum starvation is associated with increased ROS 
production, particularly, mitochondrial O2˙- as measured by MitoSOX, a 
mitochondrial O2˙- indicator (Lee SB et al, 2010). Furthermore, this increased ROS 
production is believed to play an important role in triggering cell death upon serum 
deprivation (Bae YS et al, 2011). In our experiments, serum deprivation does not 
seem to affect cell viability for as long as we follow up in our experiments, for 
example, up to 48 hrs after serum deprivation (Fig 16). It could be argued that 
removing serum is not physiological but the aim of our study is to investigate the 
effects of growth factors including serum that generate ROS including O2˙ in the 
acute setting immediately after ligand binding. Therefore removal of serum from our 
experimental set-up would allow us to start from baseline to which we would 
introduce various measures designed to increase either intracellular O2˙- or other ROS. 
 
3.1.2  Pharmacological inhibition of Cu-Zn SOD leads to an increase in 
 intracellular O2˙- without concurrent rise in H2O2 level 
 
 Having established the baseline, we next planned to manipulate the 
intracellular level of O2˙- by inhibiting a cytosolic enzyme, Cu-Zn SOD that catalyses 
dismutation of O2˙- to H2O2. Dismutation of O2˙- is a rapid spontaneous process but 
presence of SOD enzymes makes the reaction approximately 106 faster (Fridovich I, 
1983) and SOD enzyme activity is essential to keep the level of O2˙- low in the cells 
(Fukai T & Ushio-Fukai M, 2011). We employed diethyldithiocarbamate (DDC) an 
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intracellular copper chelator, and Cu-Zn SOD inhibitor that is widely used in the 
study of Cu-Zn SOD function (Lushchak V et al, 2005).    
 Among various O2˙- detection methods such as cytochrome c reduction, 
nitroblue tetrazolium reduction, adrenochrome formation,	   aconitase inhibition, 
lucigenin luminescence, hydroethidine oxidation,	   electron spin resonance and spin 
trapping, we use lucigenin luminescence assay in all our experiments because 
although it is prone to auto oxidation at high concentration, it is specific to detect O2˙- 
(Afanas'ev IB, 2001; Tarpey MM and Fridovich I, 2001; Tarpey MM et al, 2004) and 
only requires simple experimental tools (lucigenin reagent and luminometer). 
Hydroethidine oxidation assay is considered superior to lucigenin luminescence assay 
in terms of better sensitivity and specificity for detection of O2˙- but the former assay 
requires HPLC separation of O2˙- derived reaction products before fluorescence 
detection (Zielonka J et al, 2008 & 2009).  
 Lucigenin luminescence assay in Figure 8 (A) shows that inhibition of Cu-Zn 
SOD by DDC resulted in a steady rise in the level of intracellular O2˙- with time. This 
was accompanied by the reduction in the level of H2O2 as evidenced by reduced 
DCFDA fluorescence as in Figure 8 (B). But initial decrease in H2O2 level upon Cu-
Zn SOD inhibition is followed later by a trend of gradual increase in DCFDA 
fluorescence. H2DCFDA is a cell permeable probe widely used to detect intracellular 
H2O2 (Tarpey MM  et al, 2004; Wardman P, 2007) but as mentioned in Materials and 
Methods, there are other radical species such as ONOO-, OH˙, HOCl that can also 
cause DCFDA oxidation (Crow JP, 1997; Kooy NW et al, 1997; Tarpey MM et al, 
2004). The data thus suggests that prolonged inhibition of Cu-Zn SOD may lead to 
accumulation of not only O2˙- but also secondary radical species other than H2O2. 
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Figure 8: Inhibition of Cu-Zn SOD by 1mM DDC caused an increase in 
intracellular O2˙- production but a decrease in intracellular H2O2  
MEF cells were plated in normal culture medium containing 10% FBS and then serum 
deprived at 0.5% FBS for 24 hours before treatment with 1mM DDC for indicated times. 
Intracellular O2˙⋅ and H2O2 levels were assessed by using lucigenin luminescence assay (A) 
and DCFDA fluorescence assay (B) respectively as described in Materials and Methods. The 
result represents mean ± SD of three independent triplicate experiments. * p < 0.05 compared 
to the control.  
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3.1.3 Detection of protein S-nitrosylation  
3.1.3.1 Oxidation/reduction assay 
 
  Previously, we used an oxidation/reduction assay to detect S-nitrosylated 
PTEN (Lim S and Clement MV, 2007). The assay requires that under non-reducing 
condition, oxidized proteins move at a different rate from non-oxidized proteins 
allowing them to be visibly separated in gel electrophoresis (Lee SR et al, 2002). This 
is made possible by two factors - alkylating agent, N-ethylmaleimide (NEM) used to 
block reduced thiols adds extra molecular weight to the reduced form of the protein, 
and some proteins undergo configuration change upon oxidation making them to 
migrate faster in gel electrophoresis. The nature of oxidative modification is 
determined by using specific agents that reduce only a particular type of oxidation. 
For example, ascorbate specifically reduces protein S-nitrosylation whereas 
dithiothreitol, DDT is a non-specific agent reducing all reversibly oxidized proteins. 
The limitation of the assay is that it detects only one protein at a time and applicable 
to certain proteins that display different electrophoresis mobility upon oxidation such 
as PTEN and Akt (Lee SR et al, 2002; Lim S and Clement MV, 2007; Murata H et al, 
2003). The overview of the assay is given below together with a result from our 
previous work.  
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   (Taken from Lim S and Clement MV, 2007) 
Figure 9: Overview of oxidation/reduction assay  
Addition of a thiol specific alkylating agent, NEM gives extra molecular weight to the 
reduced protein. That together with conformational change caused by oxidation allow visible 
separation of oxidized and reduced proteins when they are run in gel electrophoresis under 
non-reducing condition. Oxidized protein that is reduced by ascorbate is S-nitrosylated 
protein whereas DTT reduces all types of oxidation (A). Our previous work reported that 
PTEN oxidation caused by 1mM DDC is reducible upon ascorbate treatment thus 
demonstrating that the nature of oxidation is by S-nitrosylation or SNO modification whereas 
500uM H2O2 treatment causes oxidation in PTEN that is not reduced by ascorbate but by DTT 
meaning that the nature of oxidation is by non-SNO modifications (B). 
 
3.1.3.2 Biotin Switch Technique 
 
 Realizing the limitation of oxidation/reduction assay, we decided to use an 
assay that allows detection of both global S-nitrosylation of proteins and specific 
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targets. The assay is referred to as “Biotin Switch Technique (BST)” or “Biotin 
Switch Assay” as mentioned in Materials and Methods. This is a robust assay to 
detect S-nitrosylated proteins and is very widely used in many studies (Forrester MT 
et al, 2008, 2009; Hess DT, 2009). The summary of the workflow of biotin switch 
technique is given in the following diagram.  
 
Figure 10: Overview of biotin switch technique 
In the first step, free thiols (-SH) are blocked with alkylating agent, N-ethylmaleimide 
(NEM). Secondly, S-nitrosylated proteins (-SNO) are reduced with ascorbate leaving other 
forms of oxidative modification such as disulphide (-S-S) untouched. Thirdly, nascent free 
thiols are labeled with thiol specific agent, biotin-HPDP (N-[6-(Biotinamido)hexyl]-3´-(2´-
pyridyldithio)propionamide). Lastly, total SNO-proteins are detected by immunoblotting with 
antibiotin or biotin labeled proteins are pulled down with streptavidin beads followed by 
immunoblotting with specific antibodies to detect any particular target SNO-proteins.  
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Modification of the assay is also employed to detect other types of oxidation, for 
example, replacing ascorbate with dithiothreitol (DDT) to assay for all forms of 
oxidative modification (Boivin B et al, 2008).  
 Although BST is a well-recognized assay for detection of protein S-
nitrosylation, there are methodological issues and concerns raised about it.  The assay 
is prone to false positive results. One reason for false positivity is incomplete blocking 
of free thiols with the alkylating agent prior to labeling with thiols-targeted 
biotinylating agent, biotin-HDPD. When this happens, biotin-HDPD will label these 
free thiol residues together with newly generated thiols derived from ascorbate 
treatment. Another reason is non-specific labeling by biotin-HDPD. At high 
concentration, biotin-HDPD could target not only thiols but also other amino acid 
residues. To ensure the BST assay is free from these false positive results, in every 
experiment set, one sample is processed without the reducing agent, for example, 
ascorbate for S-nitrosylation. Any signal appearing in the sample not treated with 
ascorbate would then indicate either false positive signals coming from incompletely 
blocked free thiols and non-specific labeling by biotin HDPD or endogenous 
biotinylated proteins (Forrester MT et al 2009). As described in the introduction, 
protein S-nitrosylation is a very labile post-translational modification highly 
susceptible to degradation; spontaneously or by UV light or transition metals (Hess 
DT et al, 2005). Biotin switch assay is a long process involving various harsh 
treatment conditions. To prevent SNO-degradation, the assay should proceed with 
appropriate expediency and in an environment completely free from contamination 
with reducing agents and transition metals. One of the strong criticisms on the use of 
BST to detect S-nitrosylated proteins is specificity of ascorbate to reduce only S-NO.  
One group reported that ascorbate could reduce disulphide bonds in the proteins 
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(Landino LM  et al, 2006). It is also claimed that ascorbate itself could introduce false 
positive signals in BST (Huang B & Chen C, 2006). In response to these reports, 
Forrester MT et al explain that this apparent false positive result introduced by 
ascorbate comes from reaction of the latter with UV light including indirect light 
sources (Forrester MT et al, 2007). In the study, they demonstrate that exposure to 
light induces artifactual biotinylation resulting from reduction of aryl disulphides or 
thiyl radicals by semidehydroascorbate. Therefore it is essential that BST must be 
performed under protected condition from light sources. In the same study, it is also 
pointed out that reduction of other oxidative modifications by ascorbate is 
thermodynamically unfavorable and instead reduction of SNO by ascorbate is a 
highly efficient process, particularly when performed under alkaline condition. All in 
all, it is important to realize that BST despite being a robust and widely used assay to 
detect S-nitrosylated proteins, is prone to false positive and negative signals. And 
some authorities have recommended that the results obtained by BST should be 
validated with alternative assays for S-nitrosylation such as chemiluminescence and 
fluorescence based assays or using SNO specific antibody (Hess DT et al, 2009; 
Mannick JB & Schonhoff CM, 2008). 
 Bearing in mind all these methodological issues, we set out to apply the assay 
in our system. We carried out two experiments as follows: firstly, we used a NO˙ 
donor, Deta NONoate that slowly releases NO˙ at physiological pH under aqueous 
condition and secondly, CysNO that directly S-nitrosylates proteins by 
transnitrosylation.  
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Figure 11: Both NO˙ donor and tranS-nitrosylating agent induce protein S-
nitrosylation in mouse embryonic fibroblasts.  
MEF cells grown in full medium condition containing 10% FBS were serum deprived (0.5% 
FBS) for 24 hours before treatment with 100uM Deta-NONOate for the indicated times (A) or 
various concentrations of CysNO for 15 mins (B). Total protein S-nitrosylation was assessed 
using biotin switch technique as described in Materials and Methods. Representative blots out 
of at least two independent experiments are shown. 
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 In figure 11 (A) and (B), there was little or no signal in the sample not treated 
with ascorbate (Lane 1 in either figure). As described above, the sample without 
ascorbate treatment should be clean of signals other than background endogenously 
biotinylated proteins. Thus these results thus demonstrate that there are very little 
endogenously biotinylated proteins in MEFs and blocking of thiols during the assay is 
adequate. There was also very little basal S-nitrosylation in serum deprived MEFs 
(Lane 2 of Fig. 11 (A) and (B)). Slow release NO˙ donor, Deta-NONOate 100uM 
induced generalized protein S-nitrosylation starting from 30 mins (Fig. 11 (A)). Half-
life of Deta-NONOate is 20 hours at 37˙C thus providing steady release of NO˙ into 
the culture medium for a long period of time (Joseph AH, 1993). One mole of Deta-
NONOate release 2 moles of NO˙ (Keefer LK et al, 1996) and according to our result, 
100uM Deta-NONOate is sufficient to induce protein s- nitrosylation. As discussed 
above, NO˙ induced S-nitrosylation is achieved by promoting the formation of S-
nitrosylating intermediates rather than by directly adding NO group to the target 
proteins. This result (Fig.11 (A)) thus suggests that NO˙ introduced into MEF cells 
was effectively converted to S-nitrosylating intermediates required for protein S-
nitrosylation. On the other hand, the transnitrosylating agent, CysNO induced protein 
S-nitrosylation in a dose dependent manner (Fig. 11 (B)). Based on these results 
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3.1.4 Both pharmacological inhibition and siRNA gene silencing of Cu-Zn SOD 
 induce protein S-nitrosylation 
 
 We have previously shown that activation of survival kinase, Akt by increased 
intracellular O2˙- correlates with S-nitrosylation and inactivation of its negative 
regulator, PTEN (Lim S and Clement MV, 2007). In that study, increased intracellular 
level of O2˙- was achieved by the inhibition of the O2˙- dismutation by Cu-Zn SOD 
enzyme. We then hypothesized that there could be many proteins other than PTEN 
that are S-nitrosylated because inhibition of Cu-Zn SOD results in generalized 
increase in intracellular O2˙- level that could oxidize various target proteins. Having 
established validity of biotin switch technique, we next ask if O2˙- mediated S-
nitrosylation also involves other proteins than PTEN.  
 As in our previous study, we set out to increase intracellular O2˙- by inhibiting 
Cu-Zn SOD enzyme with DDC and then we assessed the status of total protein S-
nitrosylation. Figure 12 shows that 1mM DDC treatment induced S-nitrosylation 
affecting a wide range of proteins. Although there was an increasing level of 
intracellular O2˙- with time by DDC treatment (Fig.8 (A)), DDC-induced protein S-
nitrosylation leveled off with no further increase after 30 mins treatment (Fig. 12) 
suggesting that there might be a certain limiting factor on protein S-nitrosylation 
induced by increasing level of O2˙-. 
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Figure 12: Pharmacological inhibition of Cu-Zn SOD induces protein  
S-nitrosylation 
MEF cells grown in full medium condition were serum deprived (0.5% FBS) for 24 hours 
before they are treated with 1mM DDC for the indicated times. Total protein S-nitrosylation 
was assessed by biotin switch technique as described in Materials and Methods. 
Representative blot out of at least three independent experiments is shown. 
 
 DDC is a potent copper chelator that binds and sequestrates both protein 
bound and free copper. Decomposition of S-nitrosylated proteins is catalysed by 
transition metal ions, particularly, copper (Stamler JS. & Toone EJ, 2002; Benhar M 
et al, 2009). Thus to protect protein lysates from SNO decomposition, the buffer for 
biotin switch assay contains two metal ion chelators, one of which is neocuproine, a 
copper chelator. There could be some doubt that DDC increases protein S-
nitrosylation by action of copper chelation rather than through an increase in O2˙- 
production. To address this, we proceeded to silence the expression of Cu-Zn SOD 
enzyme with siRNA and measured ROS production and protein S-nitrosylation. 





Figure 13: siRNA gene silencing of Cu-Zn SOD led to an increase O2˙- in 
production, a decrease in H2O2 level and induction of protein S-nitrosylation 
MEF cells were transfected with siRNA for Cu-Zn SOD enzyme or a control siRNA and after 
24 hour post-transfection, cells were serum deprived (0.5% FBS) for further 24 hours. 
Intracellular O2-⋅ and H2O2 levels were assessed by using lucigenin luminescence assay and 
DCFDA fluorescence assay respectively (A) and (B). The result represents mean ± SD of 
three independent triplicate experiments. * p < 0.05 compared to the control.  Total protein S-
nitrosylation was assessed using biotin switch technique (C).  Representative blot out of two 
independent experiments is shown. 
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 As with pharmacological inhibition by DDC, gene silencing using a specific 
siRNA for Cu-Zn SOD caused an increase in intracellular O2˙-  (Fig. 13 (A)). On the 
contrary, no significant change in the amount of H2O2 was detected using DCFDA 
fluorescent probe (Fig. 13 (B)). Under the same condition, siCu-Zn SOD induced 
protein S-nitrosylation (Fig. 13 (C)) strongly supporting that it is really the 
accumulation of O2˙- due to a decrease in activity of Cu-Zn SOD and not from copper 
chelating effect of DDC that caused general protein S-nitrosylation shown in figure 
12. 
 
3.2 PHYSIOLOGICALLY RELEVENT CONCENTRATIONS OF H2O2 
 INDUCE PROTEIN S-NITROSYLATION WHEREAS HIGH 
 CONCENTRATION OF H2O2 CAUSES NON-SNO OXIDATIVE 
 MODIFICATIONS 
 
 Since the discovery that H2O2 was generated and required for growth factors 
signaling (Sundaresan M et al, 1995; Bae YS et al, 1997), most of the signaling 
function of ROS has been attributed to H2O2.  In contrast to O2˙-, H2O2 is more stable, 
diffuses easily through biological membranes, and is reactive towards thiolate (S-) 
thereby capable of directly oxidizing proteins. Protein tyrosine phosphatases (PTPs) 
are most extensively studied among the targets of H2O2 during signal transduction.  
Various forms of oxidative modification have been reported, which result from direct 
oxidation by H2O2 (Denu JM et al, 1998; Lee SR et al, 2002; Salmeen A et al, 2003; 
Van Monfort RL et al, 2003). These include reversible oxidative modifications such 
as disulphide formation, suphenic acid and sulpheny-amide intermediates, and 
irreversible sulphonic acid and sulphinic acid formations. However, whether it is the 
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concentration of H2O2 or intrinsic biochemical properties of the target proteins that 
determine the type of oxidative modification caused by H2O2 is not clear. Despite its 
favourable chemistry as a signaling radical, the rate of intracellular production of 
H2O2 is tightly controlled not only because it can cause irreversible direct oxidations 
but also because of its propensity to be reduced to OH˙ radical by metal catalyzed 
Fenton reaction with subsequent cellular toxicity. 
 Among various reports on oxidative modification by H2O2, two particular 
studies came to our attention. In 2002, Lee et al demonstrated that upon exposure to 
H2O2, the tumor suppressor PTEN was inactivated by formation of disulphide bond 
between the active site cysteine 124 and neighbouring cysteine 71 using purified 
PTEN proteins (Lee SR et al, 2002). Since then subsequent studies and literature 
review refer to oxidative inactivation of PTEN as disulphide bond (Cho SH et al, 
2004; Kwon J et al, 2004; Salmena L et al, 2008). This is different from our recent 
report demonstrating that PTEN inactivation and oxidation by O2˙- is via S-
nitrosylation (Lim S and Clement MV, 2007). Our literature search came up with 
another study reporting that mild oxidative stress by low level of H2O2 causes S-
nitrosylation and inhibition of PTPs such as SHP1 and SHP2  (Barrett DM et al, 
2005). The amount of H2O2 used in that study is only up to 100uM in contrast to the 
study by Lee SR et al (2002) that employs up to 2mM H2O2. Thus we hypothesized 
that H2O2 could cause different forms of oxidation modification of proteins depending 
on its concentration. To ascertain that exogenous H2O2 enters the cells in 
proportionately to the concentrations used, we first measured intracellular ROS level 
upon treatment with various concentrations of H2O2 using the DCFDA fluorescent 
probe.  
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 Figure 14 (A) shows that MEF cells exposed to increasing concentrations of 
H2O2 caused a dose-dependent increase in intracellular H2O2 level. This is in 
agreement with the fact that H2O2 diffuses freely across the cell membrane along the 
concentration gradient (Cai H, 2005; Stone JR and Collins T, 2002; Stone JR and 
Yang S, 2006). The result thus reveals that exogenous treatment with H2O2 is suitable 
to study effect of different concentrations of H2O2 inside the cells.  All concentrations 
of H2O2 tested here do not affect intracellular O2- level in contrast to treatment with 
1mM DDC for 2 hours that significantly increases O2˙- production (Fig. 14 (B)). 
Taken together, further observations made out of all exogenous H2O2 treatments 













Figure 14: Exogenous H2O2 treatment increases intracellular H2O2 level but has 
no effect on O2˙- production.  
MEF cells grown in normal cultur medium were serum deprived (0.5% FBS) for 24 hours 
before treatment with indicated concentrations of H2O2 for 10 minutes. Intracellular H2O2 and 
O2˙⋅ were measured using DCFDA fluorescence flow cytometry (A) and lucigenin 
luminescence assay (B) as described in Materials and Methods. The result represents mean ± 
SD of three independent triplicate experiments. * p < 0.05 compared to the control. 
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 We next assessed the effect of different concentrations of H2O2 on oxidative 
modification of proteins in MEF cells. Our main interest is to find out if H2O2 causes 
protein S-nitrosylation or other forms of oxidative modification (non-SNO 
modifications). To distinguish between these two possibilities, we employed the 
biotin switch technique in two different ways. First, we used ascorbate as a specific 
reducing agent for S-nitrosylation as described in biotin switch technique protocol. 
Second, ascorbate was replaced with dithiothreitol DTT, a general thiol reducing 
agent. As shown in Figure 15 (A), degree of S-nitrosylation increased with increasing 
concentration of H2O2 from 25uM to 100uM but at 500uM, S-nitrosylation signal 
greatly diminished.  In contrast, in Figure 15 (B) where DTT was used, there was a 
dose-dependent increase in protein oxidation with H2O2. As previously mentioned, 
oxidative modifications reduced by DTT include S-nitrosylation, disulphide bond 
formation, glutathionylation and sulphenic acid formation. H2O2 could cause a 
mixture of oxidative modifications. However, according to figure 15 (A) and (B), at 
low concentrations of H2O2 (25uM to 100uM), protein S-nitrosylation predominates 
but at 500uM of H2O2, there are mainly non-SNO modifications.   
 
 




Figure 15: Protein S-nitrosylation occurs predominately at low concentrations of 
H2O2 although H2O2 causes protein oxidation in a dose dependent manner  .  
MEF cells were serum deprived (0.5% FBS) for 24 hours and then treated with various 
concentrations of H2O2 for 10 minutes. Total protein S-nitrosylation was assessed using biotin 
switch technique (A) and  and total protein oxidation was assessed by modified biotin switch 
technique using DTT as a reducing agent in place of ascorbate (B). Representative blots out 
of at least two independent experiments are shown. 
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 As discussed above, H2O2 is a precursor to formation of OH˙. The higher the 
concentration of H2O2 used, the more toxic it could be to the cells. Thus we proceeded 
to determine the effect of the range of concentration of H2O2 we used in the previous 
experiment on cell viability. We observed cell morphological changes after treatment 
with various concentration of H2O2. As seen in figure 16, viability of MEF cells 
remained unaffected up to 50uM of H2O2 but there was reduction in number of cells 
after prolonged incubation with 100uM of H2O2 starting from 2 hours treatment. In 
the cells exposed to 500uM H2O2, there was obvious disruption in cell morphology, 
and after 24 hours incubation, no viable cells remained in the culture. The result 
clearly demonstrates that 500uM of H2O2 is very toxic to the cells.  Taken together, 
the data indicate that non-SNO modifications induced by 500uM H2O2 are associated 
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Figure 16: High concentration of H2O2 is toxic to the cells. 
MEFs were serum deprived (0.5% FBS) for 24 hours before treatment with 25uM, 50uM, 
100uM and 500uM H2O2 for up to 24 hours. Morphological changes were photographed at 
indicated times.  
 
 Having established that physiologically relevant concentrations of H2O2 
predominately induce protein S-nitrosylation, we next followed the kinetics of 50uM 
H2O2 treatment to assess the pattern of protein S-nitrosylation by low dose H2O2.  
Figure 17 (A) shows that S-nitrosylation caused by 50uM H2O2 is time dependent 
coming back to basal level after 1 hour. This correlates well with the level of H2O2 
that shows an initial increase before coming back to basal level (Fig 17 (B)). This data 
thus indicate that protein S-nitrosylation caused by low concentration of H2O2 is 
reversible and follows the presence of H2O2 in the cells. 
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Figure 17: 50uM H2O2 induces protein S-nitrosylation in a time dependent 
manner. 
MEF cultures were serum deprived (0.5%FBS) for 24 hours before treatment with 50uM 
H2O2 for indicated times. Protein S-nitrosylation was assessed using biotin switch technique 
(A) and intracellular H2O2 was measured using DCFDA fluorescence flow cytometry (B). 
The result represents mean ± SD of three independent triplicate experiments. * p < 0.05 
compared to the control. Representative blot out of three independent experiments is shown. 
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3.3 PROTEIN S-NITROSYLATION INDUCED BY GROWTH FACTORS 
 
 After showing that an increase in intracellular O2˙- and low concentration of 
H2O2 both cause protein S-nitrosylation, we proceeded to investigate redox 
modifications of proteins by growth factors that generate these two ROS. Despite the 
established association of increase in intracellular level of ROS upon growth factors 
binding to cognate receptors, only a few studies have investigated the mechanistic 
aspect of growth factors-induced redox modification of proteins. One study reported 
that treatment with peptide growth factors such as PDGF and EGF results in 
reversible oxidation and inactivation of tumor suppressor PTEN but the nature of 
oxidative modification in that study was not well defined (Kwon J et al 2004). 
Therefore, we carried out the following experiments to assess and determine the type 
of oxidative modification that occurs during growth factors signaling.  
 Here, we decided to study the effect of PDGF and EGF on protein S-
nitrosylation because both are frequently used in many studies on growth factors 
induced ROS signaling (Chen K et al, 2008; Maulik N, 2002). We chose the 
concentration of PDGF and EGF as close to that used to study their physiological 
functions, which is indicated in the product literature as ED50 that is	  defined as the 
effective concentration of growth factor that elicits a 50% increase in cell growth in a 
cell based bioassay (Sporn MB and Roberts AB, 1991). And 10% FBS treatment was 
included in the study since it is the condition that is normally used to maintain cell 
growth and proliferation in various culture systems. We first measured ROS 
production upon treatment with various growth factors. Figure 18 (A) shows that 
10ng PDGF significantly increases H2O2 production at 15 minutes before coming 
back to baseline one hour post-incubation. Both 50ng EGF and 10% FBS were also 
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found to increase H2O2 to the similar level as in 10ng PDGF treatment after 10 
minutes incubation (Fig. 18 (B)). Lucigenin assay in figure 18 (C) reveals that out of 
three growth factors, only 10% FBS significantly increased intracellular O2˙- 
production. The results obtained were consistent with previous studies reporting that 
growth factors such as PDGF and EFG generate H2O2 upon receptor binding (Bae YS 
et al, 1997; Goldkorn T et al, 1998; Sundaresan M et al, 1995). In some studies, O2˙-  
is detected after stimulation with ligands such as PDGF, interleukin 1 (IL 1), 
recombinant interferon-gamma (IFN-gamma) and angiotensin II ( (Marumo T et al, 
1997; Matsubara T et al, 1986; Zimmerman MC et al, 2002) but we observed 
detectable generation of O2˙-  only in 10% FBS treatment. Note that 10% FBS is a 
mixture of growth factors and various other ligands, which could bind to their cellular 
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Figure 18: ROS production during growth factors signaling. 
Serum deprived (0.5%FBS) MEF cells were treated with 10ng PDGF, 50ng EGF and 10% 
FBS for indicated times. Intracellular H2O2 and O2˙⋅ were measured using DCFDA 
fluorescence flow cytometry (A)&(B) and lucigenin luminescence assay (C) as described in 
Materials and Methods. The result represents mean ± SD of three independent triplicate 
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 As shown in Figure 19, treatment with 10ng PDGF, 50ng EGF and 10% FBS 
all resulted in S-nitrosylation that involves a wide range of proteins. There was a 
sustained increase in protein S-nitrosylation with PDGF treatment before falling back 
to baseline level as in untreated sample at 2 hours post-incubation (Fig 19 (A)). EGF 
stimulation caused an initial peak of protein S-nitrosylation followed by rapid 
reduction in signal, which was maintained at 2 hours incubation (Fig 19 (B)). It is 
well known that EGF signaling is short-lived and is terminated upon receptor 
internalization that occurs rapidly after ligand binding. In Figure 19 (C), 10% FBS 
strongly induced protein S-nitrosylation in 5 minutes and signal strength began to 
diminish after 15 mins but it was still maintained even after treatment for 24 hours. 
Despite some difference in signal strength and time kinetics, all three growth factors 
induce generalized protein S-nitrosylation and the process occurs immediately after 
ligand binding suggesting that protein S-nitrosylation is part of their physiological 
signaling. 
   
 
 




Figure 19: Growth factors induced protein S-nitrosylation  
MEF cells were serum deprived (0.5% FBS) for 24 hours before treatment with 10ng PDGF 
(A), 50ng EGF (B) and 10% FBS (C) for the indicated times. Total protein S-nitrosylation 
was assessed using biotin switch technique as in Materials and Methods. Representative blots 
out of at least three independent experiments are shown. 
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 Since PDGF is classically associated with intracellular H2O2 generation, we 
next asked if increasing concentrations of PDGF would induce corresponding level of 
H2O2 in the cells. As previously shown, H2O2 oxidizes proteins in different manners 
depending on concentration; S-nitrosylation predominant at lower concentrations and 
non-SNO types of modification induced at high concentration (500uM H2O2). 
Therefore, one might expect that different concentrations of PDGF could cause 
different types of oxidative modification in a similar way as what was shown with 
H2O2. To address this question, we first measured the production of H2O2 upon 
treatment with increasing concentrations of PDGF.  
 As can be seen from figure 20 (A), H2O2 was generated in all treatments, but 
there was no linear relationship between H2O2 generation and PDGF concentration. 
This is in contrast to treatment with exogenous H2O2 in which the higher the 
concentration of H2O2, the higher the intracellular H2O2 level is achieved (Fig. 13 
(A)). As for O2˙- generation, there still was no detectable production with all 
concentrations of PDGF tested (Fig. 20 (B)). Under the same condition, we next 
assessed the pattern of protein oxidation. Figure 20 (C) shows that similar degree of 
protein S-nitrosylation was induced at all concentrations of PDGF from 5ng to 250ng. 
This again is different from the pattern of oxidation with H2O2 treatment in which 
high concentration favours non-SNO modifications over protein S-nitrosylation. In 
figure 20 (C), there was little S-nitrosylation with 500uM H2O2 treatment. These data 
reveal that growth factors do not generate toxic level of H2O2. Hence it is tempting to 
propose that S-nitrosylation would be favoured over other types of oxidative 
modification upon growth factors stimulation.  
 




Figure 20: Protein S-nitrosylation is maintained in the presence of high 
concentration of PDGF treatment. 
Serum deprived MEF (0.5% FBS) were treated with various concentrations of PDGF for 10 
mins. Intracellular H2O2 and O2⋅-  were measured using DCFDA fluorescence flow cytometry 
(A) and lucigenin luminescence assay as before (B). The result represents mean ± SD of three 
independent triplicate experiments. * p < 0.05 compared to the control. Total protein S-
nitrosylation was assessed by biotin switch technique and 10 mins 500uM H2O2 treatment was 
included for comparison (C). 
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3.4 OXIDATIVE MODIFICATION OF TUMOR SUPPRESSOR PTEN BY 
 ROS AND GROWTH FACTORS 
 
 In our previous study, we showed that the tumor suppressor, PTEN is S-
nitrosylated upon an increase in intracellular concentration of O2˙- (Lim S and 
Clement MV, 2007). We demonstrated above that not only increased intracellular O2˙- 
level but also low concentration of H2O2 and growth factors such as PDGF and EGF 
and 10% FBS all induce generalized protein S-nitrosylation (Fig. 17 and Fig. 19 (A) 
to (C)). We then asked if PTEN is one of the targets of S-nitrosylation under theses 
conditions. And we also hypothesize that our observation of H2O2 causing different 
types of protein oxidation depending on concentration could be applicable to PTEN. 
First, we set out to assess the validity of biotin switch assay to detect S-nitrosylated 
PTEN (SNO-PTEN). As detailed in Materials and Methods, detection of SNO-PTEN 
involves immunoprecipitation of biotin labeled proteins with strepavidin beads and 
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Figure 21: Slow release NO˙ donor, Deta-NONOate and tranS-nitrosylating 
agent, CysNO cause S-nitrosylation of PTEN 
MEF cells were cultured in full medium condition and were serum deprived at 0.5% FBS for 
24 hours before they are treated with 100uM Deta-NONOate for the indicated times (A) or 
various concentrations of CysNO for 15 mins. PTEN S-nitrosylation was assessed by biotin 
switch technique as described in Materials and Methods. Representative blots out of at least 
two independent experiments are shown. 
  
 As seen in figure 21 (A), S-nitrosylation of PTEN began as early as 10 mins 
and it was maintained up to last time point of the experiment.  As mentioned above, 
since Deta-NONOate is a slow release NO˙ donor with half-life of approximately 24 
hours, PTEN S-nitrosylation is maintained for a few hours. As with total protein S-
nitrosylation, CysNO induces S-nitrosylation of PTEN in a dose dependent manner 
(Fig. 21 (B)).  
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Figure 22: Exposure of cells to O2˙-, H2O2 and PDGF all S-nitrosylate tumor 
suppressor, PTEN in a time dependent manner. 
MEF cells grown in full medium condition were serum deprived (0.5% FBS) for 24 hours and 
then underwent various treatments for indicated times or MEF were transfected with either 
sicontrol or siRNA SOD1 enzyme for gene silencing as in figure 13. S-nitrosylation of PTEN 
was assessed using biotin switch technique as described in Materials and Methods. 
Representative blots out of at least three independent experiments are shown. 
 
 Having established the assay, we used the same conditions as in figures 11, 12 
(C), 16(A) and 18 (A) to assess S-nitrosylation of PTEN. As seen in figure 22 (A), an 
increase in intracellular O2˙- that induces total protein S-nitrosylation in figures 12 and 
13 (C) also caused PTEN S-nitrosylation. In figure 22 (B) and (C), 50uM H2O2 and 
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10ng PDGF treatment caused PTEN S-nitrosylation in a similar way that they induce 
total protein S-nitrosylation in the previous experiments above. The data thus clearly 
demonstrate that tumor suppressor PTEN is one of the targets of protein S-
nitrosylation that is induced by O2˙-, low concentration of H2O2 and a physiological 
ligand, PDGF. 
 We next determined the pattern of PTEN oxidation at different concentrations 
of H2O2 and PDGF. First, we employed the oxidation/reduction assay used in the 
study by Lee SR et al and Lim S & Clement MV (Lee SR et al, 2002, Lim S and 
Clement MV, 2007) to assess the degree of PTEN oxidation by various concentrations 
of H2O2. In figure 23 (A), at 25uM H2O2 treatment, all of oxidized PTEN was reduced 
by ascorbate. Ascorbate could also partially reduce oxidized PTEN at 50uM and 
100uM H2O2 but it failed to reduce any of PTEN oxidized by 500uM H2O2. The 
classical biotin switch assay in figure 23 (B) shows that there was little S-nitrosylation 
of PTEN at 500uM of H2O2 but instead PTEN was oxidized by non-SNO 
modifications as revealed in figure 23 (C) using modified biotin switch assay using 
DTT in place of ascorbate as a reducing agent. The data clearly indicate that PTEN S-
nitrosylation only occurs at low concentrations of H2O2 and the higher the 
concentration of H2O2, the larger the proportion of PTEN oxidized by other 
modifications that could be glutathionylation, sulphenic acid formation and disulphide 
bond formation. Considering our current data, it comes as no surprise that disulphide 
bond is formed between Cys 71 and Cys 124 by high concentration of H2O2 used in 
the study by Lee SR et al (Lee SR et al, 2002). However, when it comes to a 
physiological ligand, we observe a different phenomenon. Figure 23 (D) shows that 
despite increasing concentrations of PDGF treatment, PTEN S-nitrosylation was 
equally induced. These data thus inform us that although it is possible that PTEN can 
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be oxidized by various modifications, it is preferably SNO-PTEN that occurs under 
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Figure 23: S-nitrosylation of PTEN predominately occurs at low concentrations 
of H2O2 while it is equally induced by all concentrations of PDGF treatment. 
MEF cells were subjected to treatment with various concentrations of either H2O2 or PDGF 
after serum deprivation (0.5% FBS) for 24 hours.  S-nitrosylation of PTEN was assessed 
using electrophoretic mobility shift assay (A), and biotin switch technique (B) & (D) whereas 
oxidation of PTEN was assessed using modified biotin switch assay (C) and electrophoretic 
mobility shift assay (A) as described in Materials and Methods. Representative blots out of at 
least two independent experiments are shown. 
 
  
3.5 PROCESS OF PROTEIN S-NITROSYLATION  
3.5.1 Intracellular NO˙ is decreased with an increase in O2˙- generation 
 whereas it is actively synthesized by H2O2 and growth factors  
 
 The pre-requisite for S-nitrosylation to occur by any stimulants is the 
involvement of NO˙ to form S-nitrosylating intermediates (Hess DT et al, 2005). 
Classical stimulants for S-nitrosylation are various NO˙ donors and transnitrosylating 
agents such as GSNO and CysNO. We presented above two scenarios of protein S-
nitrosylation that are initiated by oxidative stimulants - O2˙- and H2O2. These oxidants 
must somehow involve intracellular NO˙ to transform oxidative signal to nitrosative 
signal. To this end, we assessed the change in the level of intracellular NO˙ after 
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oxidative challenge. Intracellular NO˙ is assessed either by measuring the activity of 
NOS enzymes or directly measuring the level of NO˙ using florescent probes (Nagano 
T, 2009). Using fluorescent probes might have an advantage of detecting change in 
intracellular NO˙ level independent of NOS activity. As describe in Materials and 
Methods, we use DAF fluorescent probe that is specific to NO˙ and resistant to 
photobleaching among various fluorescence probes (McQuade LE and Lippard SJ, 
2009; Nagano T, 2009) . 
 Previously, we observed that either 1mM DDC treatment or transfection of 
cells with a specific siRNA for Cu-Zn SOD enzyme caused an increase in the level of 
intracellular O2˙-.  Figure 24 (A) & (B) show that the same conditions used to increase 
O2˙- decreased the level of intracellular NO˙. In H2O2 treatments, there was a linear 
increase in the level of intracellular NO˙ following exposure to increasing 
concentrations of H2O2 (Fig. 24 (C)). NO˙ reacts very readily with O2˙- at diffusing 
limited rate to form ONOO- but this reaction is normally limited by the high activity 
of SOD enzymes in the cells that dismutate O2˙- to H2O2 thus preventing the former 
from reacting with NO˙ (Pacher P et al, 2007).  The current data thus indicate that 
intracellular NO˙ may be consumed in the reaction with increasing level of O2˙- 
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Figure 24:  Increase in intracellular O2˙- is associated with decrease in 
intracellular NO˙ level whereas exogenous H2O2 treatments cause increased 
production of intracellular nitric oxide. 
Serum starved MEF cells (0.5% FBS) were exposed to 1mM DDC for 2 hours (A) and 
various concentrations of H2O2 for 10 mins (C). SiRNA gene silencing for Cu-Zn SOD 
enzyme was carried out as in figure 13 (B). Intracellular NO˙ level was measured using DAF 
fluorescence assay as described in Materials and Methods. The result represents mean ± SD 
of three independent triplicate experiments. * p < 0.05 compared to the control. 
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 Having observed the different outcomes of intracellular NO˙ upon an increase 
in intracellular O2˙- and H2O2, we next assessed the effect of PDGF, EGF and 10% 
FBS on NO˙ level in the cells. As seen in figure 25, various concentrations of PDGF, 
50ng EGF and 10% FBS all increased the intracellular level of NO˙. The result is thus 
similar to that obtained with H2O2 treatment. 
 
 
Figure 25: PDGF, EGF and 10% FBS all increase intracellular NO˙. 
Serum starved MEF cells (0.5% FBS) were subjected to treatment with PDGF, EGF and 10% 
FBS for the indicated times. DAF fluorescence assay was used to measure intracellular NO˙ 
The result represents mean ± SD of three independent triplicate experiments. * p < 0.05 
compared to the control. 
 
 To sum up, our data reveal that intracellular NO˙ is invariably involved in one 
way or another (either up or down) in the process of protein S-nitrosylation induced 
by oxidants and growth factors. Intracellular NO˙ is increased upon treatment with 
H2O2, PDGF, EGF and 10% FBS that then could be converted to S-nitrosylating 
intermediates to induce protein S-nitrosylation. That is in agreement with findings in 
which protein S-nitrosylation occurs as a result of increased NOS activity or NO˙ 
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production (Forrester MT et al, 2007 & 2009; Hess DT et al, 2005; Jaffrey SR and 
Snyder SH, 2001). On the other hand, intracellular NO˙ is decreased upon increased 
production of O2˙-. That suggests that NO˙ is consumed in the reaction with O2˙- to 
form ONOO-, which is one of S-nitrosylating intermediates for protein S-
nitrosylation. Above, we did not measure NOS activity. Although there is no report on 
the presence of any predominate NOS isoform in MEFs, these cells have been used to 
study the role of NO˙ and NOS in oxidative signaling pathways (Lu W et al, 2009). 
Presumably, there could be certain isoforms of NOS expressed in MEFs such as 
eNOS and nNOS, which has a wide tissue distribution other than endothelial and 
neuronal cells (Alderton W et al 2001; Förstermann U et al, 1998; Mayer B et al, 
1989; Salter M et al, 1991). In the current study, we are more interested in change in 
the level of intracellular NO˙ that could have more meaningful implications in terms 
of formation of S-nitrosylating intermediates. Having said that, we understand that 
there is some doubt about presence of NO˙ in the cells prior to stimulation of NOS. 
However considering presence of NO˙ storage molecules such as GSNO and nitrites 
in the cells, we speculate that there could be basal level of free NO˙, which exists in 
equilibrium with them. 
 
3.5.2 Identification of S-nitrosylation species for oxidants- and growth factors- 
 induced S-nitrosylation 
 
 As discussed above, since S-nitrosylation is mediated by S-nitrosylating 
species rather than NO˙ itself, we went on to identify S-nitrosylating intermediates 
responsible for S-nitrosylation induced by low oxidative stress and growth factors. 
PDGF will be used to represent the effect of growth factors because it is the most 
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commonly studied growth factor involved in ROS signaling (Chiarugi P and Cirri P, 
2003; Chiarugi P and Fiaschi T, 2007; Kamata H and Hirata H,1999; Marmo T et al, 
1995; Sundaresan M et al, 1995).  
 Since NO˙ is essential for formation of S-nitrosylating intermediates, we first 
set out to remove NO˙ using intracellular NO˙ scavenger, c-PTIO. As seen in figure 
26, pretreatment of the cultures with c-PTIO effectively prevented total protein and 
PTEN S-nitrosylation induced by DDC, H2O2 and PDGF. The result thus 
demonstrates that oxidants and growth factors induced protein S-nitrosylation is 
dependent on intracellular NO˙.  
 
Figure 26:  Intracellular NO˙ is essential for protein S-nitrsylation induced by 
O2˙-, H2O2 and PDGF. 
Serum deprived (0.5% FBS) MEF cells were pre-treated with 250uM c-PTIO for 1 hour 
before exposure to 1mM DDC for 2 hours, 50uM H2O2 and 10ng PDGF for 10 mins. Total 
protein and PTEN S-nitrosylation were assessed using biotin switch technique. Representative 
blot out of at least three independent experiments are shown.  
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 As an intracellular NO˙ scavenger, c-PTIO removes both pre-existing and 
newly synthesized NO˙. To determine the role of new NO˙ production in protein S-
nitrosylation, we also inhibited the activity of nitric oxide synthase (NOS) enzyme. 
Since there is no dominant form of NOS reported for MEF, we decided to use non-
specific NOS inhibitor, L-NMMA. As could be seen in figures 27 (A), (C) and (D), L-
NMMA pretreatment partially prevented protein S-nitrosylation induced by 1mM 
DDC, 50uM H2O2 and 10ng PDGF varying from little effect in DDC treatment to 
substantial reduction of protein S-nitrosylation in PDGF treatment. Previously, we 
have seen that an increase in O2˙- level caused by either pharmacological inhibition or 
gene silencing of Cu-Zn SOD enzyme is accompanied by a decrease in intracellular 
NO˙. One possible explanation is that NO˙ reacts with O2˙- in the absence of 
competing Cu-Zn SOD function, which subsequently leads to formation of 
peroxynitrite (ONOO-) (Beckman JS and Koppenol WH, 1996; Ducrocq C et al, 
1999; Pacher P et al, 2007). Since ONOO- is one of S-nitrosylating intermediates, we 
predict that it could mediate protein S-nitrosylation induced by O2˙-. To test this 
hypothesis, we set out to remove intracellular ONOO-. For this purpose, we would use 
ONOO- decomposition catalyst, FeTPPS. FeTPPS belongs to a class of compounds 
called metalloporphyrins, which have a basic porphyrin structure with a bound metal 
(Mn or Fe) at the centre (Rabkin SW and Klassen SS, 2008). Decomposition 
mechanism involves formation of intermediate compounds with the metal centre, and 
regeneration of the catalyst and conversion of ONOO- into non-toxic products such as 
nitrite and nitrate at the end (Shimanovich R and Groves JT, 2001). 
Metalloporphyrins are widely used not only as a specific intracellular scavenger but 
also they have been proposed as therapeutic drugs to combat against ONOO- mediated 
cellular toxicity (Ferdinandy P et al, 2000; Lancel S et al, 2004; Nangle MR et al 
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2004; Rabkin SW and Klassen SS, 2008). Fe based metalloporphyrins such as 
FeTPPS, FeTMPS and FeTMPyP have been observed to catalyze the breakdown of 
ONOO- more rapidly than Mn based compounds such as MnTBAP and MnTMPyP 
(Crow JP 1999; Lee J et al, 1998; Shimanovich R and Groves JT, 2001).   In figures 
27 (A) and (B), pretreatment with 10uM FeTPPS effectively prevented protein S-
nitrosylation caused by both DDC treatment and siRNA silencing of Cu-Zn SOD 
enzyme. Similar results were obtained with H2O2 and PDGF (Fig. 27 (C) and (D)). 
This data similar to what was found with an increase in intracellular level of O2˙- thus 
indicates that ONOO- may also be involved in protein S-nitrosylation triggered by 
H2O2 and PDGF. The results of one of S-nitrosylation target proteins, PTEN also 
supports those seen with total protein S-nitrosylation (Fig. 27 (A) to (D)).  
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Figure 27: Total protein and PTEN S-nitrosylation induced by O2˙-, low 
concentration H2O2 and PDGF may depend on formation of peroxynitrite. 
Serum deprived MEFs (0.5% FBS) were pretreated with non-specific nitric oxide synthase 
(NOS) inhibitor, L-NMMA 100uM for 24 hours or peroxynitrite decomposition catalyst, 
FeTPPS 10uM for 1 hour before exposure to 1mM DDC (A), 50uM H2O2 (C) and 10ng 
PDGF (D) for indicated times. Transfection with either siSOD1 RNA or sicontrol RNA was 
carried out in fig. 13 followed by treatment with 10uM FeTPPS and 250uM c-PTIO for 1 
hour. Total protein and PTEN S-nitrosylation were assessed using biotin switch technique. 
Representative blots out of at least two independent experiments are shown. 
 
 We next assessed the change in intracellular level of NO˙ caused by 
pretreatments with NO˙ scavenger, cPTIO and pan-NOS inhibitor L-NMMA. 
However, when we attempted to measure intracellular NO˙ level with DAF 
fluorescent probe after cPTIO pretreatment, we did not see any reduction of NO˙  
(data not shown). Our literature search reveals that although cPTIO is a well 
established and widely used NO˙ scavenger (Barchowsky A et al, 1999; Jung C et al, 
2010; Turpaev K et al, 2004; Xu L et al, 2007), its reaction products with NO˙ 
contribute to false positive signals in DAF fluorescence assay (Planchet C and Kaiser 
WM, 2006; Thomas S, 2007; Vitecek J et al, 2008).  With L-NMMA pretreatment, 
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our result shows that it effectively prevented new NO˙ production by 50uM H2O2 and 
10ng PDGF but L-NMMA did not cause any further reduction in NO˙ level caused by 
DDC treatment (Fig. 28). The slight reduction of DDC induced protein S-nitrosylation 
by L-NMMA pretreatment in figure 27 (A) could result from reduction in pre-existing 
level of NO˙ rather than prevention of new synthesis because O2˙- is not known to 
activate NOS and the figure 28 also reveals that there was a significant reduction in 
basal level of intracellular NO˙ level after incubation with L-NMMA for 24 hours. To 
sum up, our current data suggest that low concentration of H2O2 and PDGF utilize 
both pre-existing and newly synthesized NO˙ to induce protein S-nitrosylation 
whereas O2˙- induced protein S-nitrosylation is dependent on pre-existing NO˙, and 
ONOO- is a common S-nitrosylating species mediating S-nitrosylation that occurs 
under these conditions.  
 
Figure 28: L-NMMA reduces basal production of NO˙ in MEF cells and prevents 
new production of NO˙ stimulated by low concentration of H2O2 and PDGF. 
Serum deprived MEFs (0.5% FBS) were pretreated with non-specific nitric oxide synthase 
(NOS) inhibitor, L-NMMA 100uM for 24 hours before exposure to 1mM DDC, 50uM H2O2 
and 10ng PDGF for the indicated times. Intracellular NO˙ was detected by DAF fluorescent 
flow cytometry assay. The result represents mean ± SD of three independent triplicate 
experiments. * p < 0.05 compared to the control. 
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3.5.3 Peroxynitrite: oxidation vs nitration 
 
 ONOO- is formed as a product of reaction between O2˙- and NO˙ that occurs at 
diffusion-controlled rate (Patcher P et al, 2007). It is highly unstable and decomposes 
into various oxidative and nitrosative products, many of which are extremely toxic to 
the cells (Patcher P et al, 2007; Szabó C et al, 2007). Therefore, its rate of formation 
is strictly controlled and its production is highly localized. The critical balance is 
achieved by controlling three key factors, two precursors- O2˙- and NO˙, and 
superoxide dismutase (SOD), which due to cellular abundance, outcompetes NO˙ for 
O2˙- thereby keeping the formation of ONOO- in check (Beckman JS and Koppenol 
WH, 1996; Ducrocq C et al, 1999; Pacher P et al, 2007). Traditionally increased 
ONOO- formation is synonymous with cellular toxicity and detection of 3-
nitrotyrosine (3-NT) is used as a footprint of increased ONOO- formation and cellular 
toxicity (Beckman JS and Koppenol WH, 1996). As a strong oxidant, ONOO- is 
capable of causing various types of oxidation such as sulphenic acid formation, 
disulphide bond formation and glutathionylation (Ducrocq C et al, 1999). It is also 
proposed to be a potent S-nitrosylating agent (Paolocci N et al, 2000). Despite its high 
potential for toxicity, ONOO- is also shown to serve as a physiological regulator 
(Ferdinandy P, 2006; Szabó C et al, 2007). For example, non-toxic concentration of 
ONOO- (100uM) promotes survival of U937 cells through mitochondrial 
translocation of PKC-α (Cerioni L et al, 2006). ONOO- has also been reported to 
activate VEGF signaling in endothelial cells independent of its nitration mechanism 
(El-Remessy AB et al, 2007). However, the type of modification subserving 
physiological signaling function of ONOO- is not clear. Considering its high 
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reactivity, we hypothesize that ONOO- might behave in a similar way as H2O2 in 
causing various types of oxidative modification depending on concentration.  
 To this end, we assessed the status of S-nitrosylation and 3-NT formation by 
various concentrations of exogenous pure ONOO-. As could be seen in figure 29 (A), 
there was a significant amount of protein S-nitrosylation including PTEN from 50uM 
to 250uM ONOO-, but at 1mM concentration, the S-nitrosylation signal greatly 
diminished. As for 3-NT proteins, it began to appear at 250uM ONOO- and there was 
a significant formation of 3-NT with 1mM peroxynitrite treatment (Fig. 29 (B).  In 
figure 29 (C), c-PTIO had no effect on protein S-nitrosylation induced by 100uM 
ONOO- but it is preventable by FeTPPS pretreatment indicating that protein S-
nitrosylation by exogenous ONOO- is independent of intracellular NO˙. Our data 
demonstrate that ONOO- follows the similar pattern as H2O2 in causing S-
nitrosylation at low concentration but other types of oxidation at high concentration. 
Furthermore, at 1mM of ONOO-, 3-nitrotyrosine formation, that is the marker of 
cellular toxicity caused by ONOO-, becomes very distinct as detected by antibody 
specific for 3-nitrotyrosine. Occurrence of non-SNO modifications at a concentration 
of ONOO- (1mM) where there is significant 3-nitrotyrosine formation suggests that 
these oxidative modifications are associated with cellular toxicity by ONOO-.  
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Figure 29: Low concentrations of exogenous ONOO- induce total protein and 
PTEN S-nitrosylation whereas at high concentration, it causes non-SNO 
oxidative modifications and 3-NT formation. 
Serum deprived (0.5% FBS) MEF cells were treated with various concentration of ONOO- as 
indicated in (A) and (B) for 10 mins. Under similar condition, serum deprived MEFs were 
pretreated with either 250uM c-PTIO or 10uM FeTPPS for 1 hour before exposure to 100uM 
ONOO- for 10 mins. Total protein and PTEN S-nitrosylation was assessed with biotin switch 
technique (A) and (C) and 3-NT proteins were detected by western blot using a specific 
antibody as described in Materials and Methods. The drawing in (A) illustrates range of 
concentration ONOO- where protein S-nitrosylation occurs and the drawing in (B) represents 
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3.5.4 Role of calcium in protein S-nitrosylation caused by ROS and PDGF 
 
 We observed above that there is an increase in level of intracellular NO˙ 
following incubation with H2O2 and PDGF (Fig. 24 (C) and Fig. 25). And we also 
discovered that this increase in NO˙ is preventable by pretreatment with L-NMMA 
thus demonstrating that the newly produced NO˙ comes from increased activity of 
NOS (Fig. 29). But how NOS activity was stimulated by H2O2 and PDGF was not 
clear. One of key regulators of NOS activity is calmodulin, CaM. Among three NOS 
isoforms, nNOS and eNOS require a high intracellular Ca2+ concentration to bind to 
CaM thus distinguishing them from iNOS that has a low Ca2+ requirement for CaM 
binding and activation. Thus iNOS is constitutionally active and its activity is under 
expression control. iNOS is mainly expressed in immune cells whereas expression of 
eNOS and nNOS is widely distributed (Alderton WK et al 2001). Since most 
stimulants for eNOS and nNOS act by increasing the intracellular Ca2+ level, we set 
out to assess the level of Ca2+ following an increase in intracellular level of O2˙- or 
exposure to H2O2 and PDGF. 
 As shown in figure 30, 50uM H2O2 increased intracellular Ca2+ level whereas 
10ng PDGF treatments did not cause any change.	  Considering the requirement of Ca2+ 
for NOS activation, our data suggest that increased activity of NOS in MEF cells by 
H2O2 could be through the release of Ca2+. However, since there is no change in the 
level of intracellular Ca2+ with PDGF, we could only speculate that the activation of 
NOS and NO˙ production by PDGF is Ca2+ independent. So far there is no evidence 
that PDGF directly activates NOS but recently, the small GTPase Rac, which lies 
downstream of receptor tyrosine kinase (RTK) including PDGF receptor was shown 
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to regulate the activity of the constitutively-expressed NOSs such as eNOS and nNOS 
(Selvakumar B et al, 2008).  
 
Figure 30: 50uM H2O2 causes an increase in intracellular Ca2+ whereas 10ng 
PDGF has on effect on intracellular Ca2+ level. 
Serum deprived MEFs (0.5% FBS) were subjected to treatment with 50uM H2O2and 10 ng 
PDGF for 10 mins.  Release of intracellular Ca2+ was measured using calcium green 
fluorescent probe as described in Materials and Methods. The result represents mean ± SD of 
three independent triplicate experiments. * p < 0.05 compared to the control. 
 
 The literature abounds in reports of a causal relation between an increase in 
intracellular Ca2+ and activation of NOS (Alderton WK et al 2001; Bredt DS and 
Snyder SH, 1990; Bredt DS, 1999; Weiner CP et al, 1994) but there is no direct 
evidence linking release of Ca2+ to protein S-nitrosylation. Thus we decided to study 
the effect of an increase in cytosolic Ca2+ on protein S-nitrosylation. Here we use the 
drug, thapsigarin, which is an inhibitor of ER Ca2+ pump preventing its uptake of Ca2+ 
from the cytosol. As shown in figure 31 (A), 1uM thapsigarin increased the basal 
level of intracellular Ca2+ (cytosolic), and the level of Ca2+ was further increased 
when H2O2 was added but not with addition of PDGF. That increase in cytosolic Ca2+ 
was accompanied by a rise in intracellular NO˙ from the baseline as well as additional 
Chapter	  3:	  Results	   105	  
increase with both PDGF and H2O2 treatments (Fig. 31 (B)). Biotin switch assay in 
figure 31 (C) reveals that 1uM thapsigarin caused an increase in both basal protein S-
nitrosylation (total and PTEN) as well as that induced by 10ng PDGF treatment. The 
line of evidence above thus demonstrates that release of Ca 2+ causes protein S-
nitrosylation through activation of NOS that increases intracellular NO˙ production. 
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Figure 31: Intracellular release of Ca2+ enhances protein S-nitrosylation through 
activation of NOS. 
Serum deprived MEFs (0.5% FBS) were pretreated with the intracellular Ca 2+ pump 
inhibitor, thapsigarin 1uM for 2 hours before exposure to either 10ng PDGF or 50uM H2O2 
for 10 mins. Intracellular Ca 2+ and NO˙ was measured by using calcium green and DAF 
fluorescence assays respectively (A) and (B). The result represents mean ± SD of three 
independent triplicate experiments. * p < 0.05 compared to the control. Total protein and 
PTEN S-nitrosylation were assessed by biotin switch technique (C). Representative blot out 
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3.5.5 GSNOR inhibition enhances protein S-nitrosylation  
 
 As with phosphorylation/dephosphorylation, the process of S-nitrosylation 
culminates in de-nitrosylation. Previously de-nitrosylation was thought to be a 
spontaneous process, but it was recently discovered that protein de-nitrosylation is 
facilitated by two enzyme systems involving S-nitrosoglutathione reductase (GSNOR) 
and thioredoxin reductase (TrxR) which act as physiological denitrosylases (Benhar 
M et al, 2009).  GSNOR influences the degree of protein S-nitrosyltion by regulating 
the amount of GSNO, which exists in equilibrium with protein-SNOs. Genetic 
knockout of GSNOR results in an increase in both cellular protein-SNOs and GSNO 
(Foster MW et al, 2009). Similarly, pharmacological inhibition of GSNOR with the 
compound C3, a GSNOR inhibitor that prevents the binding of GSNOR to GSNO 
substrate, leads to accumulation of both GSNO and protein-SNOs (Sanghani PC et al, 
2009). Using this drug, we intend to study the effect of GSNOR inhibition on protein 
S-nitrosylation induced by H2O2 and PDGF.  
 As mentioned previously in figure 6, GSNOR works through metabolism of 
GSNO. Inhibition of GSNOR would result in accumulation of GSNO. Since GSNO is 
a NO˙ storage molecule, we hypothesize that inhibition of its metabolism could 
influence intracellular NO˙ level. Therefore, we set out to measure intracellular NO˙ 
upon inhibition of GSNOR. Figure 32 (A) shows that GSNOR inhibition not only 
increased basal NO˙ level but also enhanced NO˙ production by 50uM H2O2 and 10ng 
PDGF suggesting that there is a dynamic equilibrium between GSNO and NO˙. In 
figure 32 (B), 2 hours incubation of MEF with 6uM C3 increased basal total S-
nitrosylation, which was completely prevented by c-PTIO co-incubation, indicating 
that S-nitrosylation by GSNOR inhibition is NO˙ dependent. Overall, our data suggest 
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that the process of de-nitrosylation mediated by GSNOR is partly through influencing 
the level of intracellular NO˙. 
 
 
Figure 32: Enhancement of protein S-nitrosylation by GSNOR inhibition is 
through an increase in intracellular NO˙ 
Serum deprived MEFs (0.5% FBS) were pretreated with 6uM C3 for 2 hours before 
incubation with 10ng PDGF or 50uM H2O2 for 10 mins. Intracellular NO˙ was measured 
using DAF fluorescence assay as before (A). The result represents mean ± SD of three 
independent triplicate experiments. * p < 0.05 compared to the control. In (B), serum 
deprived MEFs (0.5% FBS) were incubated with 250uM c-PTIO or 6uM C3 alone or with 
both drugs for 2 hours before total protein S-nitrosylation was assessed using biotin switch 
technique. Representative blot out of two independent experiments is shown. 
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 Having observed that inhibition of GSNOR increased basal protein S-
nitrosylation, we next assessed its effect on stimulated protein S-nitrosylation. As 
expected, inhibition of GSNOR enhanced total protein and PTEN S-nitrosylation 
induced by 50uM H2O2 and 10ng PDGF (Fig. 33 (A) and (B)). C-PTIO pretreatment 
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Figure 33. A GSNOR inhibitor, C3 enhances total protein and PTEN S-
nitrosylation induced by H2O2 and PDGF.  
Serum deprived MEFs (0.5% FBS) were pretreated with 250uM c-PTIO or 6uM C3 for 2 
hours before exposure to 50uM H2O2 or 10ng PDGF for 10mins. Total protein and PTEN S-
nitrosylation was assessed by biotin switch technique. Representative blots out of at least two 
independent experiments are shown.  
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3.5.6 Inhibition of O2˙- production enhances protein S-nitrosylation through an 
 increase in intracellular NO˙ 
 
 We have seen above that scavenging ONOO- prevents S-nitrosylation induced 
by O2˙-, H2O2 and PDGF demonstrating that ONOO- is a common S-nitrosylating 
agent.  Since O2˙- is necessary for ONOO- formation, preventing O2˙- production 
could affect S-nitrosylation that occurs during PDGF signaling. 
 We used DPI, a NADPH oxidase inhibitor to reduce O2˙- generation. Before 
the experiment, we predicted that preventing O2˙- production would prevent ONOO- 
formation, thus preventing S-nitrosylation. However to our surprise, DPI treatment 
resulted in an increase in both basal and PDGF-stimulated S-nitrosylation as shown in 
figure 34 (A). And the same figure shows that DPI-enhanced protein S-nitrosylation 
was not preventable by FeTPPS pretreatment, but it was attenuated by c-PTIO 
meaning that S-nitrosylation is no longer mediated by ONOO-. To understand this 
finding, we measured the level of two precursors of ONOO-- O2˙- and NO˙. As could 
be seen in figure 34 (B), although there was no significant change in O2˙- level with 
DPI treatments, both basal level and PDGF stimulated NO˙ production was 
significantly increased following incubation with DPI. DPI is not known to activate 
nitric oxide synthase (NOS). On the contrary, it has been shown to inhibit NOS 
activity since it is a potent flavoprotein inhibitor (Stuehr DJ et al, 1991; Wang YX et 
al, 1993). Failure to detect any significant reduction in O2˙- level with DPI treatment 
could be because there is not much of O2˙- generation under 0.5% serum condition. In 
fact, there is a significant reduction in basal level of when DPI is added to MEFs 
growing in 10% FBS (data not shown). Under 0.5% FBS condition, it seems that it 
makes less O2˙- available to react with NO˙ allowing the latter to go up and the excess 
Chapter	  3:	  Results	   112	  
NO˙ then could participate in S-nitrosylation. When this happens, it is no longer 
ONOO- mediating S-nitrosylation. It is clear from our data that prevention of O2˙- 
production alone is not enough to prevent S-nitrosylation as decreased O2˙- level in 
one hand allows more NO˙ available in the other hand that forms S-nitrosylation 
intermediates other than ONOO- and subsequently, S-nitrosylation is maintained.  
 
 
Figure 34: Inhibition of O2- generation enhances protein S-nitrosylation 
MEF cultures were serum-deprived (0.5% FBS) for 24 hours and then pretreated with 6uM 
DPI for 1 hour before exposure to 10 ng PDGF for 10 mins or co-incubated with 6uM DPI 
and either 10uM FeTPPS or 250uM c-PTIO for 1 hour followed by treatment with 10ng 
PDGF for 10 mins. Total protein was assessed by biotin switch technique (A). Intracellular 
O2˙- and NO˙ were measured by using lucigenin luminescence assay and DAF fluorescence 
assay respectively (B). The result represents mean ± SD of three independent triplicate 
experiments. * p < 0.05 compared to the control. Representative blot out of two independent 
experiments is shown. 
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3.6 PROTEIN S-NITROSYLATION IN SIGNAL TRANSDUCTION 
 
 We have presented above different means of manipulating low level oxidant 
and growth factors induced S-nitrosylation such as preventing S-nitrosylation by 
scavenging essential intracellular nitric oxide or the relevant S-nitrosylating species 
(ONOO-), and enhancing S-nitrosylation by inhibiting GSNOR or making NO˙ more 
available in O2˙-/ NO˙ balance. We next set out to find out how these measures could 
affect growth factor signal transduction.  
 
3.6.1 Scavenging ONOO- prevents PDGF activation of Akt kinase whereas 
 GSNOR inhibition enhances it 
 
 Akt is a key kinase of PI3K/Akt signaling that is activated upon growth factors 
binding to their receptors. Phosphorylation of Akt can result from two key events - 
activation of PI3K and inactivation of PTEN. As discussed above, PTEN is a redox 
sensitive phosphatase and is subject to various oxidative modifications. Oxidation and 
inactivation of PTEN is necessary to maintain Akt phosphorylation. In many of the 
experiments above, we have demonstrated that PTEN is one of the targets of protein 
S-nitrosylation induced by O2˙-, low concentration H2O2 and growth factors. Here, we 
would employ the same treatments that influence PTEN S-nitrosylation to assess their 
effects on PDGF signal transduction.  
 First, we assessed the effect of scavenging ONOO- and inhibiting GSNOR on 
PDFG signaling since ONOO- is the putative S-nitrosylating species for PDGF 
induced S-nitrosylation and GSNOR inhibition generally enhances protein S-
nitrosylation (basal as well as stimulated). As shown in figure 35 (A), pretreatment 
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with 10uM FeTPPS completely abolished Akt phosphorylation actived by 10ng 
PDGF demonstrating that ONOO- is the physiologically relevant radical generated 
during PDGF signaling and it is required for signal transduction. One the other hand, 
GSNOR inhibition enhanced both amplitude and duration of Akt activation (Fig: 35 
(B)). Taken together with the data showing that PDGF induces PTEN S-nitrosylation, 
which is prevented by FeTPPS and enhanced by GSNOR inhibition (Fig. 27 (D) and 
Fig. 32 (B)), our data suggest that it is protein S-nitrosylation that facilitates PDGF 
activation of Akt kinase by targeting PTEN, the negative regulator of PI3K/Akt 
signaling pathway.  
 
Figure 35: Scavenging ONOO- prevents Akt-phosphorylation by PDGF whereas 
GSNOR inhibition enhances it. 
Serum deprived (0.5% FBS) MEF cells were pretreated with 10uM FeTPPS for 1 hour (A) or 
6uM C3 for 2 hours (B) before exposure to 10ng PDGF for indicated times. Phosphorylation 
of Akt was assessed by western blotting as described in Materials and Methods. 
Representative blots out of at least three independent experiments are shown.  
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3.6.2 O2˙-/ NO˙ Balance in Signal Transduction 
 
 We observed above that scavenging intracellular NO˙ with cPTIO prevents 
total protein and PTEN S-nitrosylation induced by PDGF. Now, we would like to 
assess how the same measure affects Akt activation by PDGF. Figure 36 (A) shows 
that c-PTIO pretreatment did not prevent Akt phosphorylation stimulated by PDGF. 
This is contrary to our expectation considering that c-PTIO abolished PDGF induced 
PTEN S-nitrosylation (Fig. 26). But upon measuring intracellular ROS, we found out 
that there was a significant increase in the level of both O2˙- and H2O2 by c-PTIO 
treatment (Fig: 36 (B)). This prompt us to hypothesize that although PTEN S-
nitrosylation is prevented, increased ROS level caused by c-PTIO treatment could still 
activate Akt. For example, H2O2 is known to directly activate PI3K (Radisavljevic 
ZM and González-Flecha B, 2004; Tu VC et al, 2002). This notion was supported by 
the findings in figure 36 (C) that showed that co-incubation of c-PTIO with the anti-
oxidant N-acetyl cysteine (NAC) greatly attenuated Akt phosphorylation stimulated 
by PDGF, and in figure 36 (D) that shows that NAC prevented c-PTIO enhanced ROS 
production. Our data provide the evidence that removing NO˙ alone to prevent S-
nitrosylation does not stop signal transduction, which is continued under increased 
oxidative stress.  
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Figure 36: NO˙ scavenging increases intracellular ROS level that maintains Akt 
phosphorylation  
Serum deprived (0.5% FBS) MEF cells were pretreated with 250uM c-PTIO for 1 hour (A) 
and (B) or pretreated with 5mM NAC for 2 hours followed by co-incubation with c-PTIO 
250uM for further 1 hour (C) and (D) before exposure to 10ng PDGF for indicated times. Akt 
phosphorylation was assessed by western blotting. Intracellular O2- and H2O2 were measured 
by lucigenin luminescence and DCFDA fluorescence assays respectively. The result in (B) 
represents mean ± SD of three independent triplicate experiments. * p < 0.05 compared to the 
control. 
 
 We have shown above that prevention of O2˙- generation alone does not 
prevent PDGF induced S-nitrosylation because there is more NO˙ available after DPI 
treatment (Fig. 34 (A) and (B)). The same is true for signal transduction as seen in 
figure 37 (A) that shows that PDGF stimulated Akt phosphorylation remained 
unaffected by DPI treatment. But when NO˙ was removed simultaneously by c-PTIO 
treatment, Akt phosphorylation by PDGF was prevented (Fig:  37 (B)). This 
combination was previously shown to be effective in preventing S-nitrosylation 
induced by PDGF (Fig. 34 (A)). All in all, the results from figure 36 and 37 point to 
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Figure 37: Inhibition of O2˙- alone does not affect Akt activation by PDGF but 
simultaneous removal of NO˙ prevents it. 
Serum deprived (0.5% FBS) MEF cells were incubated with 6uM DPI alone or 6uM DPI 
together with 250uM c-PTIO for 1 hour before being treated with 10 ng PDGF for indicated 
times. Akt phosphorylation status was determined by western blot technique as described in 
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3.6.3 ONOO- mediates Akt activation by O2˙- and low concentration of H2O2 
  
 In our previous study, we reported that increasing intracellular O2˙-   activates 
Akt kinase through S-nitrosylation of PTEN (Lim S and Clément MV, 2007). 
Following up on this study, we demonstrated that ONOO- serves as a relevant S-
nitrosylating species for PTEN S-nitrosylation (Fig. 27 (A) and (B). Activation of Akt 
by H2O2 has been reported in many studies but mechanism of its activation is not well 
defined (Lee SR et al, 2002; Radisavljevic ZM and González-Flecha B, 2004; Tu VC 
et al, 2002). In the current study, we have provided evidence that low concentration of 
H2O2 causes PTEN S-nitrosylation, which is preventable by scavenging ONOO- (Fig. 
27 (C). In the preceding sections, we have demonstrated that either scavenging 
ONOO- or simultaneous removal of its precursors- O2˙- and NO˙ prevents Akt 
activation by PDGF stimulation. Now we would like to go back to see if the same 
holds true for O2˙- and low concentration of H2O2 that mimic growth factors signaling. 
 As shown in Figure 38 (A) that 1mM DDC treatment caused Akt 
phosphorylation, which was attenuated by FeTPPS pretreatment, but at 4 hours co-
incubation of DDC and FeTPPS, there was a return of Akt phosphorylation. In figure 
38 (B), FeTPPS prevented Akt activation by 50uM H2O2 across all time points. 
Except for long incubation with DDC (4 hours), ONOO- decomposition catalyst, 
FeTPPS is effective in preventing Akt activation induced by O2˙- and low 
concentration of H2O2. In other words, the data suggest that ONOO- could mediate 
growth mimicking function of O2˙- and low concentration of H2O2.  
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Figure 38: ONOO- attenuates Akt activation by O2˙- and low concentration of 
H2O2 
Serum deprived (0.5% FBS) MEF cells were pretreated with 10uM FeTPPS for 1 hour before 
incubation with 1mM DDC (A) or 50uM H2O2 for indicated times. Phosphorylation of Akt 
was assessed by western blotting as described in Materials and Methods. Representative blots 








   
Chapter	  3:	  Results	   121	  
  
3.7 S-NITROSYLATION AND TUMOR MAINTENANCE   
  
 Over the past decade, the notion that ROS/RNS are involved in the process of 
carcinogenesis independent of their genotoxic effects is increasingly recognized 
(Arnold RS et al, 2001; Behrend L et al, 2003). For example, increased ROS 
production in tumors facilitates various oncogenic signaling (Shinohara M et al, 2007; 
Vafa O et al, 2002). But mechanism underlying non-genotoxic oncogenicity of 
ROS/RNS is not well defined. In our current study, we have provided evidence that 
growth factor signaling is facilitated by S-nitrosylation in the context of Akt 
activation by PDGF. Since cancer results from dysregulation of cell proliferation, we 
wonder if protein S-nitrosylation contributes to enhanced growth signaling observed 
in cancer cells. 
 
3.7.1 Maintenance of protein S-nitrosylation in the absence of serum is 
associated with sustained signal transduction in precancerous and cancer cells. 
  
 Reduction in PTEN function as a result of deletion or mutations is associated 
with various types of cancers. Its loss of function contributes to cancer predisposition 
disorder such as Cowden syndrome (Marsh DJ et al, 1998). It is also implicated in 
early stage of carcinogenesis. (Brenner W et al, 2002; Eng C, 2002; Salmena L et al, 
2008). Therefore, genetic knockout of PTEN could serve as precancerous condition. 
With that in mind, we set out to assess status of protein S-nitrosylation between MEF 
wild type (MEF WT) and PTEN knockout MEF (MEF K/O) as a comparison between 
normal and precancerous cells. 
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 As shown in figure 39 (A), there was no difference in protein S-nitrosylation 
between MEF WT and MEF K/O when cultured in 10% FBS but upon serum 
deprivation, protein S-nitrosylation was maintained in MEF K/O but not in MEF WT. 
When S-nitrosylation of PTEN was assessed in MEF WT cells, PTEN-SNO decreased 
upon serum starvation compared to MEF WT cells growin in 10% FBS. Since S-
nitrosylation is a type of oxidative modification, we hypothesize that maintenance of 
protein S-nitrosylation in serum deprived MEF K/O should come from increased ROS 
or RNS production. True enough, the figure 39 (B) shows that there was increased 
O2˙- production in MEF K/O compared to MEF WT but no significant difference was 
observed in the level of either H2O2 or NO˙ between the two cell lines. 
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Figure 39: Protein S-nitrosylation is maintained in the absence of serum in MEF 
PTEN knockout cell line. 
MEF WT and MEF PTEN K/O were cultured in normal culture medium containing 10% 
FBS. A set of cells was serum deprived at 0.5% FBS and another set was replaced with fresh 
10% FBS. Both sets were then allowed to grow for further 24 hours before total protein and 
PTEN S-nitrosylation were assessed by biotin switch assay (A). In (B), MEF WT and MEF 
PTEN K/O were serum deprived (0.5% FBS) for 24 hours before intracellular O2˙-, H2O2 and 
NO˙ were measured by lucigenin assay, DCFDA and DAF fluorescence assays respectively. 
The result represents mean ± SD of three independent triplicate experiments. * p < 0.05 
compared to the control. Representative blot out of two independent experiments is shown. 
  
 Having observed that precancerous cell line, MEF K/O, maintains protein S-
nitrosylation in the absence of serum, we would like to extend our comparison to 
cancer cells.  As shown in figure 40 (A), the amount of protein S-nitrosylation was 
much more in MCF7 breast cancer cells than in MEF WT and the distinction became 
more obvious in 0.5% serum in which S-nitrosylation including PTEN was 
maintained in MCF7 but not in MEF WT. Measurement of ROS/RNS levels revealed 
that MCF7 cancer cells produced much more O2˙-, H2O2 and NO˙ than MEF WT (Fig. 
40 (B)). The result obtained here is similar to that of comparison between MEF WT 
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vs MEF K/O but the difference in protein S-nitrosylation is much more pronounced 
and an increase in ROS/RNS production is more significant involving not only O2˙- 




Figure 40:  Increased S-nitrosylation in MCF7 breast cancer cells 
MEF WT and MCF7 cells were cultured in normal growth medium containing either 10% 
FBS or serum deprived (0.5% FBS) for 24 hours before total protein and PTEN S-
nitrosylation were assessed using biotin switch technique (A). Comparison of the levels of 
O2˙-, H2O2 and NO˙ between the two cell lines was made using lucigenin luminescence assay, 
DCFDA and DAF fluorescence assays respectively (B). The result represents mean ± SD of 
three independent triplicate experiments. * p < 0.05 compared to the control. Representative 
blot out of two independent experiments is shown. 
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 Our next question is “what is the benefit of maintaining protein S-nitrosylation 
in the absence of serum?” We have seen above that protein S-nitrosylation mediates 
Akt activation induced by PDGF, O2˙- and low concentration of H2O2. Thus we 
wonder if there is any association between maintenance of protein S-nitrosylation and 
Akt phosphorylation status. Figure 41 showed that there was sustained 
phosphorylation of Akt in the absence of serum in MEF K/O and MCF7 cell lines but 
not in MEF WT indicating that Akt phosphorylation status correlates well with S-
nitrosylation under serum deprived condition.  
 
 
Figure 41: Akt phosphorylation is maintained in the absence of serum in MEF 
K/O and MCF7 cell lines. 
MEF WT, MEF K/O and MCF7 cell lines were cultured in full medium containing 10% FBS 
or under serum deprived condition (0.5% FBS) for 24 hours before Akt phosphorylation 
status was assessed by western blotting. Representative blots out of at least three independent 
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3.7.2 Protein de-nitrosylation in cancer 
 
 We have presented above that sustained protein S-nitrosylation is associated 
with activation of growth factor signaling such as Akt phosphorylaiton. If we de-
nitrosylate proteins, this might stop signal transdution. Considering increased 
ROS/RNS production and increased protein S-nitrosylaiton status in cancer cells are 
associated with sustained activation of survival kinases such as Akt, we wonder if 
targeting protein S-nitrosylation or protein de-nitrosylation could prove to be an 
effective therapeutic strategy. Here, we chose to employ FeTPPS to de-nitrosylate 
proteins since it is effective in preventing S-nitrosylation induced by O2˙-, low 
concentration of H2O2 and PDGF.  
 As shown in figure 42 (A), although one-hour treatment with FeTPPS had no 
effect on protein S-nitrosylation in MEF WT, prolonged incubation with the drug for 
24 hours partially de-nitrosylate proteins. In MCF7 cells, both short and long duration 
treatment with FeTPPS failed to de-nitrosylate proteins (Fig. 42 (B)). Similarly, 
FeTPPS dephosphorylated Akt in MEF WT starting after incubation for one hour but 
it does not affect Akt phosphorylation in MCF7 cells even after 24 hours of 
incubation (Fig. 42 (C)). This data thus indicate that compared to normal cells, protein 
S-nitrosylation in cancer is very stable and failure to denitrosylate proteins in cancer 
cells correlates well with sustained Akt phosphorylation suggesting that this stable 
protein S-nitrosylation could play an important role in cancer survival. 
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Figure 42: FeTPPS de-nitrosylate proteins and dephosphorylate Akt in MEF 
WT but not in MCF7. 
MEF WT and MCF7 cultures grown in full medium containing 10% FBS were treated with 
10uM FeTPPS for indicated times. Protein S-nitrosylation was assayed by biotin switch 
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CHAPTER 4: DISCUSSION 
______________________________________________ 
 
 Accumulating evidence indicates that ROS/RNS act as second messengers in 
response to external stimuli such as growth factors, cytokines and hormones thus 
involving various cellular functions from cell division, migration to mediator 
production (Chiarugi P and Fiaschi T, 2002; Kamata H and Hirata H, 1999; Hess DT 
and Stamler JS, 2012; Ray PD et al, 2012). This role of ROS/RNS is termed “Redox 
Signaling” and it is achieved by modifying protein functions or “Redox 
Modification”. The mystery of ROS involved and how they modify protein functions 
to influence cellular processes has been unfolding over the past decade (Derakhshan B 
et al, 2007; Klomsiri C et al, 2010; Spadaro D et al, 2010; Wang Y et al, 2006). The 
current study contributes to the mechanistic understanding of redox modification of 
proteins by the free radicals generated during growth factor signaling and 
carcinogenesis.  
 
4.1  S-NITROSYLATION IS THE COMMON MECHANISM OF PROTEIN 
 OXIDATION USED BY O2˙- AND PHYSIOLOGICALLY RELEVANT 
 CONCENTRATION OF H2O2  
 
4.1.1 O2˙- and SNO Modification 
 
 Previously, there was little understanding on how O2˙- could act as a signaling 
molecule since O2˙- is a nucleophile and not reactive towards the reactive thiolate of 
cysteine residues in the proteins. The only known direct targets of O2˙- are 
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iron/sulphur clusters in some proteins such as mitochondrial proteins, and the 
destruction of these moieties by O2˙- is associated with cellular toxicity (Li Y et al, 
1995; Morten KJ et al, 2006). Most studies on involvement of O2˙- in cell signaling 
draw conclusion from the results obtained with the use of various O2˙- generation 
systems and specific scavenger such as SOD mimetics (Huang WC et al, 2002; 
Zimmerman MC et al, 2002).  However, no study so far has directly assessed 
oxidative modification of proteins by imbalance of redox environment due to an 
increase in O2˙-. This thesis is the first piece of work demonstrating that increasing 
intracellular O2˙- leads to generalized protein S-nitrosylation (Fig. 12 & Fig 13 (C)). 
Note that our system of manipulating intracellular O2˙- by inhibiting Cu-Zn SOD 
enzyme has both advantage and disadvantage. The advantage is that it allows us to 
study the effect of O2˙- separated from that of H2O2. The disadvantage is that in the 
absence of Cu-Zn SOD function, continued rising level of O2˙- could ultimately lead 
to apoptosis and cell death (Pimentel DR et al, 2001). This artificial system does not 
represent what actually happens during cell signaling but allows mechanistic insight 
into oxidative modification by O2˙- that is generated as a primary ROS upon receptor 
activation.  
 
4.1.2 H2O2 and SNO Modification  
 
 H2O2 is known to directly oxidize reactive thiols of proteins causing various 
types of oxidative modification such as S-nitrosylation, glutathonylation, disulphide 
bond formation and sulphenic acid formation (Forman HJ et al, 2004 & 2010; 
Winterbourn CC and Hampton MB, 2008).  However, physiological relevance of 
these studies could be in doubt because of indiscriminate use of high concentration of 
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exogenous H2O2 in these experiments (Forman HJ, 2007; Lee SR, 2002). In our 
current study, we employ a concentration of H2O2 that is not associated with cellular 
toxicity and high concentration of H2O2 that affects cell viability (Fig. 16). Here, we 
would like to propose that protein S-nitrosylation that is predominately caused by low 
non-toxic concentrations of H2O2 (25-100uM) could be of physiological relevance as 
compared to other types of non-SNO modifications (Fig. 14 (A)&(B)) induced by 
high concentration of H2O2 (500uM) because the later is associated with reduced cell 
viability and physiologically, this high level of H2O2 cannot be achieved even with the 
use of a very high concentration of a ligand such as 250ng PDGF (Fig. 19 (A)). This 
is a good example of how biological systems operate differently from in-vitro test 
tube experiments. The test tube reactions are purely chemical and straightforward 
with no influence from intracellular milieu. On the contrary in the cells, the cellular 
regulatory system must ensure that all biological processes proceed smoothly and 
without harm. Hence, indirect but safer SNO-modification may be chosen over direct 
but potentially harmful non-SNO modifications by transforming oxidative signal into 
nitrosative signal. This notion is supported by the work of Chen et al demonstrating 
that S-nitrosylation of protein-tyrosine-phosphatase 1B (PTP1B) induced by NO˙ 
donors can protect PTP1B against subsequent oxidative assault by H2O2 that causes 
irreversible inactivation of the enzyme (Chen K et al, 2008).  
 
4.1.3  Redox Signaling: O2˙- vs H2O2 
 
 This current study could also help address one contentious issue in the field - 
relative importance of O2˙- vs H2O2 in cell signaling, growth and proliferation. In 
1999, Suh YA et al reported that O2˙- produced by MOX1 (NOX1) induced 
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transformed phenotype in NIH3T3 cells (Suh YA et al, 1999) but later, it was 
contended by Arnold RS that it is H2O2 that mediates cell growth and transformation 
(Arnold RS et al, 2001). Since then, there is an open debate between groups focusing 
on one type of species over the other in their studies of redox signaling, cell 
proliferation and cell death (Clément MV and Stamenkovic I, 1996; Juarez JC et al, 
2008; Lim S and Clément MV, 2007; Pervaiz et al, 1999 & 2001;Rhee SG, 2006). All 
previous studies could be true in claiming their putative outcomes because according 
to our finding, both O2˙- and non-toxic concentration of H2O2 carry out signaling 
function through a common redox mechanism - S-nitrosylation- thus resulting in 
similar outcomes.  
 
4.2 REDOX SIGNALING BY GROWTH FACTORS IS THROUGH S-
 NITROSYLATION 
 
 Similarly to the case with O2˙-, there was scarcely any study that directly looks 
at protein oxidation caused by growth factors. Usually, the nature of growth factors 
induced protein oxidation was extrapolated from the previous studies using exogenous 
oxidants since the target proteins are the same. For example, Kwon and co-workers 
reported the oxidation and inactivation of tumor suppressor PTEN by peptide growth 
factors as di-sulphide bond formation since these purified peptides produce H2O2 and 
it was previously demonstrated that PTEN oxidation by H2O2 is by di-sulphide bond 
formation (Lee SR et al, 2002; Kwon J et al, 2004). In our current work, it turns out 
that protein oxidation induced by PDGF, EGF and 10% FBS is through S-
nitrosylation (Fig 19 (A) to (C)). This finding is further supported by subsequent 
observation that increasing concentrations of PDGF failed to generate proportionate 
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amount of H2O2 in contrast to exogenous treatments of H2O2 (Fig 14 (A) vs Fig. 20 
(A)), and S-nitrosylation is consistently induced even at a very high concentration of 
PDGF (Fig. 20 (C)). Here we choose to use PDGF as representative of growth factors 
because most of the findings related to redox signaling by growth factors are based on 
PDGF (Adachi T et al, 2005; Bae YS et al, 2011; Hawkins PT et al, 1995; Hu R et al, 
2007; Jay DB et al, 2008) 
 
4.2.1 PTEN: an example of oxidative modification of protein upon growth 
 factor induction of cell proliferation 
 
 One of the target proteins in growth factors induced S-nitrosylation is PTEN. 
The nature of oxidative modification of PTEN under physiological condition has been 
in debate. It is essential that Cys 124 in the active site of PTEN remains reduced for 
phosphatase activity. In 2002, Lee et al demonstrated for the first time that Cys 124 
forms a disulphide bridge with neighbouring Cys 71 upon treatment with H2O2 
resulting in inactivation of the enzyme (Lee SR et al, 2002). Since then, it is presumed 
in the literature that oxidation of PTEN by ligands producing ROS is by disulphide 
bond formation and involves these two cysteine sites (Cho SH et al, 2004; Connor 
KM et al, 2005; Kwon J et al, 2004). However, Yu CX et al later reported that 
exogenous NO donors and transnitrosylation agents could oxidize PTEN through 
mechanisms such as S-nitrosylation and s-glutathionylation (Yu CX et al, 2005). 
Similarly, our group also found out that Akt activation by an increase in intracellular 
O2˙- is through S-nitrosylation of PTEN (Lime S and Clement MV, 2007). Thus it has 
become apparent that PTEN can be oxidatively modified in more than one way. 
Furthermore, a recent study reports that PTEN is S-nitrosylated at at a site (Cys-83) 
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(Numajiri N et al, 2011) distinct from the sites (Cys 124& Cys71) that are involved in 
di-sulphide bond formation by H2O2 (Lee SR et al, 2002). S-nitrosylation though not 
occurring at the active site of enzyme (Cys124) inhibits PTEN function in a 
seemingly allosteric manner (Numajiri N et al, 2011). These diverse reports indicate 
that the question of the physiological relevant redox modification of PTEN still 
remains unanswered. Our current study addressed that question using different 
concentrations of H2O2 and demonstrating that low concentrations of H2O2 (25uM to 
100uM) preferably induces PTEN S-nitrosylation over other types of redox 
modification (Fig. 23 (A) and (B)). Considering these concentrations of H2O2 fall 
close to those produced by growth factors (Fig, 14 (A) vs Fig 18 (B) and Fig. 20 (A)), 
PTEN S-nitrosylation could represent physiologically relevant type of oxidative 
modification. Furthermore, we also provide in our study direct evidence that 
physiological ligand, PDGF, regardless of concentration consistently induce PTEN S-
nitrosylation. Taken together, our data strongly support that S-nitrosylation is the type 
of oxidative modification occurring to PTEN during physiological signaling.  
 
4.3 PEROXYNITRITE: A POTENTIAL PHYSIOLOGICALLY 
 RELEVANT S-NITROSYLATING INTERMEDIATE  
 
 ONOO- lies at the crossroad between ROS and RNS with its formation being 
contributed from both sources - O2˙- and NO˙. The rate of formation of ONOO- from 
these two radicals is very rapid and diffusion limited with rate constant κ between 6.6 
and 19 X 109M−1sec−1 (Pacher P et al, 2007). The simultaneous and controlled 
production of both O2˙- and NO˙ is critical to regulate the production of ONOO- 
because individual increase in O2- and NO˙ at a 10-fold greater rate will increase 
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peroxynitrite formation by 100-fold causing cellular toxicity (Pacher P et al, 2007). 
Normally, O2˙- is driven away from reacting with NO˙ by SOD enzymes which are 
abundantly present both in the cytosol (Cu-Zn SOD) and in the mitochondrial (Mn-
SOD) although the rate of O2˙- dismutation by these enzymes is 3-8 times slower than 
the reaction between O2˙- and NO˙ (Liaudet L et al, 2009; Pacher P et al, 2007). 
 During our investigation into S-nitrosylating species responsible for protein S-
nitrosylation induced by O2˙-, non-toxic concentration of H2O2 and PDGF, we found 
that ONOO- scavenging effectively prevents S-nitrosylation in these contexts (Fig. 27 
(A) to (D)). When we assessed any change in the level of ROS/RNS upon stimulation 
with these three agents, we identified conditions conducive to the formation of 
ONOO-. Firstly with O2˙-, our experimental design in which an increase in 
intracellular O2˙- is achieved by inhibiting Cu-Zn SOD function promotes ONOO- 
formation by allowing O2˙- to react with NO˙ as a result of the accumulation of 
intracellular O2˙- and less competition from Cu-Zn SOD enzyme. The possibility of 
this reaction taking place is supported by our finding that an increase in O2˙- 
production is accompanied by a decrease in intracellular NO˙ level (Fig. 24 (A) & 
(B)) indicating net NO˙ loss in the reaction with O2˙- in the absence of significant 
ongoing NO˙ generation. However, the formation of ONOO- and protein S-
nitrosylation that it induced by increasing O2˙- in this manner would be limited by the 
supply of NO˙. This might explain why there is no corresponding increase in protein 
S-nitrosylation in spite of increasing level of O2˙- with time after DDC treatment (Fig. 
8 (A) and Fig. (12)). We briefly discussed above that ONOO- could contribute to 
DCFDA fluorescence, which is used to measure H2O2 (Crow JP, 1997; Kooy NW et 
al, 1997; Tarpey MM et al, 2004). Thus the finding that initial decrease in DCFDA 
fluorescence that reflects reduced production of H2O2 is followed by a later rise could 
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be explained by formation of ONOO- (Fig. 8 (B)). The summary of ONOO- formation 
by increasing intracellular O2˙- level is given in figure 43. 
   
Figure 43: Proposed pathway for the formation of ONOO- upon an increase in 
intracellular O2˙-. 
Although O2˙- reacts with NO˙ at a diffusion-limited rate, the abundance of Cu-Zn SOD 
ensures most cytosolic O2˙- is dismutated to H2O2 thus limiting the formation of ONOO-. But 
when function of Cu-Zn SOD is compromised as a result of gene silencing or 
pharmacological inhibition, O2˙- accumulates and is available to react with NO˙ to form 
ONOO˙. (NOS- nitric oxide synthese; Cu-Zn SOD- Cu-Zn dependent superoxide dismutase) 
 
 In the second scenario with H2O2, we observed a significant production of 
NO˙ with H2O2 treatment but no detectable increase in O2˙- level (Fig. 14 (B) and Fig. 
24 (C)). Still, there are a few reports that H2O2 either transiently inactivates Cu-Zn 
SOD enzyme or degrades it depending on the concentration (Casano LM et al, 1997; 
Liochev SI et al, 1998; Ramirez DC et al, 2005; Salo DC et al, 1988). Indeed, in 
agreement with these findings, our group has recently observed that 50uM H2O2 
causes a decrease in activity of Cu-Zn SOD enzyme by approximately 20% 
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(Unpublished Data; Fig. 44). 
 
(Taken from the thesis of Lim, Sharon (2008)) 
Figure 44: Low concentration of H2O2 decrease intracellular Cu-Zn SOD activity 
Densitometric representation of the % changes in CuZnSOD activity as assessed using vitro 
in gel NBT assay following exposure to 50uM H2O2 in serum deprived (0.5% FBS) MEF 
cells. 
 
 Therefore, it is possible that transient inactivation of Cu-Zn SOD enzyme by 
low concentration of H2O2 could divert O2˙- to react with NO˙ resulting in formation 
of ONOO-. Alternatively, high level of NO˙ could also outnumber Cu-Zn SOD to 
have more access to O2˙- thus forming ONOO- (Pacher P et al, 2007). Note that in 
ROS/RNS detection, it is generally believed that what is detectable is the surplus of 
radicals after their reactions with various targets including cellular anti-oxidant 
systems  (Nagano T, 2009; Wardman P, 2007). Therefore, the observed detectable 
level of NO˙ production by H2O2 should be considered significant. We have also 
provided some evidence that increased NO˙ production by H2O2 is through activation 
of NOS in a Ca2+ dependent manner that is in agreement with the findings that report 
the release of intracellular Ca2+ upon exogenous treatment with H2O2  (Granados MP 
et al, 2006; Pariente JA et al, 2001; Redondo PC et al, 2004)	   and with the studies 
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demonstrating the activation of NOS by H2O2 (Sartoretto JL et al, 2011; Thomas SR 
et al, 2002). One would expect O2˙- to decrease if it were to participate in the reaction 
with NO˙. In the current scenario, failure to detect any change in O2˙- level might 
come from the fact that an increase in O2˙- as a result of Cu-Zn SOD inactivation is 
cancelled out by a decrease as result of its participation in the reaction with NO˙. The 
formation of ONOO- by H2O2 is depicted below: 
 
Figure 45: Proposed pathway of ONOO- formation by exogenous H2O2  
Transient inactivation of Cu-Zn SOD by H2O2 diverts O2˙- to react with NO˙. Alternatively, 
Ca2+ dependent production of NO˙ by H2O2 is high enough to outcompete Cu-Zn SOD and 
react with NO˙ resulting in formation of ONOO-. (NOS- nitric oxide synthese; Cu-Zn SOD- 
Cu-Zn dependent superoxide dismutase; H2O2(exo)- exogenous H2O2; H2O2(endo)- endogenous 
H2O2 derived from O2- dismutation) 
 
 Thirdly with growth factors, PDGF stimulates NO˙ production as with H2O2 
but in a Ca2+ independent manner (Fig. 25 and Fig. 30). Although it is not clear yet 
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how PDGF activates NOS for increased NO˙ production, this is not through H2O2 
loop that is Ca2+ dependent. Furthermore, pathway of ONOO- formation by PDGF 
appears different from that of exogenous H2O2 treatment. As depicted in figure 46, 
formation of ONOO- could come from simultaneous activation of NOS and NOX 
(NADPH oxidase) enzymes by PDGF. PDGF is well known to activate NOX (Adachi 
T et al, 2005; Brown DJ and Griendling KK, 2009; Hu R et al, 2007; Jay DB et al, 
2008; Lambeth JD 2004;  Lassègue B et al, 2001; Petry A et al, 2010). Since most 
cellular H2O2 comes from dismutation of O2˙-, detection of increased production of 
H2O2 by PDGF (Fig. 18(A), (B) and Fig. 20(A)) could represent an indirect evidence 
that NOX is activated. As O2˙- level remains unchanged (Fig. 17 (C) and Fig. 19 (B)), 
we hypothesize that this could be due to combined action of Cu-Zn SOD and reaction 
with NO˙. Probability that PDGF could cause simultaneous production of O2˙- and 
NO˙ is also supported by a recent report that activation of NADPH oxidase by PDGF 
is carried out through a Rho-like small GTPase protein, Rac, (Bäumer AT et al, 2007) 
and a subsequent report that Rac protein not only activates NADPH oxidase but also 
co-regulate the activity of constitutive NOS isoforms demonstrating simultaneous 
production of O2˙- and NO˙ by Rac activation (Selvakumar B et al, 2008). Therefore, 
it is reasonable to propose that PDGF binding to its receptor leads to activation of 
both NOX and NOS through a common regulator Rac that lies downstream of 
receptor tyrosine kinase (RTK) such as PDGF receptor (Hawkins PT et al, 1995). On 
that account, EGF and 10% FBS, which contains various kinds of growth factors, 
would act on their respective RTK and activate Rac, thereby NOX and NOS, finally 
culminating in formation of ONOO-. 
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Figure 46: Proposed pathway for ONOO- formation by growth factors 
PDGF, EGF and 10% FBS activates both NOS and NOX with simultaneous production of O2- 
and NO˙ that reacts with each other to form ONOO-. Level of O2˙- is O2˙- kept constant by the 
combined action of Cu-Zn SOD and NO˙. (NOS- Nitric oxide synthase; NOX- NADPH 
oxidase; Cu-Zn SOD- Cu-Zn dependent superoxide dismutase) 
 
 Although ONOO- is has been proposed as a potent S-nitrosylating agent, its 
physiological role is overcast by a myriad of chemical reactions that ONOO- could 
participate in. The simplified summary of possible reactions of ONOO- is given 
below: 
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(Adapted from Pacher P et al, 2007) 
Figure 47: The interplay of NO˙, O2˙-, ONOO-, and NO2-  
When NO˙ and O2˙- are both present, they may react with NO2 to form N2O3 and ONOO- 
respectively. ONOO- decomposes to give NO2- (nitrating agent) and O2, while N2O3 
(nitrosylating agent) reacts with thiols to give nitrosothiols (-SNO) or with hydroxide anion to 
give NO2-. N2O3 could also react at a diffusion-limited rate with ONOO- to yield two 
molecules of NO2 and one of NO2-. This creates a cycle to generate more NO2 when bolus 
additions of ONOO- are added at neutral pH and substantially increases the number of 
potential reactions occurring. (NO2- - nitrite; N2O3 -dinitrogen trioxide; NO2˙ -nitrogen 
dioxide) 
 
 Two mechanisms of ONOO--mediated oxidations have been recognized. One 
is the direct oxidative modification through one or two electron oxidations (Beckman 
JS and Koppenol WH, 1996; Szabó C et al, 2007).  One-electron oxidation involves 
reaction with metalloproteins whereas two-electron oxidation mainly occurs with 
thiols as follows (Szabó C et al 2007) : 
1.        Men+X  + ONOO-    →      O=Me(n+1)+X= .NO2 
2.  a)   RS-      + ONOOH   →      RSOH + NO2- 
     b)   RSOH + Rʹ′S-          →       RSSRʹ′ 
The second mechanism of oxidation by ONOO- is carried out through its highly 
reactive decomposition products. Most important radicals are carbonates CO3-, 
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decomposition products of ONOO- with CO2, and hydroxyl radicals OH° that 
decompose from peroxynitrous acid (ONOOH) (Alvarez B and Radi R, 2003; 
Augusto O et al, 2002). Both are toxic to the cells and they account for protein 
modifications that are damaging to the cells - irreversible oxidations and tyrosine 
nitration (Ducrocq C et al, 1999; Ischiropoulos H et al, 1998). 
 
 In general, various chemical reactions mediated by ONOO- could fall under 
three broad categories - nitrosation (S-nitrosylation), oxidations (non-SNO 
modifications) and nitration (3-NT formation). S-nitrosylation (nitrosation) by 
ONOO- is mostly unappreciated. We demonstrated in our experiment that low 
concentration range of ONOO- (50-250uM) predominately causes protein S-
nitrosylation (Fig. 29 (A). Indeed, this range of ONOO- concentration has been shown 
to be associated with cell survival (Cerioni L et al, 2006; Pacher P et al, 2007). 
Furthermore, within the same signaling pathway, ONOO- produces dichotomous 
outcome depending on the concentration. Mallozzi and co-workers demonstrated that 
ONOO- in the range of 10-100uM activates glycolysis in human erythrocytes that is 
associate with band 3 tyrosine phosphorylation, but at higher concentrations (200-
1000uM), band 3 tyrosine nitration is observed in place of phosphorylation that 
results in irreversible inhibition of gylcolysis (Mallozzi C et al, 1997). It is thus 
apparent that pro-survival and signaling activation by ONOO- occur at low 
concentration, probably mediated by protein S-nitrosylation according to our finding, 
but when high concentration of ONOO- is formed, it causes non-SNO modifications 
and 3-NT formation that mediate signaling inhibition, cellular toxicity and cell death. 
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 In summary, we discussed above possible pathways of formation of ONOO- 
by O2˙-, and low concentration of H2O2 and PDGF, EGF and 10% FBS and chemistry 
and mechanisms of action of ONOO-. We recognize that direct proof of ONOO- 
formation would be by measuring it directly but unfortunately to date, there is no 
detection assay available that is specific to ONOO- ( Folkes LK  et al, 2009; McQuade 
LE and Lippard SJ, 2009; Wardman P, 2007; Wrona M et al, 2005). Therefore, we 
could only take indirect approach by presenting evidence of production of precursors 
radicals such as O2˙- and NO˙ and the use of specific scavengers such as FeTPPS 
which is widely used in the study of ONOO- mediated cellular physiology and 
pathology (Arora M et al, 2008; El-Remessy AB et al, 2007; Klassen SS and Rabkin 
SW, 2009; Kohr MJ et al, 2010; Torres-Dueñas D	  et	  al,	  2007;	  Zhou	  J	  and	  Huang	  K, 
2009). Considering low concentration range of ONOO- where protein  
S-nitrosylation occurs and low-level generation of ROS/RNS by physiological ligands 
such as PDGF that could only form low concentration of ONOO-, we would like to 
propose that ONOO- could represent a bona fide physiologically relevant  
S-nitrosylation intermediate during signaling. Various pathways to formation of 
ONOO- is summarized in the following diagram:  
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Figure 48: Proposed pathways for ONOO- formation and S-nitrosylation 
1) Inhibition of Cu-Zn SOD function by DDC or siSOD increases O2˙- and allow it to react 
with NO˙; 2) physiological concentration of H2O2 activates NOS through an increase in Ca2+ 
leading to increased NO˙ production on one hand and transiently inactivates Cu-Zn SOD on 
the other thus allowing O2˙- to react with NO˙; 3) Growth factors activate NOS and NOX 
through the common co-regulator Rac leading to simultaneous production of both O2˙- and 
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4.4 O2- AND NO˙: STRIKING THE RIGHT BALANCE FOR SIGNAL 
 TRANSDUCTION 
 
 Having discussed ONOO- as a physiologically relevant S-nitrosylating 
intermediate, we next would like to elaborate on the effect of manipulation of its 
formation on signal transduction. At first, to prove our point that protein S-
nitrosylation facilitates signal transduction, we assessed the effects of preventing or 
enhancing protein S-nitrosylation by PDGF on the activation of Akt. We discovered 
that scavenging ONOO- completely abolishes Akt phosphorylation by PDGF 
establishing that ONOO- and S-nitrosylation are required for PDGF signaling (Fig 35 
(A)). On the other hand, enhancing protein S-nitrosylation by inhibiting GSNOR 
augments Akt phosphosylation again reinforcing the relevant role of S-nitrosylation in 
PDGF signaling (Fig. 32 (B) and Fig. 35 (B)). However, when we assessed the effect 
of removal of precursors of ONOO-, namely- O2˙- and NO˙, on the activation of Akt, 
we made some interesting observations. Although removal of intracellular NO˙ 
abolishes PDGF induced S-nitrosylation, it fails to prevent Akt phosphorylation by 
PDGF (Fig. 26 and Fig. 36 (A)). But further investigations revealed that removing 
NO˙ causes intracellular ROS - O2˙- and H2O2 to rise indicating increased oxidative 
stress (Fig. 36 (B)).  O2˙- scavenging action of NO˙ is well recognized (Dutta UK et al, 
2006; Majid DS et al, 2004 & 2007). In fact, because of this property and also its 
preventive role in lipid peroxidation, NO˙ is included in cellular anti-oxidant defense 
mechanism by some authority (Hogg N and Kalyanaraman B, 1999; Hummel SG et 
al, 2006). There is ample evidence that cell signaling could also occur under oxidative 
stress but this is associated with activation of processes such as apoptosis, autophagy 
and calcium influx ultimately leading to cell death (Almeida M et al, 2010; Cheng 
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WT et al, 2009; Ermak G and Davies KJ, 2002). This notion is supported by our result 
that treatment with anti-oxidant, N-acetyl-cysteine that prevents increased ROS 
production caused by NO˙ removal attenuates Akt phosphorylation (Fig. 36 (C) and 
(D)). By the same token, inhibition of O2˙- generation alone with NADPH oxidase 
inhibitor, DPI fails to prevent Akt phosphorylation by PDGF (Fig. 37 (A)) In fact, 
DPI treatment even enhances protein S-nitrosylation (ONOO- independent) as a result 
of an increase in intracellular NO˙ level (Fig. 34 (A) and (B), thus sustaining Akt 
phosphorylation. This notion is supported by our result demonstrating that co-
incubation with NO˙ scavenger, c-PTIO reduces protein S-nitrosylation as well as Akt 
phosphorylation (Fig. 34 (A) and Fig. 37 (B)). In fact, removal of O2˙- and NO˙ is 
akin to scavenging ONOO-. Finally, effectiveness of ONOO- scavenging is also 
evident in signaling activation induced by O2˙- and low concentration of H2O2 (Fig. 38 
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Figure 49: Schematic representation of the impact of O2˙- and NO˙ balance in 
cell signaling.   
O2˙- and NO˙ are mutually scavenging radical species. When their levels are in balance 
ensuring formation of low concentration of ONOO-, normal physiological signaling driven by 
ONOO- dependent S-nitrosylation occurs. However when NO˙ is removed, there is an 
increase in ROS production and cell signaling continues under oxidative stress. Similarly, if 
only O2˙- is scavenged, level of NO˙ will increase maintaining S-nitrosylation in ONOO- an 
independent manner.  
 
 The understanding of this balance of O2˙- and NO˙ could have some useful 
applications. Traditionally targeting NO˙ is a well-established way of preventing S-
nitrosylation. This is achieved by either pharmacological or molecular inhibition of 
various NOS and scavenging intracellular NO˙ (Azad N et al, 2006; Chanvorachote P 
et al, 2006; Jaffrey SR and Snyder SH 2001; Rahman MA et al, 2009). Since protein 
S-nitrosylation is associated with cell proliferation and inhibition of apoptosis, many 
studies have attempted to reverse the protective effect of S-nitrosylation by inhibiting 
or scavenging NO˙. In one recent study, Chanvorachote P et al reported that Bcl-2 
stabilization through S-nitrosylation inhibits cisplatin-induced apoptosis that is 
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reversible upon NO˙ scavenging by c-PTIO or NOS inhibition by aminoguanidine 
(Chanvorachote P et al 2006). One particular experiment in that study demonstrated 
that c-PTIO mediated Bcl-2 degradation is lost with anti-oxidant - NAC pretreatment 
implying that oxidative stress play a role. There are also many reports that connect 
Bcl-2 degradation and induction of apoptosis to increased intracellular ROS 
production (Luanpitpong S et al, 2011; Moungjaroen J et al, 2006; Wang L et al, 
2008). Taken together with our current study, removing NO˙ could have two-folds 
effects on Bcl-2 stability by de-nitrosylating it and inducing oxidative stress.  In fact, 
it might serve as a good strategy in killing tumor cells since de-nitrosylation could 
remove protective effect whereas oxidative stress could promote cell death. However, 
removing NO˙ in normal cells could induce oxidative stress and furthermore, NO˙ is a 
critical messenger molecule in the body carrying out various important functions such 
as blood pressure regulation, neuronal transmission and immune defense against 
pathogens. Therefore, we would like to propose that scavenging ONOO- could 
provide a safer alternative way to induce de-nitrosylation because ONOO- is not 
known to serve any critical signaling functions in normal physiology (Beckman JS 
and Koppenol WH, 1996; Pacher P et al, 2007) 
 If inhibition of O2˙ - production is intended to prevent signaling, the strategy 
might be not effective because this will cause NO˙ to increase and activate signaling 
via ONOO- independent S-nitrosylation or other NO˙ mechanism such activation of 
cGMP pathway. Over the years, our group has reported on the survival and anti-
apoptotic effects of O2˙- in various systems by demonstrating that scavenging O2˙- 
attenuates these advantages (Clément MV et al, 1996, 2005; Lee SC et al, 2007). Our 
current study now makes us wonder if ONOO- scavenging might prove to be more 
effective way of abolishing survival pathways that are addicted to redox signaling. In 
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a similar manner, the observed outcome of scavenging O2˙- could be partly carried out 
by subsequent increase in NO˙.  One study reports that blood pressure regulation by 
Angiotensin II, a potent vasoconstrictor, is mediated through O2˙- because scavenging 
the latter abolishes the blood pressure response (Zimmerman MC et al, 2002). 
According to our result, it is possible that NO˙ being a potent vasodilator might have 
contributed to that effect.  
 
4.5 PROTEIN S-NITROSYLATION AND ROS-DRIVEN 
 CARCINOGENESIS 
 
 Recognition that production of ROS/RNS is increased in cancer cells 
compared to normal cells has given rise to two potential therapeutic strategies - 
further increasing oxidative stress in tumor cells (elevating therapy) or reducing 
oxidative drive to redox-signaling (eliminating therapy) (Trachootham D et al, 2009; 
Wang J and Yi J, 2008). Each approach has its advantage and disadvantage. The 
advantage of increasing ROS is that cancer cells are already under oxidative stress 
from endogenous overproduction and thus any further increase in ROS stress could 
break the last straw (Jing Y et al, 2006; Kong Q et al, 2000; Schumacker PT, 2006; 
Trachootham D et al, 2006).  However, the downside is that if increase in ROS stress 
is not tumor specific, this could turn normal cells tumoriogenic or cause other serious 
side effects to major organs and systems (Halliwell B, 2007; Hershman DL and Shao 
T, 2009; Zhang YW et al, 2009). Moreover, if the treatment does not eliminate a 
cancer once and for all, additional ROS assault would cause further DNA damage and 
mutagenesis with new tumor traits and emerging drug resistance. On the other hand, 
the ROS reduction strategy is attractive in various aspects - it could restore aberration 
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in redox-signaling that benefits tumour cells, it is essentially harmless to normal cells 
and it could prevent further genomic instability and tumour evolution which are 
largely thought to be mediated by sustained ROS/RNS production. However, this 
approach has drawn some criticism. It is reasoned that existing mainstream anti-
cancer drugs employ ROS/RNS production as part of their cancer killing mechanism 
and thus introducing anti-oxidants could compromise therapeutic efficacies of anti-
cancer drugs (Conklin KA, 2002 & 2004; Moss RW, 2006; Salganik RI, 2001). This 
notion is countered by the findings that anti-oxidant indeed has proved to be a very 
effective adjuvant in cancer chemotherapy in terms of improved tumoricidal effects of 
drugs and reduced toxicity (side effects) to the patients (Bach SP et al, 2001; Block 
KI, 2004; Chinery R et al, 1997; Nargi JL et al, 1999; Simone CB 2nd et al, 2007).   
 Usually anti-oxidant approach in cancer therapeutics employs general anti-
oxidants such as N-acetyl-cysteine (NAC), and Vitamins such as Vitamin A and E 
(Bach SP et al, 2001; Byron KM et al, 2006; Nargi JL et al, 1999) and thus does not 
target any particular redox modifications or redox-signaling pathway. This could stem 
from the fact that the nature of oxidative modification caused by increased ROS/RNS 
in cancers is not fully understood. However, recently many targets of S-nitrosylation 
are implicated in various carcinogenic processes such as evasion of apoptosis by S-
nitrosylating caspases and Bcl-2 (Azad N et al, 2006; Chanvorachote P et al, 2006; 
Jiang Y et al, 2010; Mannick JB et al, 2001) and metabolic switch to glycolysis by S-
nitrosylating HIF1α (Li F et al, 2007; Palmer LA et al, 2007). One elegant study by 
Lim KH et al demonstrates that phosphorylation of eNOS at S1117 S-nitrosylates and 
activates Ras oncoproteins (H-Ras and N-Ras), which are required to initiate and 
maintain carcinogenesis. eNOS phosphorylation is carried out by K-Ras through 
PI3/Akt thus forming a Ras-eNOS-Ras feedback loop for tumor maintenance  (Lim 
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KH et al, 2008). More recently, increased protein S-nitrosylation as a result of 
GSONR inhibition is shown to interfere with DNA repair and promote 
hepatocarcinogenesis (Wei W et al, 2010).  
 Our current study provides additional evidence for the role of protein S-
nitrosylation in carcinogenesis. We demonstrated that increased ROS production in 
precancerous (MEF PTEN K/O) and breast cancer cells (MCF7) is associated with 
maintenance of protein S-nitrosylation under serum-deprived condition (Fig. 39 and 
Fig. 40). This in turn correlates with the phosphorylation status of Akt in which Akt 
remains phosphorylated after serum deprivation in MEF PTEN K/O and MCF7 cells 
but in not MEF WT (Fig. 41). This is probably carried out through S-nitrosylation of 
PTEN in the case of MEF WT vs MCF7 (Fig. 40 (A)). Serum deprived condition in 
our study could be considered as similar to nutrient deprivation occurring to some 
areas of cancer in vivo. In fact, PI3K/Akt is just one of the pathways targeted by S-
nitrosylation. There might be many other target proteins and pathways involved in 
maintaining cancer cells survival. This is evident in our result that shows involvement 
of a wide range of proteins (Fig 37(A)). Furthermore, in the same result, it is also 
obvious that degree of protein S-nitrosylation in MCF7 is higher than in MEF WT in 
both 10% FBS and 0.5% FBS conditions. This high level of protein S-nitrosylation in 
MCF7 might be responsible for the difficulty in de-nitrosylating proteins and 
dephosphorylating Akt with FeTPPS in MCF7 compared to MEF WT. Twenty four 
hours incubation of MEF WT with FeTPPS managed to de-nitrosylate proteins and 
dephosphorylate Akt but this has on effect on MCF7 (Fig. 42). Increased ROS/RNS 
production in MCF7, which involves O2˙-, H2O2 and NO˙, could provide continuous 
supply of ONOO- for stable S-nitrosylation to occur. Another possibility is that S-
nitrosylation in MCF7 is ONOO- independent.  In short, although we now know to 
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some extent according to previous studies and our current data that protein S-
nitrosylation is important for tumor maintenance (Chanvorachote P et al, 2006: Lim 
KH et al, 2008; Wang Z, 2012), the task of identifying relevant S-nitrosylating 
intermediates and/or denitrosylating target proteins for therapeutic purpose remains a 




 There is good evidence to support the role of O2˙- as a signaling molecule 
mediating various cellular functions. Increased production of O2˙- is associated with 
survival and proliferative advantages but the mechanistic insight into how O2˙- exerts 
all these effects is missing. In the current study, we demonstrate that O2˙- oxidizes 
proteins by S-nitrosylation through the formation of S-nitrosylating intermediate, 
ONOO- from O2˙- reacting with NO˙. This finding implies that previous observations 
made of O2˙- carrying out various signaling functions is effected through protein S-
nitrosylation.  There are many studies reporting signaling function of H2O2 in various 
in-vitro and in-vivo systems. The attraction of H2O2 as a thiol reactive molecule has 
made H2O2 as a model molecule to study oxidative modification of many proteins. 
But indiscriminate use of exogenous H2O2 results in the outcomes that do not 
distinguish between physiological signaling and oxidative stress. Our finding 
concerning oxidative modifications caused by various concentrations of H2O2 brings 
to light what redox modification is to be expected of non-toxic concentration of H2O2 
(SNO-modification) compared to the concentration that invariably causes oxidative 
stress (Non-SNO-modifications). Our biological system seems to prefer indirect way 
of oxidizing proteins by H2O2 through formation of ONOO- and S-nitrosylation to 
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protect itself from any potential harm until the system is overwhelmed under 
oxidative stress. Although it has been known that H2O2 induces NO˙ production in the 
cells, it is the first time we show that NO˙ produced by H2O2 participates in ONOO- 
formation and protein S-nitrosylation. Thus our data imply that previous observation 
of physiological functions of H2O2 could be carried out through protein S-
nitrosylation in contrast to pathological outcomes resulting from H2O2 toxicity that 
are most probably associated with non-SNO modifications. The same line of 
reasoning would apply to ONOO- as well. Previously, S-nitrosylation caused by 
ONOO- is highly underappreciated amidst overwhelming number of potential 
chemical reactions and recombination reaction and decomposition pathways of 
ONOO-. According to our results, the range of concentration of ONOO- (50uM to 
250uM) that is considered non-toxic and signal activating in the literature induces 
protein S-nitrosylation. In contrast, we also demonstrate that toxic and signal 
inhibitory concentration of ONOO- (1mM) is associated with 3-nitrotyrosine 
formation and non-SNO modifications. Therefore, it appears that physiological and 
pro-survival cell signaling activity occurs only at low-range concentration of any 
oxidants - be it O2˙-, H2O2 or ONOO-, all inducing protein S-nitrosylation. The notion 
is further supported by our studies on growth factors-induced protein S-nitrosylation 
in which PDGF could only produces low concentration of H2O2 regardless of 
concentration of PDGF used and consistently induces protein S-nitrosylation. Another 
important finding is that ONOO- not only mediates protein S-nitrosylation but also it 
is required for signal transduction. Once it is removed, PI3K/Akt signal activation by 
low level oxidants and PDGF is stopped thus reinforcing the fact that it is a 
physiologically relevant radical produced during cell signaling. We also highlight the 
consequences of disturbing O2˙-/NO˙ balance such as removing NO˙ alone could be 
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effective in preventing S-nitrosylation but it would cause oxidative stress with 
damaging consequences, and ineffectiveness of removing O2˙- alone to stop pro-
survival signaling as the latter could continue by ONOO--independent but NO˙-
dependent S-nitrosylation. Since S-nitrosylation facilitates growth signaling, we also 
investigated its role in perturbation of growth signaling - tumoriogenesis. We 
demonstrate that when cells evolve from normal to pre-cancerous state and tumor, 
there is an increase in protein S-nitrosylation that is particularly pronounced in the 
absence of serum. That increased S-nitrosylation status in serum deprived condition 
correlates with increased ROS production and sustained activation of survival kinase 
Akt suggesting that protein S-nitrosylation contributes to serum independent growth 
and survival of cancers.  However there are a few questions remained to be answered. 
Firstly, increased protein S-nitrosylation is demonstrated only in one precancerous 
and one cancer cell line. Therefore, it is important to find out prevalence of this form 
of protein modification across various cancer types. Secondly, as signaling pathways 
differ from one stage of tumor to the other so could be S-nitrosylation. It would thus 
be interesting to look for any relationship between S-nitrosylation status and cancer 
staging. Thirdly, if de-nitrosylation is to be effectively and safely employed for anti-
cancer treatment, it would be critical to find out what relevant S-nitrosylating 
intermediate(s) is (are) involved in order to selectively target S-nitrosylation, instead 
of removing NO˙, which has various important functions in normal physiology. 
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